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ABSTRACT 
Interleukin-2 (IL-2) is an important mediator in the vertebrate immune system. IL-2 is a 
potent growth factor that mature T lymphocytes use as a proliferation signal and the production of 
IL-2 is crucial for the clonal expansion of antigen-specific T cells in the primary immune response. 
IL-2 driven proliferation is dependent on the interaction of the lymphokine with its cognate 
multichain receptor. IL-2 expression is induced only upon stimulation and transcriptional 
activation of the IL-2 gene relies extensively on the coordinate interaction of numerous inducible 
and constitutive trans-acting factors. Over the past several years, thousands of papers have been 
published regarding molecular and cellular aspects ofiL-2 gene expression and IL-2 function. The 
vast majority of these reports describe work that has been carried out in vitro. However, 
considerably less is known about control of IL-2 gene expression and IL-2 function in vivo. 
To gain new insight into the regulation of IL-2 gene expression in vivo, anatomical and 
developmental patterns of IL-2 gene expression in the mouse were established by employing in situ 
hybridization and immunohistochemical staining methodologies to tissue sections generated from 
normal mice and mutant animals in which T -cell development was perturbed. Results from these 
studies revealed several interesting aspects of IL-2 gene expression, such as ( 1) induction of IL-2 
gene expression and protein synthesis in the thymus, the primary site ofT-cell development in the 
body, (2) cell-type specificity of IL-2 gene expression in vivo, (3) participation of IL-2 in the 
extrathymic expansion of mature T cells in particular tissues, independent of an acute immune 
response to foreign antigen, (4) involvement of IL-2 in maintaining immunologic balance in the 
mucosal immune system, and (5) potential function of IL-2 in early events associated with 
hematopoiesis. 
Extensive analysis of IL-2 mRNA accumulation and protein production in the murine 
thymus at various stages of development established the existence of two classes of intrathymic 
IL-2 producing cells. One class of intrathymic IL-2 producers was found exclusively in the fetal 
thymus. Cells belonging to this subset were restricted to the outermost region of the thymus. IL-2 
expression in the fetal thymus was highly transient; a dramatic peak of IL-2 mRNA accumulation 
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was identified at day 14.5 of gestation and maximal ll...-2 protein production was observed 12 
hours later, after which both ll...-2 mRNA and protein levels rapidly decreased. Significantly, the 
presence of IL-2 expressing cells in the day 14-15 fetal thymus was not contingent on the 
generation ofT-cell receptor (TcR) positive cells. The second class of ll...-2 producing cells was 
also detectable in the fetal thymus (cells found in this class represented a minority subset of ll...-2 
producers in the fetal thymus) but persist in the thymus during later stages of development and 
after birth. Intrathymic ll...-2 producers in postnatal animals were located in the subcapsular region 
and cortex, indicating that these cells reside in the same areas where immature T cells are 
consigned. The frequency of ll...-2 expressing cells in the postnatal thymus was extremely low, 
indicating that induction of ll...-2 expression and protein synthesis are indicative of a rare activation 
event. Unlike the fetal class of intrathymic ll..-2 producers, the presence of ll..-2 producing cells in 
the postnatal thymus was dependent on to the generation of TcR+ cells. Subsequent examination 
of intrathymic ll...-2 production in mutant postnatal mice unable to produce either ~ or '(0 T cells 
showed that postnatal IL-2 producers in the thymus belong to both ex~ and y~ lineages. 
Additionally, further studies indicated that ll...-2 synthesis by immature cxi3-T cells depends on the 
expression of bonafide TcR ~-heterodimers. Taken altogether, ll...-2 production in the postnatal 
thymus relies on the generation of~ or yO-TcR+ cells and induction of ll...-2 protein synthesis can 
be linked to an activation event mediated via the TcR. 
With regard to tissue specificity of ll...-2 gene expression in vivo, analysis of whole body 
sections obtained from normal neonatal mouse pups by in situ hybridization demonstrated that ll...-2 
mRNA + cells were found in both lymphoid and nonlymphoid tissues with which T cells are 
associated, such as the thymus (as described above), dermis and gut. Tissues devoid of ll...-2 
mRNA+ cells included brain, heart, lung, liver, stomach, spine, spinal cord, kidney, and bladder. 
Additional analysis of isolated tissues taken from older animals revealed that ll...-2 expression was 
undetectable in bone marrow and in nonactivated spleen and lymph nodes. Thus, it appears that 
extrathymic ll...-2 expressing cells in nonimmunologically challenged animals are relegated to 
particular epidermal and epithelial tissues in which characterized subsets of T cells reside and that 
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induction of II....-2 gene expression associated with these tissues may be a result ofT -cell activation 
therein. 
Based on the neonatal in situ hybridization results, a detailed investigation into possible 
induction of Il...-2 expression resulting in IL-2 protein synthesis in the skin and gut revealed that 
IL-2 expression is induced in the epidermis and intestine and IL-2 protein is available to drive cell 
proliferation of resident cells and/or participate in immune function in these tissues. Pertaining to 
IL-2 expression in the skin, maximal II.....-2 mRNA accumulation and protein production were 
observed when resident V13+ T-cell populations were expanding. At this age, both IL-2 mRNA+ 
cells and II.....-2 protein production were intimately associated with hair follicles. Likewise, at this 
age a significant number of CD3e+ cells were also found in association with follicles. The 
colocalization of Il...-2 expression and CD3e+ cells suggests that Il...-2 expression is induced when T 
cells are in contact with hair follicles. In contrast, neither IL-2 mRNA nor IL-2 protein were 
readily detected once T -cell density in the skin reached steady-state proportions. At this point, T 
cells were no longer found associated with hair follicles but were evenly distributed throughout the 
epidermis. In addition, IL-2 expression in the skin was contingent upon the presence of mature T 
cells therein and induction of Il...-2 protein synthesis in the skin did not depend on the expression of 
a specific TcR on resident T cells. These newly disclosed properties of Il...-2 expression in the skin 
indicate that Il...-2 may play an additional role in controlling mature T-cell proliferation by 
participating in the extrathymic expansion of T cells, particularly those associated with the 
epidermis. 
Finally, regarding IL-2 expression and protein synthesis in the gut, IL-2 producing cells 
were found associated with the lamina propria of neonatal animals and gut-associated IL-2 
production persisted throughout life. In older animals, the frequency of IL-2 producing cells in the 
small intestine was not identical to that in the large intestineand this difference may reflect regional 
specialization of the mucosal immune system in response to enteric antigen. Similar to other 
instances of IL-2 gene expression in vivo, a failure to generate mature T cells also led to an 
abrogation of IL-2 protein production in the gut. The presence of Il...-2 producing cells in the 
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neonatal gut suggested that these cells may be generated during fetal development. Examination of 
the fetal gut to determine the distribution of ll..-2 producing cells therein indicated that there was a 
tenfold increase in the number of gut-associated ll..-2 producers at day 20 of gestation compared to 
that observed four days earlier and there was little difference between the frequency of ll..-2 
producing cells in prenatal versus neonatal gut. The origin of these fetally-derived ll..-2 producing 
cells is unclear. Prior to the immigration ofll..-2 inducible cells to the fetal gut and/or induction of 
ll..-2 expression therein, ll..-2 protein was observed in the fetal liver and fetal omentum, as well as 
the fetal thymus. Considering that induction of ll..-2 protein synthesis may be an indication of 
future functional capability, detection of ll..-2 producing cells in the fetal liver and fetal omentum 
raises the possibility that ll..-2 producing cells in the fetal gut may be extrathymic in origin and ll..-2 
producing cells in these fetal tissues may not belong solely to the T lineage. Overall, these results 
provide increased understanding of the nature of ll..-2 producing cells in the gut and how the 
absence of ll..-2 production therein and in fetal hematopoietic tissues can result in the acute 
pathology observed in ll..-2 deficient animals. 
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INTRODUCTION 
Background 
The vertebrate immune system relies chiefly on the activities of functional B and T 
lymphocytes. B cells produce antibodies that constitute the humoral immune response, while T 
cells participate primarily in regulating antibody production, rejecting foreign tissue grafts, and 
eliminating virus-infected cells. B and T cells arise from pluripotent stem cells that are capable of 
giving rise to all blood cell lineages. These hematopoietic stem cells (HSCs) are derived from the 
blood islands of the yolk sac and fetal liver during embryonic life and the bone marrow during 
postnatal life. Unlike B cells, which develop at the site where HSCs are generated, T cells require 
a specialized microenvironment outside the fetal liver or bone marrow in order to develop. T -cell 
precursors immigrate from the fetal liver or bone marrow to the thymus, an organ that is 
ectodermal and endodennal in origin. Once in the thymic microenvironment, "prothymocytes" 
undergo a series of phenotypic changes that is accompanied by marked cell proliferation. During 
this period, genes encoding the T-cell receptor for antigen (TcR) rearrange in a highly ordered 
fashion. The ensuing expression of TcR on the cell surface results in the termination of 
proliferation. After this point, the majority of thymocytes are subject to programmed cell death 
(PCD), whereas only a small fraction of cells are "selected" to mature and become functional T 
cells. Mature T cells must be capable to carry out specific genetic programs including the synthesis 
of cytokines upon activation by foreign antigen and/or molecules utilized in cell-mediated 
cytotoxicity. Since this functional capacity must be acquired during development, it is crucial to 
determine the stage at which developing thymocytes are capable of expressing genes characteristic 
of a mature phenotype and whether immature cells express any of these genes during the course of 
development. 
One such gene that has been studied extensively over the years, in terms of regulation in 
both mature T cells and developing thymocytes, is interleukin-2 (IL-2). IL-2 was one of the first 
lymphokines to be identified and was initially described as a soluble factor present in culture 
supernatants of phytohemagglutinin (PHA)-stimulated bone marrow cells capable of stimulating 
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T-cell proliferation (1). Interaction of IL-2 with its cell surface receptor (IL-2R) is crucial for the 
clonal expansion of activated T cells, resulting in amplification of the antigen specific T-cell 
immune response. Recently, a number of reviews have specifically addressed numerous aspects 
of IL-2 gene expression (2, 3), IL-2 function (4), and IL-2-induced signal transduction pathways 
(5). 
Although extensive in vitro studies have been carried out to further understanding of IL-2 
gene regulation, proportionally fewer studies to examine IL-2 gene expression and function in vivo 
have been performed. With the advent of transgenic and gene knockout technologies, as well as 
utilization of natural occurring mutations in the mouse yielding immunodeficient or 
immunocompromised animals, it has been possible to penurb T -cell development in vivo with 
relative ease to study the impact of such manipulation on the expression ofT -cell "function" genes, 
such as IL-2, both in vitro and in vivo. The disruption of IL-2 gene expression in vivo produced 
several interesting results. In initial studies (6), it was shown that IL-2 was not necessary for the 
generation of the major thymocyte populations (i.e., the lack of ll...-2 did not overtly affect T-cell 
development), and peripheral T cells isolated from homozygous knockout animals were unable to 
produce IL-2 upon activation. Later, it was reponed that older mutant animals exhibit 
splenomegaly, lymphoadenopathy and severe anemia and/or develop ulcerative colitis with high 
penetrance (7). Thus, these results demonstrate that IL-2 is not required at any panicular stage of 
T-cell development, but that an apparent lack ofiL-2 expression subsequently results in defects in 
hematopoiesis and deregulation of the mucosal immune system which leads to inflammatory bowel 
disease (ffiD). 
Experimental Considerations 
The IL-2 disruption studies are highly informative, yet they provide little information on the 
following issues that are vital to understanding IL-2 gene expression in vivo. First, even though 
IL-2 is not essential for in the generation of predominant thymocyte subsets, it is unclear if 
thymocytes are induced to express IL-2 during the course of development. This is of panicular 
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interest for several reasons. The intrinsic competence to induce IL-2 gene expression is shared by 
both mature and very immature thymocytes, but the yas.t majority ofT -lineage cells generated in the 
thymus refractory to signals that would otherwise result in the induction of IL-2 gene expression in 
competent cells. Hence during the generation of functional T cells, it is crucial that thymocytes, 
which are selected to mature, regain the functional competence. This would include the ability to 
express the IL-2 gene. Therefore, if IL-2 is indeed induced in thymocytes in vivo, this not only 
raises the possibility that IL-2 is present in the thymus to exert autocrine and paracrine effects, but 
also suggests that thymocytes may exercise functional competence during their development. The 
acquisition and/or maintenance of functional competence during thymocyte development as 
indicated by the ability to induce IL-2 gene expression technically cannot be answered by studying 
IL-2 -/- mice alone. 
Second, the disruption studies do not address the question whether cell types other than 
those belonging to the T lineage express IL-2 in vivo. Induction of IL-2 gene expression appears 
to be a property exhibited exclusively by T cells in vitro and has classically been considered a 
functional marker for T -lineage cells. In addition, the induction of IL-2 gene expression requires 
the coordinate action of T -cell specific and ubiquitous transcription factors. However, it is 
uncertain that cell-type specificity of IL-2 gene expression is maintained in vivo. Identification of 
cell types that express IL-2 in vivo would provide insight into the regulation of IL-2 in the animal 
proper. 
Finally, it is not known whether IL-2 is involved in the expansion of particular extrathymic 
populations ofT cells or whether IL-2 is expressed in a nonimmunologically challenged animals. 
IL-2 mediates the rapid proliferation of antigen-specific T cells and clonal expansion ofT cells is a 
crucial event for the success of the primary immune response. Notwithstanding, questions remain 
largely unanswered with regard to a potential role for IL-2 in the extrathymic expansion ofT cells 
to populate the tissues in which they reside. Establishing the pattern of IL-2 gene expression in 
certain tissues where T cells are located as a function of development would help resolve these 
issues. 
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The body of work presented here focuses on experiments designed to answer these 
questions. In the following chapters, studies pertaining to IL-2 gene expression in the thymus, 
specificity of IL-2 gene expression in vivo, and extrathymic sites of IL-2 gene expression in 
nonimmunized animals will be described. Before proceeding further, a review of molecular and 
cellular aspects of ll...-2 gene expression (including information on how T-cell activation influences 
the induction of ll...-2 gene expression), as well as a summary of salient points and events during T-
cell development will be given. 
Molecular Aspects of IL-2 Gene Expression 
Signal Transduction Pathways Crucial for the Induction of IL -2 Gene Expression 
In general, the expression of specific genes involved in the functional T -cell response is 
contingent upon T-cell activation. IL-2 gene expression is completely dependent on T-cell 
stimulation, and this is one of the major ways that stimulation regulates the immune system. 
Antigenic stimulation ofT cells initiates the appropriate signal transduction cascade that eventually 
results in the transient transcriptional activation of response genes, including IL-2. It should be 
noted that activation via the TcR can be bypassed using pharmacological agents that mimic 
activation by triggering the signal transduction pathways directly. Engagement of the TcR is 
crucial forT-cell activation. Specifically, T cells cannot be activated by native, intact antigen. The 
TcR exclusively recognizes small peptides generated from processed antigen (9-11 amino acids in 
length) embedded in the cleft of a major histocompatibility complex (MHC) molecule (8) on the 
surface of antigen presenting cells (APCs). The recognition of antigenic peptide/MHC by the TcR 
is further facilitated by the interaction of CD4 or CD8 coreceptors with invariant portions of MHC 
class II or MHC class I molecules, respectively. Finally, although engaging the TcR is crucial for 
T-cell activation, the interaction of other cell surface molecules, especially CD28, is necessary for 
the induction of IL-2 gene expression (to be discussed later). 
The TcR complex itself is composed of numerous polypeptide chains which can be 
separated into antigen recognition and signal transduction subunits. Antigen (plus MHC) 
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recognition is specified by the disulfide-linked aJ3 or -yO heterodimer. Diversity of the a, J3, y, or o 
TcR genes is generated by combinatorial joining of variable (V), diversity (D), joining (J), and 
constant (C) gene segments during T-cell development (9). The cytoplasmic domains of these 
chains are short (5 residues for a and J3 chains) and are not believed to be involved in signaling, per 
se. The aJ3 or -yO heterodimers are noncovalently linked to invariant CD3y, o, e chains and a C 
chain homodimer or CTI heterodimer. Though the exact stoichiometry of these CD3 chains within 
the TcR complex remains unknown, each aJ3 or -yO heterodimer is thought to be associated with a 
CD3-ye and a CD3oe dimer (10). The cytoplasmic domains of the CD3 chains are substantially 
longer (40 to 113 residues) than those of the TcRa, J3, y, and 8 chains and are responsible for 
coupling the antigen-recognition subunits to the intracellular signal transduction machinery (10). 
TcR-Dependent PTK Activation 1: Participation of Src PTK Family Members 
Protein tyrosine phosphorylation is vital for the initiation of cellular responses following the 
interaction of the TcR with antigen plus MHC. The CD3 subunits do not have intrinsic protein-
tyrosine kinase (PTK) activity. However, the cytoplasmic domains of all CD3 subunits contain 
common sequences that are responsible for interacting with cytoplasmic PTKs of the Src and non-
Src classes. A sequence motif, initially described by Reth (11), is characterized by paired tyrosine 
and leucine (or isoleucine) residues; the consensus sequence consists of (D!E)XXYXXL(X)6-
8YXXL. This sequence is commonly referred to as the antigen recognition activation motif (AR-
AM). ARAMs are found in single copies in the CD3y, o, and e chains and are triplicated in the C 
chain. The multiplicity/redundancy of ARAMs with the TcR may serve to increase the efficiency 
of signal transduction by quantitatively increasing the ability of the TcR to bind and mobilize 
cytoplasmic PTKs (10). 
Several Src family members have been shown to be expressed in T cells; two members, 
Lck and Fyn, have been studied extensively. Lck and Fyn are 56% homologous at the amino acid 
level and both exhibit increased PTK activity following TcR stimulation (12-14). Lck (MW, 56 
kD) interacts at high stoichiometry with the cytoplasmic domains of either CD4 or CD8 (15, 16). 
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The association of Lck with CD4 or CD8 coreceptors could serve as a means by which Lck is 
brought into proximity of ARAMs within the TcR following TcR/coreceptor interaction with 
antigen/MHC. Lck can be activated solely by CD4 or CD8 crosslinking, but Lck activation in itself 
is insufficient to lead toT-cell activation (16, 17); in some cases, ligation of coreceptors alone 
frequently renders cells refractory to subsequent activation through the TcR (18). This may 
represent a form of regulation that necessitates coincident engagement of the TcR with 
antigen/MHC and coreceptor with MHC in order for T-cell activation to occur, thereby 
safeguarding against "spurious" activation should CD4 or CD8 interact with MHC alone in the 
absence of the appropriate TcR-antigen/MHC interactions. On the other hand, Fyn (MW, 59 kD) 
associates with the TcR at relatively low frequency. Of these two PTKs, the role of Lck in T-cell 
activation (and T-cell development) is more fully realized than that ofFyn. 
Although Lck generally associates with CD4 and CD8, it has been shown that in the 
absence of coreceptor expression, Lck can directly associate with CD3 (19). This indicates that 
Lck may possess an intrinsic affinity for ARAMs in CD3. Additionally, Lck is able to interact with 
other cell surface receptors that lack ARAMs, suggesting that Lck may be utilized in signal 
transduction pathways other than those that are strictly TcR/CD3 dependent. For example, Lck 
may participate in ll...-2 dependent signal transduction via interaction with the !3-chain of the ll..-2R; 
this notion is further supported by observations showing increased PTK activity and modification 
(serine/threonine phosphorylation) ofLck following IL-2 stimulation (20, 21). 
The roles of Lck and Fyn in TcR signal transduction have been examined using genetic and 
biochemical approaches. Both lck and.f.yn genes have been disrupted in mice (22, 23). Whereas 
mice deficient in Lck have a block early in T -cell development, animals homozygous for a 
disrupted.fyn gene exhibited no gross alterations in T-cell development (the function of Lck in T-
cell development will be discussed later). Additionally, the few peripheral T cells that develop in 
animals lacking Lck activity have diminished responses to TcR stimulation (22). The lck knockout 
data are further supported by work done with T-cell lines and clones which lack Lck kinase 
activity, demonstrating an abrogation of early and late events associated with TcR-mediated signal 
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transduction, such as TcR-dependent intracellular calcium flux (24), and cytolytic effector 
functions (25), respectively. In contrast, the absence of Fyn activity has a less pronounced effect 
on TcR-dependent signaling; even though mature thymocytes (thymocytes that are phenotypically 
similar to peripheral T cells) isolated from Fyn deficient mice showed a TcR signaling defect, both 
immature TcR+ thymocyte and peripheral T-cell populations were not profoundly affected (23). 
Nonetheless, Fyn does appear to be involved in TcR signal transduction, based on data obtained 
from overexpression of wild-type Fyn in transgenic mice (26) or overexpression of a constitutively 
activated form of Fyn in a T -cell hybridoma (27), resulting in the generation of altered cells that 
were hyperresponsive to TcR stimulation. Thus, Fyn appears to be involved in TcR-dependent 
signaling, but unlike Lck, its activity appears to be dispensable. 
Lck and Fyn activation is also highly regulated by inhibiting PTPases. Src PTKs are 
negatively regulated by Csk, a widely expressed PTK that is itself structurally homologous to Src 
PTKs (28). Evidence suggests that dephosphorylation of the negative regulatory sites in Lck and 
Fyn is dependent upon the presence of the CD45 PTPase. This PTPase (MW, 180-220 kD) is 
differentially expressed on all cells of the hematopoietic lineage except fully differentiated erythroid 
cells; the various isoforms of CD45 PTPase are generated by alternative splicing (the regulation of 
differential splicing/cell type specificity and function of the different extracellular domains of CD45 
isoforms has yet to be established). On T cells, two isoforms are predominantly utilized, CD45RB 
and CD45RO, which are expressed on resting/virgin and activated T cells, respectively. CD45 is 
also expressed on thymocytes, but its role in T -cell development is not well understood. The 
CD45 PTPase is involved in early events in T-cell signal transduction, including the induction of 
PTK activity as indicated by genetic evidence gathered from studies using T -cell lines deficient in 
CD45 expression (29,30). Likewise, in mice that are homozygous for a disrupted CD45 gene, T-
cell development is blocked at the CD4/CD8 double positive stage, resulting in a reduced number 
of peripheral T cells; the T cells that manage to mature in these mutant animals exhibit a gross 
defect in TcR-mediated responses (31). Finally, in vitro reconstitution studies have shown that 
CD45 can dephosphorylate Lck, leading to the activation of PTK catalytic function by rendering 
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Lck accessible to phosphorylation substrates (32). Thus, dephosphorylation of Lck (and 
presumably Fyn) appears to be an important step in initiating the TcR signal transduction cascade. 
TcR-Dependent PTK Activation II: Involvement of Syk/ZAP-70 Class PTKs 
As mentioned previously, PTKs of the Src and non-Src families are believed to be crucial 
for TcR function. The second class, the Syk/ZAP-70 class, differs from the Src class in numerous 
ways. Unlike Src class PTKs that possess a myristilated N-terminus, Syk (expressed 
preferentially in B cells) and ZAP-70 (expressed exclusively in T cells) are not myristylated and are 
most likely not constitutively associated with the plasma membrane. Additionally, Syk!ZAP-70 
family members contain two N-terminal SH2 domains, but lack an SH3 domain and C-terminal 
negative regulatory tyrosine phosphorylation site, indicating that this class of PTKs is not under 
identical regulation as the Src class PTKs (10). 
ZAP-70 has been shown to be directly associated with the TcR upon stimulation. In the 
basal state, ZAP-70 is not associated with the TcR, but is rapidly bound to phosphorylated forms 
of~ and CD3 chains following TcR stimulation (33). ARAMs are directly involved in recruiting 
ZAP-70 to the TcR (34 ); reciprocally, the SH2 domains of ZAP-70 are essential for the interaction 
of this PTK with phosphorylated ARAMs (35). These data also indicate that in order to ZAP-70 to 
interact with the TcR, the TcR must be modified by tyrosine phosphorylation prior to ZAP-70 
association. 
The likely candidates for PTKs that modify ~ and CD3 chains before ZAP-70 mobilization 
to the TcR are Lck and Fyn. The Lck/Fyn-ZAP-70 relationship has been examined using a 
heterologous Cos cell system in which specific components involved in T -cell activation can be 
studied in relative isolation. For example, Cos cells expressing ZAP-70 and a chimeric receptor 
containing a large portion of the ~ cytoplasmic domain must also be cotransfected with Lck or Fyn 
in order for ZAP-70 to associate with sequences following receptor crosslinking (36). The 
expression of either Lck or Fyn, but not ZAP-70 alone, in this system results in detectable 
~-domain phosphorylation. Based on these and other data, a sequential model of PTK activities 
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has been proposed (10). After receptor-ligand interaction, ARAMs in the TcR are phosphorylated 
by a Src family PTK, followed by ZAP-70 association with modified CD3 subunits. In addition, 
ZAP-70 is also modified by tyrosine phosphorylation following mobilization to the TcR (34). The 
mechanism by which ZAP-70 is modified is not known; it is unclear if ZAP-70 is subject to direct 
or indirect phosphorylation by Lck or Fyn or to autophosphorylation. Likewise, the effect of 
phosphorylation on ZAP-70 function is not understood (10). Nevertheless, the stepwise activation 
of PTKs, beginning with Lck (and Fyn) dephosphorylation and leading to ZAP-70 mobilization 
and modification is essential for TcR mediated signaling. 
Finally, ZAP-70 has been shown to be essential for TcR-mediated signal transduction. It 
was reported recently that patients with selective T-cell deficiency (SID) were homozygous for an 
insertional mutation in the ZAP-70 gene (37). The lack of ZAP-70 had a profound effect on T-cell 
development (to be discussed later) and peripheral T cells isolated from afflicted individuals 
exhibited a marked decrease in tyrosine phosphorylation and a failure to produce IL-2 and to 
proliferate in response to T -cell receptor stimulation by mitogens and antigen. The decrease in 
PTK activity in SID patients led to a reduction of both PLCyl phosphorylation (fivefold decrease 
composed to controls) and intracellular calcium flux (40% of normal) that have a direct bearing on 
IL-2 gene expression (see below). Thus, this genetic evidence indicates that ZAP-70 is 
indispensable for TcR signaling and T-cell function. 
Generation of Second Messengers 
Numerous events downstream of TcR-dependent PTK activation are implicated in specific 
T -cell responses, including transcriptional initiation of IL-2 gene expression. One such event is the 
activation of the phosphatidyl inositol (PI) pathway (38). Inositol phospholipid 
metabolism/turnover is contingent upon the activation of phospholipase Cyl (PLCyl) which 
catalyzes the hydrolysis of PI 4,5-bisphosphate yielding inositol 1,4,5-trisphosphate (IP3) and 
diaglycerol (DAG); for TcR-mediated signaling, activation of PLCyl appears to occur in a G-
protein-independent manner. These second messengers are responsible for the rapid rise and 
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sustained pulses in intracellular free calcium ([Ca2+]i) and the activation of protein kinase C 
(PTK), respectively. Induction of TcR-dependent PLC activity relies on tyrosine phosphorylation 
of PLCy1 (39, 40). In this case, the manner by which PLCy1 becomes phosphorylated is not well 
understood. Although PLCy1 is mobilized to PTK growth factor receptors via interaction of its 
SH2-domain to a tyrosine phosphorylated receptor, the actual mobilization of PLCy1 to the TcR 
has not been readily detected (10). Likewise, it has been reported that PLCy1 can 
coimmunoprecipitate with Lck (41) and PLCy1 activation requires Lck function (24, 40), but it 
remains unclear whether Lck activity is directly or indirectly responsible for the activation of 
PLC1. 
The Importance of [Ca2+]i in Regulating Transcriptional Activation of the IL-2 
Gene 
Activation of PLCy1 leads to a release of [Ca2+] from intracellular stores along with an 
influx of [Ca2+] from the exterior, resulting in a rapid and sustained rise in [Ca2+]i. Such an 
increase is thought to be responsible for regulating calcium/calmodulin-dependent events, including 
the induction of IL-2 gene transcription. Studies focusing on the action of immunosuppressive 
drugs on T-cell activation and function have been highly useful in dissecting the mechanism(s) by 
which increased [Ca2+]i regulates events associated with T-cell activation, especially IL-2 gene 
expression. The mode of action of immunosuppressive drugs on T -cell function has been 
reviewed recently (42). Cyclosporin A (CsA), FK506, and rapamycin have been used extensively 
to prevent graft rejection following organ transplantation and exert their immunosuppressive 
activity by primarily inhibiting the T -cell specific expression of lymphokine genes, foremost of 
which is IL-2. FK506 and rapamycin possess considerable structural similarity, but are 
substantially dissimilar to CsA.. Nonetheless, CsA and FK506 exhibit similar effects on T-cell 
function (it should be noted that the effects of rapamycin on T-cell function is not identical to those 
of either CsA or FK506). The intracellular targets of CsA and FK506 are known as 
immunophilins; CsA and FK506. Cyclophilins and FKBPs share little sequence homology, but 
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both types of immunophilins are cis-trans peptidyl-prolyl isomerases and binding of CsA and 
FK506 inhibits isoserase activity (43-46). Immunophilins are widely distributed amongst various 
tissues and are believed to function in vivo by stabilizing nonnative conformations of proline-
containing proteins. Biologically active drug-immunophilin complexes bind at high affmity to the 
Ca2+ and calmodulin-dependent serine phosphatase, calcineurin; calcineurin is activated as a result 
of increased [Ca2+]; upon T-cell stimulation and its activity is crucial for the transcriptional 
regulation of IL-2 gene expression. Binding of drug-immunophilin complexes to a common site 
on the calcineurin molecule effectively inhibits PTPase activity ( 47). The resulting inhibition of 
calcineurin activity has a profound effect on IL-2 gene expression (see below). Significantly, 
overexpression of calcineurin renders T -cell activation more resistant to immunosuppressive drugs 
(48 and [Ca2+]i; dependence following T-cell activation can be overcome by the expression of a 
deregulated subunit of calcineurin (49), both of which would have marked effects on the induction 
of IL-2 gene expression. 
As mentioned above, the transcriptional activation of the IL-2 gene is highly dependent on 
the PTPase activity of calcineurin. Calcineurin is involved in the translocation ofT-cell specific 
transcriptional activators that are essential for IL-2 gene expression from the cytoplasm into the 
nucleus. The vital target of calcineurin dephosphorylation in this process is the cytosolic 
component of nuclear factor of activated T cells (NF A Tc ). The exact mechanism by which NF A Tc 
is translocated from the cytoplasm to the nucleus is not known, i.e., it remains speculative with 
regard to whether NFATc is directly or indirectly dephosphorylated by calcineurin. 
To elaborate, NFAT is an inducible DNA-binding protein that recognizes two independent 
sites in the IL-2 promoter (NFAT-proximal and NFAT-distal binding sites; 50, 51). NFAT is a 
multisubunit transcription factor (52), consisting of at least three DNA-binding polypeptides: a 
pre-existing subunit, NFATc (as mentioned above), and a combination of minimally 2 components 
of AP-1 (52-61). The nuclear-associated/CsA-insensitive components of NFAT (i.e., Fos and Jun 
family members and Fos-related proteins) are apparently activated by a pathway involving Ras 
(outlined in 1 0). In contrast, NF A Tc is restricted to the cytosolic fraction of unstimulated T cells; 
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following T-cell activation, it is present in nuclear extracts and forms DNA-protein complexes with 
Fos and Jun family members and specific fos-related proteins (57-59). In addition, NFAT may be 
utilized in the transcriptional activation of other lymphokine genes, including the genes encoding 
granulocyte-macrophage colony-stimulating factor (GM-CSF), ll.--3, ll.--4, and tumor necrosis 
factor-a (TNF-a) (62-65). It was reported recently that NFATc has been cloned; sequence 
analysis revealed that NFATc has a predicted MW of 97 kD and the isolation and sequencing of 
additional eDNA clones indicate that T cells express several forms ofNFATc related to each other 
by alternative splicing and differing at their COOH-termini (60; as an aside, it would be highly 
interesting to determine the relative abundance of these NF A Tc isoforms in different populations of 
immature and mature T cells to see if a correlation between the ratio of different isoforms and the 
differential regulation of lymphokine gene expression). 
NFAT binding activity is crucial for the transcriptional activation of the ll..--2 gene. Indeed, 
multimers of NF AT -binding sites alone are sufficient to drive tissue-specific and TcR activation-
dependent expression of a recorder gene (62). However, other inducible and constitutive trans-
acting factors are involved in the coordinate transcriptional regulation of the actual ll..--2 gene. 
Significantly the minimal ll..--2 promoter in mouse and human (share 86% identity throughout 
approximately 580 bp of 5'-flanking region (63). Within this region are densely packed and 
frequently overlapping recognition sites for numerous DNA-binding proteins (reviewed in 64), 
including NF-rl3 or TcF-1 (65-67), AP-1 (53, 68), Oct-1 and other octamer-binding proteins (69), 
NFAT (as mentioned previously), and CD28RC or the CD28 response element (CD28RE) binding 
factor (70, 71; the importance of CD28 in T-cell activation and the regulation of ll..--2 gene 
expression will be discussed later). The DNA-binding activities of several of these factors (NF-
KB, CD28RC, NFAT, and AP-1) partitioned differentially in different subsets of developing 
thymocytes, as defined by electrophoretic mobility shift assays (72). The distribution of inducible 
DNA-binding factors in these subsets reflected the ability (or inability) of developing thymocytes to 
induce ll...-2 gene expression in vitro. Additionally, in vivo footprinting of the ll...-2 gene in an llr2 
expressing murine thymoma revealed several interesting aspects about the transcriptional activation 
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of the IL-2 gene (73). In these studies, additional inducible DNA-binding sites of (as of yet) 
unidentified factors were uncovered. Likewise, transcriptional activation of the IL-2 gene in 
stimulated cells was dependent on the coordinate binding of all trans-acting factors. In 
unstimulated or CsA-treated cells, the IL-2 promoter was completely unoccupied (i.e., no 
footprints were observed), thereby indicating that not only is translocation of NFATc to the 
nucleus CsA-sensitive, but formation of stable DNA-protein complexes at the remaining factor 
binding sites in the IL-2 promoter appears to be CsA-sensitive as well (72). 
Negative Regulation of IL-2 Gene Transcription 
The transcriptional regulation of IL-2 gene expression is also under stringent negative 
regulation. As indicated above, an increase in intracellular cAMP is able to suppress T-cell 
proliferation; suggestion is achieved by blocking IL-2 production (74-77). Besides being able to 
overcome cAMP-induced inhibition of IL-2 production by CD28 costimulation (see below; 78-80), 
IL-2 gene expression can be rendered insensitive to a forskolin-induced increase in intracellular 
cAMP by the expression of a dominant-negative mutant regulatory subunit of adenylate cyclase 
(81). Previous in vivo footprinting studies showed that complexes at the IL-2 promoter in 
stimulated IL-2 expressing cells are stable for more than 12 hours (73). Recently, it was reported 
that forskolin did not block the initial assembly of transcription-related complexes at the IL-2 
promoter, however, forskolin treatment caused an accelerated destabilization of the transcription 
apparatus, as indicated by the disappearance of inducible footprints at the IL-2 promoter four to six 
hours following stimulation (81) (in cells expressing the mutant regulatory subunit of adenylate 
cyclase, inducible footprints were resistant to forskolin-induced destabilization). Hence, CsA and 
increased intracellular cAMP have different effects on the transcriptional regulation of IL-2 gene 
expression. Whereas CsA blocks the formation of active transcription-related DNA-protein 
complexes at the IL-2 promoter, intracellular cAMP appears to be involved in controlling the 
sustained stability of transcription complexes at the IL-2 promoter once they are established. Thus, 
the transcriptional activation of IL-2 gene expression is dependent on the coordinate regulation of 
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several signaling pathways which ultimately contribute to the highly regulated induction and 
maintenance of transcription factor-binding to the ~-2 promoter. 
Post-Transcriptional Regulation of IL-2 Gene Expression 
As mentioned previously, the cell surface molecule CD28 (MW: 44 kD) participates in the 
regulation of IL-2 gene activity (82). Even though little is known in terms of how CD28-
costimulation influences the transcriptional activation of ~-2 gene expression, more is known 
about the effects of CD28ligation on the post-transcriptional regulation of ~-2 gene expression. 
(The role of CD28 in antigen-induced T-cell responses is reviewed in 86.) With regard toT-cell 
activation and signal transduction, upon CD28-costimulation, CD28 is thought to recruit activated 
PTKs to the cell membrane, thereby facilitating the activation of PLCy1 and a Ca2+_ 
independent/CsA-resistant pathway (83-86). The CD28-induced/Ca2+-independent signals have 
been implicated in controlling post-transcriptional effects on cytokine m.RNA half-life by greatly 
increasing transcript stability (87). CD28 costimulation also confers substantial resistance to 
suppression of proliferation caused by an increase in intracellular cAMP in T cells (78-80). Thus, 
pathways activated by CD28 ligation provide additional regulation and amplification ofT-cell 
activation and ll...-2 gene expression. 
CD28 costimulation relies on the interaction of CD28 with its cognate counter-receptor. 
CD28 is structurally related to another T-cell surface molecule, CTLA-4 (88). The counter-
receptor for CD28 is a B7-related molecule (89, 90). B7 is a cell-surface glycoprotein expressed 
on activated B cells, dendritic cells, and macrophages. Inhibition of CD28 counterreceptor 
interactions blocks immune responses in vitro and in vivo. For example, anti-CD28 mAbs 
augmented proliferation of human T cells in the presence of treated APCs that were deficient in 
costimulatory activity (91). In addition, CD28 cross-linking blocked the induction of 
unresponsiveness (anergy) in murine CD28+ T-cell clones (92), while blocking CD28/coreceptor 
interactions during a primary human mixed lymphocyte reaction (MLR) with CTLA-4Ig inducted 
antigen-specific unresponsiveness of CD4+ T cells during subsequent stimulation (79; 
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unresponsiveness was reversed upon addition of anti-CD28 mAb or IL-2). 
Anergy/unresponsiveness is defined as a patial or incomplete activation state in which IL-2 is n21 
induced. Thus, these data indicate a role for CD28/coreceptor interaction in the induction ofT -cell 
responses and the prevention of anergy. However, CD28-deficient mice, though greatly 
compromised in the ability to mount adoptive immune responses, are not absolutely 
immunodeficient, suggesting that CILA-4 may compensate for the absence of CD28 or other 
costimulatory pathways may be contributing toT-cell activation (93, 94). Notwithstanding, the 
dependence ofT -cell activation on CD28/coreceptor interaction could be a mechanism by which T 
cells are stimulated only by appropriate cell types (those that are coreceptor+) and are not 
stimulated by the majority of inappropriate cell types that are coreceptor-, thereby insuring that T 
cells are, in large, unreactive to the plethora of cells that cannot (and should not) act as bona fide 
APCs. 
Finally, events downstream of the transcriptional activation of the IL-2 gene provide an 
additional means of regulating IL-2 gene expression. IL-2 mRNA has a t112 of 1 to 2 hours (95). 
IL-2 mRNA accumulation appears to be stringently regulated by RNase degradation; despite a 
relatively prolonged, high rate of synthesis, the intracellular level ofiL-2 mRNA decreases rapidly, 
apparently due to the enhanced rate at which IL-2 mRNA is degraded (95). Interestingly, the 
addition of CsA following initial stimulation, while disrupting transcription of the IL-2 gene, led to 
an even faster disappearance of IL-2 mRNA compared to the natural decay of IL-2 message (98), 
suggesting that IL-2 mRNA degradation is enhanced in the presence of CsA and that CsA also 
affects the post-transcriptional regulation of IL-2 gene expression. It is not unreasonable to 
speculate that calcineurin or an immunophilin-regulated event controls some aspect of IL-2 mRNA 
degradation and exposure to immunosuppressive drugs also leads to deregulation of the 
degradation pathway. IL-2 mRNA is targeted for rapid degradation by the presence of an AU-rich 
domain in the 3'-untranslated region that is conserved between the mRNAs of many mediators of 
inflammation (96). It has been proposed that a specific, short-lived degradative RNase system is 
induced along with the coordinate expression of lymphokine genes (95). This degradation is 
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selectively sensitive to actinomycin D and cyclohexamide (CHX), inhibitors of RNA and protein 
synthesis, respectively (95). Specifically, CHX treatment results in the superinduction of ll...-2 
mRNA accumulation without affecting the transcriptional activity of the gene (95, 97). Hence, 
post-transcriptional mechanisms that appear to be induced simultaneously with the transcriptional 
activation of the ll...-2 gene contribute to the highly transient nature of ll...-2 gene expression upon 
induction. 
Concluding Remarks 
In conclusion, on a molecular level, ll...-2 gene expression is stringently regulated, both in 
terms of transcriptional activation and post-transcriptional mRNA stability. The induction of ll...-2 
gene expression is contingent on the activation of numerous signaling pathways, beginning with 
TcR stimulation at the cell surface and leading to activation of ea2+Jcalmodulin-regulated events in 
the cytoplasm and transcriptional initiation at the ll...-2 promoter in the nucleus. Post-
transcriptionally, ll...-2 is rapidly degraded by an apparently inducible but labile degradation system. 
All these factors contribute to the extreme transcience of ll...-2 gene expression and have direct 
bearing on the function ofll...-2 the inflammatory immune response. 
Cellular Aspects of IL-2 Gene Regulation and Function 
IL-2 Expression in Mature T cells Belonging to the a~ Lineage: Thl versus Th2 
In general, only a subset of mature T lymphocytes are capable of producing ll...-2. T cells 
residing in peripheral lymphoid tissues that utilize ~-heterodimers in the TcR complex (al3-T cells) 
are traditionally divided into two main functional groups based on the mutually exclusive 
expression of CD4 and CD8 coreceptors (the differential regulation of these subsets is reviewed in 
98). T cells that express the CD4 cell-surface glycoprotein are "amplifier" or "helper" cells that 
respond to the recognition of antigen by secreting lymphokines (Th cells; 99). In contrast, cells 
that express CD8 possess cytolytic activity and little helper activity (killer T cells). Furthermore, 
analysis of a series of T-celllines suggests that functional heterogeneity exists within the Th subset 
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based on lymphokine production (100). Type 1 helper T cells (Th1 cells) produce IL-2, IL-3, 
interferon-y (IFNy), and TNF-a; these factors are involved in the regulation of cytotoxicity and 
delayed-type hypersensitivity. Type 2 clones (Th2 cells) synthesize factors that modulate B-cell 
growth and differentiation such as ll..-4 and IL-5 (production of these factors augment humoral 
immunity), as well as IL-3, IL-6, and IL-10, but do not synthesize IL-2 or IFNy. Interestingly, 
IL-10 has been implicated in the negative regulation of Th 1-specific gene expression; exposure of 
APCs to IL-10 results in the down-regulation of B7 (and B7-related molecules) which, in tum, 
inhibits CD28 costimulation (101; reviewed in 102). 
The differential induction of Th 1 versus Th2-type responses may influence characteristics 
of some immune responses in vivo. The Leishmania major infections, mouse strains that are 
resistant to infection elicit predominantly Th1-type responses, whereas other strains that are 
susceptible to progressive disease elicit predominantly Th2-type responses (103). The Th1 versus 
Th2-type responses is directly correlated with the ability of resistant versus susceptible strains of 
mice to efficiently destroy this protozoan parasite. Protection against L. major infection is 
contingent upon the vigorous activation of macrophages; once activated, macrophages are able to 
effectively eliminate intracellular Leishmania organisms, while nonactivated macrophages are 
unable to do so. Since macrophage activation is preferentially regulated by IFNy, whereas IL-4 
and IL-10 abrogate the effects of IFNy on microbial immunity (104), immune responses 
dominated by the production of IFNy by CD4+ T cells (Th1-type responses) would be protective 
against L. major infections. In contrast, responses dominated by the production of IL-4 (Th2-type 
responses) would not provide protection (105). Likewise, preferential induction of IL-4 (and 
IL-10) expression may contribute to susceptibility to infection by Listeria, Trichinella, and 
Scistosoma (106). Finally, Th1-versus Th2-type responses are obsetved when comparing patients 
with tuberculoid (resistant) and lepromatous (susceptible) leprotic lesions, respectively, with 
regard to cytokine mRNA expression and protein production (107, 108). Thus, the induction of a 
Th 1-type response or Th2-type response against pathenogenic organisms is critical for establishing 
resistance to disease. 
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The Generation of Th Cells: Do Thl and Th2 Cells Represent Common or 
Separate Lineages? 
Until recently, the lineage relationship between Th subsets has not been well established. A 
considerable body of work, examining the induction and regulation of Th1 and Th2-type 
responses, exists, but does not shed a great deal of illumination on the subject of ( 1) whether Th 1 
and Th2 cells arise from a common precursor (the branched lineage model), (2) whether these 
subsets arise from different precursors (the separate lineage model), or (3) whether Th1 cells give 
rise to Th2 cells (the linear lineage model). Up to this point, it has been difficult to distinguish 
between these possibilities; however, several lines of investigation have addressed particular 
aspects related to these issues. For example, Firestein et al. (109) reported the isolation of murine 
CD4 T -cell clones that exhibited an "unrestricted" cytokine production profile, i.e., these cells 
secreted IL-2, ll..-3, ll..-4, IFNy and TNFa. This new subtype was designated type 0 or ThO. 
Further observations supported the notion that ThO. Further observations supported the notion that 
the ThO cell comprised a precursor subset. Following long-term culture, two independent ThO 
clones lost the ability to secrete IL-2 and IFNy, but not IL-4 upon mitogen activation (109). These 
results are compelling, but it is not known if these distinctions exist in vivo. In addition, it has 
been shown that IL-2 production is associated with a naive or virgin T-cell response. When 
stimulated by receptor engagement coincident with a costimulatory signal, naive T cells produce 
IL-2 but little IL-4 or IFNy (110). On the other hand, IL-4 production is associated with T-cell 
memory (117; immunological memory has been the topic of several recent reviews, 112-114). 
Finally, a caveat to the Th1!Th2 distinction based solely on IL-2 and IL-4 production is presented 
by Harding et al. (115), as indicated by results showing that CD4+ cells may respond to different 
mitogens by preferentially secreting IL-2, IL-4 or both, hence the segregation of Th cells into 
separate subsets or lineages may be somewhat artificial. 
It has been proposed that ThO cells arise from a precursor T -helper cell (pTh) that produced 
IL-2 exclusively (116), but it remains controversial as to whether a ThO-like state is obligatory for 
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the development of Th 1 and Th2 effector cells (in this case, IFNy production is the major indicator 
of a Th1-type response). Recent studies using a selective ablation technique has provided 
information pertinent to the resolution of this issue. In this system, transgenic mice that expressed 
the herpes simplex virus-1 thymidine kinase (HSV-TK) gene under the transcriptional control of 
the murine IL-2 promoter (117) or IL-4 promoter (118) were generated, thereby rendering IL-2 
producing or IL-4 producing cells sensitive to the cytotoxic effects of the antiviral drug, 
gancyclovir (GANC), respectively. When CD4+ Tcells from IL-2:HSV-TK transgenic mice were 
stimulated with the superantigen, staphylococcal enterotoxin A (SEA) in the presence of GANC, 
proliferation and IL-2 production were inhibited and SEA-activated CD4+ T cells were eliminated; 
on the other hand, when CD4+ T cells from similar animals were stimulated with the lectin, 
conconavalin A (ConA), which mimics activation via the TcR, and GANC, proliferation was only 
partially blocked, even though IL-2 producing cells were efficiently eliminated (117). These data 
support the notion that an IL-2 producing state is not obligatory to elicit a (presumably IL-4 
dependent) proliferative response to ConA. In contrast, exposure of naive CD4+ T cells isolated 
from IL-4:HSV-TK transgenic animals to ConA and GANC in vitro under culture conditions that 
favored the expansion of cells that produce IL-4 or IFNy not only resulted in the elimination of 
IL-4 expressing cells, but also of cells that principally made IFNy (118). These results strongly 
suggest that effector cells producing either IL-4 or IFNy have a common precursor which 
expresses the IL-4 gene. Based on these findings, a modified branch lineage model on the 
generation of IFNy producing!Th1 cells and IL-4 producing!Th2 cells has been proposed (126). 
Thus, even though an-IL-2 expressing state is not an absolute requisite to progress to an IL-4 
expressing state an IL-4 expressing precursor is able to give rise to both Thl and Th2-type effector 
cells. The lineage relationship between the apparently more naive IL-2 expressing cells and IL-4 
expressing cells requires further elucidation. 
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Functional Phenotype Plasticity In Vitro: Induction of IL-2 Gene Expression in 
CD8+ T Cells 
The phenotypic distinction that the ability to express ll...-2 partitions exclusively with the 
CD4+ T -cell population and not with the CDS population can exhibit considerable plasticity in vitro 
(see Chapter 1). Whereas ConA plus the phorbol ester PMA (a direct activator of PKC) or anti-
CD3 mAb plus PMA stimulation of virgin CDS+ splenic T cells resulted in poor ll..-2 production 
(as manifested by a failure to accumulate detectable levels of ll...-2 mRNA), Ca2+-ionophore 
(A231S7) plus PMA stimulation (which altogether bypasses the TcR-dependent generation of 
second messengers) of fresh CDS+ cells led to substantial ll...-2 production (greater than 50% of 
CDS+ splenic T cells were stimulated to express ll...-2 under these conditions; Chapter 1). These 
results indicate that primary CD4+ and CDS+ cell do not differ so much in their intrinsic ability to 
initiate ll...-2 transcription and that differences in signal transduction or post-transcriptional 
regulatory mechanisms (rather than the ability to induce ll...-2 gene expression per se) may play a 
vital role in the segregation of CD4+ and CDS+ cells into distinct functional roles. 
Inducibility of IL-2 Gene Expression in Immature T Cells 
Not only can naive CDS+ T cells be induced to express ll...-2, but immature T cells are also 
inducible for ll..-2 gene expression in vitro under the appropriate stimulation conditions, suggesting 
that ll...-2 gene inducibility is an innate property of cells whose development is thymus dependent. 
Cells inducible for ll...-2 gene expression are undetectable in unfractionated bone marrow (BM) 
which presumably contains T -cell precursors (BM cells were stimulated in vitro under a broad 
spectrum of conditions, including conditions sufficient to induce ll...-2 gene expression in 
thymocytes and T cells; 119). However, it has been demonstrated that immature CD4-CDS-TcR-
thymocytes are capable of expressing ll..-2 upon stimulation with A231S7 plus PMA, but unlike 
mature T cells, require an additional signal, provided by ll...-1, in order to induce ll...-2 gene 
expression (120). ll...-2 gene inducibility is rapidly lost as developing thymocytes progress to the 
CD4+CDS+TcRlo stage and this competence is not restored until thymocytes reach the CD4+CD8-
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TcRhi (or CD4-CD8+TcRhi) stage. As alluded to previously, the ability of developing thymocytes 
to induce IL-2 gene expression is a reflection of the ability of different thymocyte subsets to 
mobilize or induce transcription factors involved in ll...-2 gene transcription (72). Thus, ll...-2 gene 
inducibility is not exclusively a Th "lineage" marker per se. Albeit has yet to be clarified whether 
all TcR- thymocytes pass through an ll...-2 inducible stage or only a "predetermined" TcR- subset is 
inducible, ll...-2 gene inducibility may potentially be a marker indicating commitment to the T 
lineage. 
IL-2 Gene Expression in yo T Cells 
Finally, T cells belonging to the "(0 lineage can also be induced to express the ll...-2 gene. 
Whereas af3 T cells predominate in secondary lymphoid organs and the blood, yo T cells 
predominate in epithelial tissues. With regard to specific populations ofT cells for which the 
activating ligands have been characterized, within these subsets, ll...-2 production can be induced in 
vitro and in vivo. For example, Vy3+ T cells (yo cells that utilize the Vy3 gene segment in the 
TcR"((-chain) can be activated by keratinocytes. Following co-culture with the appropriate 
activating cell type, or stimulation by CD3E or V y3 eros slinking, V y3+ cells produce detectable 
amounts of ll...-2 (121,122). Likewise, yo cells that recognize Hsp60 of Mycobactereum 
tuberculosis (MT) (123) can be activated in vivo by immunization with MT and "(0 cells isolated 
from draining lymph nodes of primed animals are inducible for ll...-2 production (124). Strong 
circumstantial evidence exists with respect to yo cells that express a certain V0 or gene family 
(VoM23) being spontaneous ll...-2 producers; fusion of thymocytes isolated from newborn mice 
were fused with BW5417 cells yielded autoreactive yo T-cell hybridomas that spontaneously 
produced ll...-2 overnight in culture without stimulation, of which >80% expressed a member of the 
V0M23 family (no correlation was found between Vy usage and spontaneous ll...-2 production) 
(131). In addition, splenic and intestinal yo T cells stimulated with mobilized anti-CD3 mAb 
produced ll...-2 and IFNy but no ll...-4 (125). Thus ll...-2 production is a property of both af3 and "(0 
lineages (it would be interesting to determine if the mechanisms that regulate ll...-2 gene expression 
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in particular subsets of~ cells is identical to those acting in al3 cells). 
Thymic Ontogeny and T -Cell Development 
The development of functionally responsive T ells has been the subject of an extensive 
review (126). The body of work addressing this subject or any particular aspect therein is 
enormous. Taking this into consideration, even a cursory summary covering every area ofT-cell 
development would be unduly long and perhaps, somewhat impractical. Therefore, only certain 
facets ofT-cell development which have direct bearing to or are helpful for understanding the work 
that is presented in the subsequent chapters will be discussed. 
The Thymus: Structure and Function 
Unlike processes by which all other known hematopoietic cells are generated, the 
production of the majority ofT cells is entirely contingent on the thymus, a specialized organ that is 
responsible for facilitating the expansion and rigorous selection of T -cell precursors. The steps 
involved in these processes are achieved via precursor interaction with the thymic 
microenvironment; the thymic microenvironment is a complex combination of epithelial cells and 
BM-derived cells such as dendritic cells and macrophages (127-130). Specifically, the 
nonlymphoid component of the thymus (the thymic epithelium) influences or controls the extensive 
proliferation and differentiation of early precursor cells, as well as the "education" of immature 
cells (the precise signals involved in these events are just beginning to be identified). As a 
consequence of the education process, properly educated cells are allowed to mature and exist the 
thymus, while all other inadequately or improperly educated cells are detained and eliminated. 
In the postnatal animal, the thymic epithelium is separated into two distinct compartments, a 
cortex surrounding a medulla (the structure of the thymus is reviewed in 128 and 129). These 
epithelial domains are nonequivalent and are considerably heterogeneous in terms of cellular 
composition. The cortex is composed of a lattice of epithelial cells with long processes containing 
scattered macrophages and is densely packed with T-cell precursors (from this point onward, these 
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cells will be referred to as thymocytes). By contrast, the medulla contains a distinct population of 
epithelial cells of a more conventional form along with BM-derived cells that are found associated 
with the cortical-medullary junction and is a repository for thymocytes that display a mature T -cell 
phenotype. The cortex can be subdivided further into outer and inner cortical regions; the outer 
cortex, immediately beneath the fibrous capsule of the organ, provides a distinct microenvironment 
in which the majority of resident thymocytes are actively dividing (it is believed that the stroma 
delivers a powerful mitogenic signal) and the inner cortex serves as a holding area for the large 
number of thymocytes awaiting selection and/or elimination. There is also considerable evidence 
showing that the structural organization of the thymus is not only determined by the presence of the 
required nonlymphoid elements; indeed, it appears that the interaction of the thymic 
microenvironment with resident thymocytes influences the overall structural organization of the 
organ (131). Finally, T-cell development proceeds along a programmed intrathymic migration 
route (126). Precursor cells most likely enter the thymus at the cortical-medullary border and 
migrate to the outer region of the cortex, during which they commence to divide. Once in the 
subcapsular zone, the rate of proliferation reaches its maximum and this phase culminates in the 
surface expression of conventional TcR complexes. Soon afterwards, thymocytes cease to 
proliferate and move back into the cortex proper. Only positively selected cells are allowed to pass 
from the cortex to the medulla. Thus, in general, T -cell development relies on a complex set of 
cell-cell interactions which are determined by lymphoid and non-lymphoid cell types in the thymus. 
Thymic Ontogeny 
In mammals, the thymic epithelium is generated via the interaction of the third and fourth 
branchial pouch endoderm with the overlying ectoderm of the pharyngeal cleft, occurring at days 
10-11 of gestation in the mouse and between weeks 7 and 8 in the human ( 126). The seeding of 
the thymus rudiment with precursors derived from HSCs occurs soon after its formation and 
continues up to birth. In mice and avian species, the first lymphoid precursors arise from the yolk 
sac (132). Derivatives from the yolk sac seed both the fetal liver (fL) and the thymus (126). 
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During embryogenesis, the tL is the predominant source of lymphoid precursors; additionally, the 
derivatives from the fL proceed to colonize the BM which becomes the major site of hematopoiesis 
after birth. There is substantial evidence from a variety of animals indicating that lymphoid 
precursors enter the thymus of several waves during gestation. These waves of immigrants have 
been observed in Xenopus (133, 134), chicken (135), quail (136), and mouse (137). A series of 
elegant experiments using reciprocal chick-quail chimeras with donor thymuses and recipients of 
different stages demonstrated that there are discrete periods in development when the th'ymus takes 
up cells separated by nonreceptive periods ( 136). Each cohort of precursors enters the thymus and 
remains quiescent as the cells from the previous wave proliferate; once the earlier cell types 
emigrate or die, the next cohort becomes active. Three distinct waves of precursors populate the 
embryonic thymus in chicken and quail (136), whereas only two are observed in mouse (137). As 
alluded to previously, the first wave of precursors in the mouse is derived from the fL and seeds 
the thymus between days 11 and 13 of gestation ( 137). Cells generated from this wave persist up 
to birth after which they gradually disappear by the rrrst week of postnatal life. The second wave 
of precursors is derived from the BM and first enters the thymus around the time of birth and cells 
from this wave continue to populate the thymus for at least eight weeks postpartum. These results 
in the mouse indicate that the embryonic and postnatal T-lineage cells may be derived from 
different precursors. In addition, the architecture of the fetal thymus is substantially different than 
that of the adult thymus (128, 138). Thus, at least in the mouse, some of the steps involved in the 
generation ofT cells in the fetus versus the postnatal animal are most likely unique to that particular 
period in development. 
The Multipotential Hematopoietic Stem Cell 
The characterization of the stem cell that ultimately gives rise to T -cell precursors has been a 
topic of extensive study over the past several years. Lymphoid cells (B and T lymphocytes), 
myeloid cells (macrophages, neutrophils, eosinophils, basophils, mast cells, platelets) and 
erythrocytes are derived from a common multipotent hematopoietic stem cell (MHSC). MHSCs 
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must maintain the ability for self-renewal and possess the capacity to give rise to all differentiated 
cell types, common features displayed by all multipotent progenitors. MHSCs are not actively 
cycling and can be distinguished from cycling HSCs that have lost the ability for self renewal 
based on the capacity of MHSCs to provide long-term repopulation of all hematopoietic 
compartments in irradiated recipients. Cycling HSCs give rise solely to short-term repopulation 
(139). MHSCs can be isolated from both fL (140, 141) and adult BM (142-143). In the mouse, 
MHSCs do not express most hematopoietic cell lineage markers (MHSCs are Lin-, equivalent to 
CD3-CD4-CD8-B22Q-Mac-I-Gr-I-Erythrocyte Ag-), but do express low levels ofThy-1 and high 
levels of stem cell antigen- I (Sea-l) (142, 143). MHSCs isolated from fL versus adult BM differ 
in their ability to give rise to different subsets ofT cells (144). Whereas fL MHSCs can give rise 
to both fetal and thymus-derived cell populations, adult BM MHSCs can only generate the adult T-
cell pool. Again, these data support the notion that T-cell precursors derived from MHSCs isolated 
from fL versus adult BM represent nonequivalent cell types. 
The Committed Lymphoid Precursor 
A committed lymphoid precursor (CLP) that has lost the ability to give rise to myeloid and 
erythroid lineages but retains the ability to develop into T and B cells has been identified in the 
adult mouse thymus (145, 146). However, it has been difficult to identify a CLP at the site(s) 
where all other events associated with hematopoiesis are active or to determine what influences an 
HSC to become a CLP. The CLP differs in cell surface phenotype from HSC to become a CLP. 
The CLP differs in cell surface phenotype from HSCs in two respects; the more differentiated cell 
type expresses low levels of CD4 and high levels of Sca-2 (144, 146). When injected 
intravenously, the CLP gives rise toT and B cells only (likewise, when CLPs are injected directly 
into the thymus, they differentiate exclusively into T cells). Recently, a cell type similar to the 
adult thymic CLP has been detected in the fetal thymus (147). However, the fetal thymic CLP, 
while being able to reconstitute the B-lineage compartment, was unable to provide long-term 
repopulation of the T-lineage compartment in irradiated adult recipients. Additionally, CLPs 
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isolated from postnatal animals up to 4 weeks postpartum were unable to provide long-term 
repopulation of the adult thymus. The differences in repopulation capacities of fetal versus adult 
CLPs can be accounted for by potential inherent differences in the two types. Recall that fetal 
CLPs are adult CLPs are derived from the fL and BM, respectively, and that the first wave to 
repopulate the fetal thymus lasts for approximately 2 weeks and is completely displaced by the 
second wave one week after birth. Hence fetal CLPs may be "preprogrammed" to give rise only to 
short-term repopulation of the thymus). On the other hand, an alternative explanation can be 
formulated. Beginning at day 13 of gestation and continuing until approximately four weeks after 
birth, the thymus is expanding (i.e., cell numbers do not reach steady state until about four weeks 
after birth), thus CLPs during the period may be continuously forced to cycle. It is possible that 
being in active cycle versus being able to provide long repopulation are mutually exclusive 
routines. 
The Generation of yo T Cells 
Two lineages ofT cells are generated in the thymus and are distinguished by the expression 
of ab or gd heterodimers in the TcR complex (TcRy- and o-chains are not to be confused with 
CD3y and o chains). T cells represent a minority population in the postnatal thymus and peripheral 
lymphoid organs. It is still not clear at what point the ~ lineage diverges from the aj3 lineage, but 
the development of ~ cells is not contingent on the development of a~ cells or vise versa. The 
elimination of a~ T cells by target mutation of the TcRa- or ~-chain genes has no effect on the 
generation of~ cells (148, 149) (likewise, a~ T -cell development is unperturbed in mice bearing 
mutant TcRo genes, 150). Similar to their more prevalent a~+ counterparts, ~ cells appear to be 
subject to positive and negative selection. When mice that are transgenic for a defmed ~ TcR with 
"nonconventional" class I MHC specificity were crossed with animals deficient in ~2-microglobulin 
(ihm) expression (these mice are class I MHC-), transgenic TcR+ immature cells were abundant in 
the thymus, but transgenic cells were absent in peripheral lymphoid tissues, indicating that~ cells 
are subject to a process analogous to positive selection, i.e., in the absence of selecting ligand, 
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transgene positive cells could not be positively selected and were blocked at an immature stage in 
the thymus (151, 152). In several defined cases, the targt antigen for a defined ro TcR has 
appeared to be class I MHC-restricted. However, no gross abnormalities of roT cells were 
observed in 132m-deficient mice that were not transgenic for a particular yo TcR (153). 
Consequently, it has been proposed that ')6 cells can be divided into two categories, one with 132m-
related specificities whose maturation is dependent on the presence of 132m-associated proteins, and 
another with 132m-unrelated specificity whose development is l32m independent and can expand in 
132m-deficient mice to populate the roT-cell compartment (154). There may also be inherent 
differences in the positive selection of ro versus al3 cells. Recent findings revealing that the 
general rules that define af3 T -cell specificity do not influence ')6 T -cell specificity ( 155), therefore 
the process by which functional specificity is determined may be distinct for these two lineages. 
Finally, in terms of effector function, T cells exhibit cytolytic activity and are also capable of 
producing lymphokines, including IL-2. With regard to these aspects, ')6 cells do not appear to be 
all that different from their af3 counterparts. 
The development of ')6 T cells has been reviewed recently (154, 156-158). Interestingly, 
ro T cells can be divided into several subsets based on variable (V) gene usage, junctional 
diversity, and tissue distribution. In the fetal thymus, ')6 T cells appear as a series of overlapping 
waves commending at approximately day 13 of gestation. The first two waves express V 13 and 
V y4, respectively, and both y-chains are apparently paired with a o-chain composed of 
V01/D02/J02 segments. A striking feature of these early receptors is there is little junctional 
diversity of the rearranged genes, suggesting that the mechanisms by which junctional diversity is 
achieved in T cells derived from BM precursors are not active cells derived from fL precursors. 
Later in ontogeny, Vy3 and Vy4 cells disappear from the thymus and are replaced by cells 
expressing diverse receptors containing V 12 and V 11 and a variety of V 'Y gene products. Up until 
approximately day 16 of gestation, ro cells are the predominant CD3+ population in the fetal 
thymus, after which the proportion of -yO cells drops and are displaced by af3 cells, which become 
the major lineage found in the thymus. The highly ordered appearance of ')6 T cells is believed to 
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be regulated by programmed rearrangement at they-chain gene locus (159) as dictated by the 
thymic microenvironment and/or the -yO progenitor celL There is a striking correlation between the 
transcription of unrearranged Yy genes and the timing of their rearrangement (159). The sequential 
activation of Vy genes may regulate the accessibility of the surrounding chromatin to the 
recombination machinery, resulting in the ordering of V y gene rearrangement during development. 
This correlation between transcriptional activation and targeted gene rearrangement is a general 
feature of TcR and Ig gene rearrangement. Notwithstanding, signals that induce transcriptional 
activation at the TcR gene loci is largely unknown. In normal adult mice, V13+ cells are associated 
exclusively in the skin, in which they are the predominant T-cell type, while Vy4+ cells are 
restricted to the tongue and female reproductive tract. V12+ and Vyl+ cells largely populate 
lymphoid tissues (spleen and lymph nodes) and the blood. Lastly, the intestinal epithelium 
contains a large number of -yO T cells, many of which possess diverse TcRs with V y-containing 
Vy5 gene segments and o-chains containing a variety of V0 elements (these intestinal yo cells 
apparently arise extrathymically; the extrathymic generation ofT cells will be elaborated upon later. 
The Generation of al3 T Cells 
The bulk of work on T -cell development focuses on the generation of aJ3 cells. Discrete 
phenotypic changes are associated with particular events in aJ3 T -cell development and the 
mechanisms that control of influence these changes are currently being dissected. In highly 
abridged form, cells of the aJ3 lineage arising from CD4loco8-TcR- precursors progress from a 
CD4-CD8-aJ3TcR- (triple negative{fN) "immature" stage (comprising 4% of thymocytes) to 
CD4+CD8+TcRlo (double positive/DP) "cortical stage" (representing the bulk population in the 
postnatal thymus at 80% ). Potentially autoreactive cells are eliminated from the repertoire by the 
process of negative selection. Maturation beyond the cortical stage is dictated by positive selection, 
yielding TcRhi cells that are either CD4+CD8- or CD4-CD8+ single positive (SP) and accumulate in 
the medulla. Of cells at the medullary stage, 10% are CD4-SP and 4% are CD8-SP. The cells that 
emigrate from the thymus to populate the periphery are primarily of the medullary SP type (126). 
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This simplified depiction provides useful landmarks, but it should be stressed that numerous 
"intermediate" phenotypes exist, indicating transitions between all three stages (for a detailed 
description of the phenotypic changes that accompany transitions throughout T -cell development, 
see 133). Specific intermediate phenotypes will be discussed but only in the context of transitions 
from one major stage to the next. 
Transitions Prior to al3-TcR Surface Expression 
Prior to TcR gene rearrangement, TNs downregulate expression of Pgp-1 (CD44) and 
upregulate expression of Thy-1, heat stable antigen (HSA) and ll.,-2R a-chain (CD25). To 
reiterate the signals that induce this change in phenotype are not known. This is a particularly 
significant intermediate phenotype because the state that is associated with this phenotype appears 
to be an arrest point before TcR(3-chain gene rearrangement Cells in which p-chain rearrangement 
or expression is perturbed or suppressed are frozen in the CD44 -CD25+ 1N state or in a CD25-
immediately beyond. For example, thymi of mice homozygous for the severe combined 
immunodeficiency (SCID) mutation (manifestation of this defect results in an inability to rearrange 
TcR and lg chain genes, successfully 160) are enriched for TN cells, especially for those 
expressing CD25, and are depleted for all other downstream cell types (161). Likewise, mice 
deficient in recombinase activating gene (RAG-1 or RAG-2 activity (162-163) or TcRp-chain 
expression (149, 150) exhibit a block at the TN to DP transition, and the thymus isolated from 
these animals contain two orders of magnitude fewer cells than wild-type animals. On the other 
hand, unlike RAG-deficient or SCID mice that possess defects in the actual recombination process, 
TcRp-deficient animals are not recombination defective. p-chain -/- mice are able to rearrange their 
a-chain loci to some extent; nevertheless, these mice do not produce DP thymocytes, indicating 
that a-chain rearrangement is irrelevant for induction of the 1N or DP transition. 
The role of TcRp-chain expression in the absence of a-chain expression in the TN or DP 
transition has been defmed in several genetic studies. Introduction of a rearranged p-transgene into 
RAG-deficient (164) or SCID animals (165) results in the generation of CD4+CD8+ cortical 
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thymocytes. However, the J3+SCID thymus contains one tenth the number of cells found in the 
~+RAG-2 -/-thymus (166). It has been proposed that these differences may be caused by the 
inability of SCID thymocytes to properly ligate lethal DNA double-strand breaks (160) and the 
SCID-related lethality is not rescued by introduction of a rearranged ~-chain (166); indeed, these 
cells may continue to attempt a-chain rearrangement with little success. As an aside, as extension 
of this argument implies that in nontransgenic RAG-deficient and SCID mice, RAG-2 -/-
thymocytes are essentially held at a state in which TcR genes are completely unrearranged, whereas 
SCID thymocytes are actively attempting to rearrange their TcR genes, suggesting that SCID 
thymocytes may have progressed further along the developmental pathway than RAG-2 -/-
thymocytes. To the contrary, thymocytes isolated from SCID animals appear to be blocked at the 
CD44+CD25- stage prior to the upregulation of CD25 (126). However, SCID-related lethality may 
be responsible for the accumulation of CD44+CD25- cells, since cells with potentially more mature 
phenotypes may be eliminated as they initiate rearrangement of ~-chain genes. Recent findings 
revealed that RAG-2 -1- thymocytes are arrested further downstream at the CD44-CD25- stage, 
representing the immediate progeny of CD25+ immature cells (unpublished). Hence, the 
developmental block in RAG-2 -/- versus SCID mice do not appear to be identical. Likewise, the 
block in TcR ~-chain deficient animals may not be identical to that in RAG-2 -1- animals, since ~­
chain -/- thymocytes can proceed with rearrangement at other TcR-chain gene loci and are not 
subject to SCID-related lethality. 
The discovery that TcR~-chain is expressed on the surface of immature thymocytes in the 
absence of a-chain has sparked substantial interest in identifying TcR~-chain (in which TcR 
~-chain-complexes detected would be represented of complexes expressed during the 1N to DP 
transition) revealed that TcR~-protein complexes contained CD3y, o, E and ~ or l1 chains as well as 
a glycosylated polypeptide identified as gp33 (166). gp33 is disulfide linked to TcRJ3 protein and 
acts as a putative TcRa surrogate chain. The association of TcRJ3-chain with gp33 appears to be 
developmentally regulated, since TcR~-chain/gp33-containing complexes are not detected in DP 
cells in which TcRJ3-chains are associated exclusively with TcRa chains (167). The TcRJ3/gp33 
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heterodimer function in T-cell development is believed to be analogous to that of the J.L-heavy 
chainNpre-BAS complex in B-cell development (168-170). 
Interaction of the TcR/gp33 complex with its unidentified ligand is thought to generate an 
intracellular signal which promotes further development as indicated by the downregulation of 
CD25 expression, appearance of CD4 and CD8 coreceptors, explosive cell proliferation, and 
suppression of further TcR 13-chain gene rearrangement (allelic exclusion). Recently, studies have 
demonstrated that CD3y, o, and e but not ~ chains are detectable on the cell surface of RAG-2 -/-
mice and that in vivo treatment of these recombination deficient animals with anti-CD3 mAb results 
in the generation of DP cells (171). Hence, even when TcRI3-chain cannot be expressed, CD3 
complexes can be found on the surface and can mediate signals sufficient to induce coreceptor 
expression and extensive cell proliferation. The absence of CD3~-chain surface expression in 
RAG-2 -/- thymocytes can be reconciled with the result showing that ~-chain is present on the cell 
surface of the SCID!fcR 13-chain transfectant, because it is possible that surface expression of 
CD3~ is dependent on TcRI3 expression (recall that RAG-2 -/- thymocytes are still TcRJ3-deficient). 
Additionally, circumstantial evidence suggests that CD3t;;-associated signaling events may not be 
vital for the TN to DP transition; in thymi removed from STD patients who are ZAP-70 -/-, the 
generation of cortical thymocytes is not blocked, implying that CD3 '(jZA.P-70 mediated signaling 
events are not necessary with regard toT-cell development up to the DP stage. To the contrary, 
targeted disruption of the CD3C chain in mice resulted in a tenfold reduction of the DP population 
compared to wild type (172). Nevertheless, it has not been determined whether CD3t;; -/-mice still 
express other CD3 subunits along with TcR13/gp33 on immature cells and if the DP population in 
these animals can be restored to normal levels following anti-CD3e mAb treatment, or whether the 
TN to DP transition is simply inefficient in CD3C -/-mice. Perhaps CD3C influences the generation 
of DPs by facilitating the TN to DP transition but is not absolutely required in this process. 
Finally, Lck function has been implicated in controlling the TN to DP transition. In Lck-deficient 
mice or transgenic animals expressing a dominant-negative variant of Lck (22, 173), T-cell 
development is blocked at the TN stage. Progression to the DP stage in these animals is not 
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restored by the introduction of a rearranged TcRJ3-chain gene (22). Conversely, overexpression of 
a wild-type lck gene prevents TcRJ3-chain rearrangement, while leaving TeRn-chain rearrangement 
unimpaired (17 4 ). This implies that while Lck is required for initiating TcRJ)-chain rearrangement, 
an increase in Lck activity may arrest this process, ergo the modulation of Lck activity is crucial for 
the proper regulation of [3-chain rearrangement. 
Overall, early transitions prior to the DP stage are determined by the induction of a series of 
signaling pathways in the absence of bona fide nf3-TcR surface expression. Using genetic 
approaches, facilitated by transgenic and targeted gene disruption technologies, many of these 
pathways are being dissected. Several components of the signaling apparati are shared between 
immature TN and mature SP thymocytes (CD3 components, TcRJ3 chain, Lck). However, the 
effects exerted by these components in immature versus mature cells are profoundly different. 
Crucial to the differences observed in TN thymocytes is the coexpression of gp33 with rearranged 
f3 chain. Additionally, Lck activity has differential effects in immature thymocytes. In conclusion, 
immature thymocytes are subject to a barrage of signals that are vital for the progression from an 
nf3-TcR- to an nJ3-TcR+ state. It remains largely known whether these signaling events in TN 
thymocytes in vivo are sufficient to induce the expressioln of genes characteristic of a mature T -cell 
response, first and foremost is the induction of IL-2 gene expression. 
Transitions Following nJ3-TcR Surface Expression 
In a normal animal, once nJ3 TcR is expressed on the cell surface, the proliferation initiated 
by the putative engagement of TcRb/gp33 ceases, after which DP thymocytes decrease in size 
(these cells are classified as small cortical thymocytes). Small cortical thymocytes do not express 
high levels of nJ3 TcR on the cell surface, due to the degradation of an unusually high proportion of 
newly synthesized chains before they reach the cell surface (126). The vast majority of cortical 
thymocytes do not progress past the DP stage and undergo programmed cell death (the topic of 
PCD is reviewed in 175 and 176). The average life span of a TcRJ3+, TeRn-rearranging 
CD4+CD8+ thymocyte is 3.5 days, during which time a small proportion of thymocytes are 
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positively selected for further maturation ( <5%) or after which the remaining cells die in situ 
(>95%; 177, 178). This death process is also known as apoptosis and is characterized by surface 
membrane "blebbing," condensation of chromatin, degradation of DNA into nucleosome-sized 
fragments of approximately 180 bp, and subsequent fragmentation of affected cells. The 
apoptototic suicide response is triggered by a rapid increase in [Ca2+]i. Bcl-2, a nuclear encoded 
mitochondrial protein, is believed to be involved in rescuing cells from apoptosis. bc/-2 is not 
expressed by cortical cells but is upregulated in medullary thymocytes (179, 180). Genetic 
evidence indicates that bcl-2 is not the only gene responsible for limiting the extent to PCD in the 
thymus. Overexpression of bcl-2 in normal mice, while increasing the resistance of thymocytes to 
apoptosis induced by glucocorticoids of ionizing radiation, does not result in the overpopulation of 
the thymus with DP cells nor rescue cells from negative selection or PCD induced by acute CD3e-
crosslinking. Therefore, expression of bc/-2 in cortical thymocytes expressing a transgenic TcR 
appears to delay apoptosis in nonselected DP thymocytes and reduce the efficiency of negative 
selection, but is not sufficient to enable further maturation of these cells (181, 182). The 
disruption of bc/-2 expression in mice has little effect on fetal or early neonatal development, 
whereas after two weeks of postnatal life, both T and B lymphocytes and their precursors in the 
thymus and BM gradually disappear, suggesting that differential requirements for bcl-2 exist in the 
generation ofT and B cells derived from the fL versus those derived from the BM (183). Lastly, 
recent studies have revealed that PCD in the thymus may be controlled by the combined effects of 
bcl-2 and bc/-2-like/related genes (184, 185). 
Negative Selection 
The progression from the DP stage to the SP stage is regulated by the negative and positive 
selection. Negative selection is the active process by which autoreactive cells are removed from the 
repertoire, and positive selection is the means by which cells bearing useful TcRs with the potential 
to recognize foreign antigen in the context of self-MHC products are rescued from PCD. Both 
processes resemble mature T-cell activation in ligand-receptor requirements. However, the next 
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results of negative selection, positive selection and mature T-cell activation are not equivalent 
(elimination versus survival versus induction of functional responses). Initial reports on negative 
selection described the arrested development and clonal deletion of superantigen-reactive V 13+ cells 
in the thymus of mice positive for superantigen expression (186, 189; overviews of negative 
selection and superantigen recognition can be found in 189, 190, respectively). Negative selection 
has been examined in detail using transgenic mice expressing rearranged TcRa and TcRJ3-chain 
genes that encode receptors of defined specificities. When transgenes encoding class !-restricted 
receptors that recognize male H-Y antigen in the context of H-2Db in one case, or H-2Ld in 
another, were bred onto genetic backgrounds in which the target antigen was a self-antigen (male 
H-2b or H-2d, respectively), the resulting mice had thymi that were greatly depleted in both DP 
cortical and SP medullary cells (191-194). Similar observations were observed in mice bearing 
transgenic TcRs with class II -specificities ( 195, 197). Although the net result of negative selection 
in these transgenic systems are the same (i.e., the clonal deletion of autoreactive cells), particular 
details pertaining to this process may not be completely identical between class I and class 11-
specific T cells. For example, whereas class I MHC molecules are expressed more-or-less 
ubiquitously throughout the thymic microenvironment, class rr+ cells are found on only a subset of 
cells therein, hence resident thymocytes will potentially "see" class I molecules continuously as 
they develop and will encounter class II molecules only in specific areas of thymic 
microenvironment where class rr+ cells are localized. Introduction of TcRa- and f3-chain 
transgenes causes premature expression of transgenic TcRs on resident thymocytes, thus many 
class !-specific transgenic TcR+ thymocytes which would not be expressing TcR at the equivalent 
state in nontransgenic animals could be subject to "premature" negative selection soon after TcR 
surface expression; in contrast, premature expression of a transgenic class II-specific TcR may not 
grossly effect the kinetics of negative selection, since class II-specific transgenic TcR+ thymocytes 
may not encounter negatively selecting ligand for sometime following TcR surface expression. In 
general, negative selection of class !-specific TcR+ thymocytes may be more efficient than that of 
cells expressing class IT-specific TcRs (the points discussed here also apply to the process of 
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positive selection). Such studies have revealed that two signals are required to induce negative 
selection, the first activated by TcR ligation, the second by an unidentified interaction that is 1lQ1 
contingent on CD28 engagement. 
Particular aspects of negative selection have been successfully studied in vitro. Clonal 
deletion of DP thymocytes isolated from transgenic mice expressing a class IT-restricted af3-TcR 
specific for cytochrome C was induced following co-culture with £b-transfected fibroblasts and 
antigenic peptide in a dose-dependent manner (198). Further studies obtained from this in vitro 
culture system revealed that negative selection was insensitive to CsA and that substantial clonal 
deletion of DP thymocytes was induced at a relatively low concentration of antigenic peptide 
which, at the same concentration, was insufficient to stimulate detectable lymphokine production in 
isolated peripheral T cells. Albeit that injection of anti-CD3e mAb induces acute depletion of 
cortical cells in vitro, exposure of transgenic TcR+ DP thymocytes to anti-CD3 mAb in vitro did 
not induce clonal deletion. DP thymocytes remained viable but downregulated CD4 and CD8 
coreceptors in a process defined as DP "dulling," (199). Subsequent deletion was induced upon 
addition of APCs, thereby indicating that two signals are required for negative selection. This 
second signal is not generated through interaction with B7, since antagonists of B7 -CD28 
signaling had no effect on clonal deletion (199). Taken together, these results reinforce the notion 
that signals crucial for inducing clonal deletion of potentially autoreactive cells may be 
quantitatively and qualitatively different than those for activating mature T cells. 
Positive Selection and TcR Ligand Interactions: Affinity Versus Avidity 
As alluded to previously, though interactions required for negative selection, positive 
selection and mature T -cell activation are similar if not identical (TcR-peptide-MHC and coreceptor 
engagement), the resulting signals generated by these interactions in immature versus mature cells 
may be quantitatively and qualitatively different. Transgenic and targeted gene disruption 
technologies have been applied to understand the nature of interactions involved in positive 
selection. Positive selection has been reported in both class I and class II MHC-restricted TcR 
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transgenic mice (191-197), as evinced by the generation of mature transgenic TcR+ SP thymocytes 
in the appropriate positively selecting genetic background. However, a controversial aspect of 
positive selection has been the nature of positively selecting ligands in the thymus. The most 
widely accepted model for positive selection maintains that the process requires the presentation of 
peptides in conjunction with MHe molecules; however, until recently, the properties of positively 
selecting peptides have remained undefined. Unlike negative selection which can be examined in 
vitro, positive selection has not been adequately reconstituted in the absence of a thymus using 
defined cell populations. Hence, in order to examine and define the character of positively 
selecting ligands in vitro, several investigators have adapted a modified fetal thymic organ culture 
(FfOC) system in which thymi from class I MHe-restricted TcR transgenic mice on a mutant class 
!-deficient background were used and both MHe surface expression and presentation of different 
defined peptides were manipulated in culture and the effects of such manipulation on the generation 
of mature eng+ SP thymocytes were analyzed (200, 201). Positive selection of eng+ SP 
thymocytes from FfOC of thymi isolated from transgenic mice expressing a TcR with specificity 
for an octamer peptide from ovalbumin (0VA257-264) in the context of the H-2Kb molecule bred 
onto a f32m -/- background was reconstituted upon addition of peptide plus exogenous f32m (the 
addition of f32m stabilized the empty class I heavy chains that had made their way to the cell surface 
in the absence of f32m). Under these conditions, the peptides that were able to induce positive 
selection were all variants of the antigenic peptide and had previously been defined as being 
antagonistic for this receptor, whereas addition of antigenic peptide caused clonal deletion (200). 
Based on these results alone, low affinity interactions appear to mediate positive selection. 
In contrast, a similar set of experiments using FrOe of thymi from animals expressing a 
transgenic TcR recognizing a lymphocytic choriomeningitis virus (LeMV) peptide in the context of 
H-2Db and deficient in transporter associated with antigen processing (TAP) activity demonstrated 
that avidity as well as affinity influences positive selection (in the TAP -/- background, a low 
number of unstable empty class I molecules is expressed on the cell surface and molecules are 
stabilized upon addition of exogenous peptide; 201). In the second case, even though antigenic 
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LCMV peptide does not stabilize H-20b molecules efficiently, the TcR-specific peptide was the 
only one capable of inducing positive selection of COS+ SP cells, but only at low concentration 
(again, higher concentrations of antigenic peptide induced negative selection). Thus, antigenic 
peptide is capable of inducing positive selection (similar results were obtained in yet another FfOC 
system, 202). The findings generated from these two studies are not completely at odds with one 
another. Taken together, these findings show that positive selection occurs on low affinity ligands 
when ligand density is high (OVA-specific TcR plus ~2m -/-case); on the other hand, positive 
selection is induced only upon interaction with high affinity ligands when ligand density is low 
(LMCV-specific TcR plus TAP-/- case). Hence both affinity and avidity are parameters that affect 
positive selection. 
Signals Induced by Positive Selection 
Although these seminal studies shed considerable light on the molecular interactions 
involved in positive selection at the cell surface, considerably less is known about the specific 
signals generated by these interactions that rescue positively selected cells from PCO. Since the 
dual affinity/avidity model of positive selection mandates that both low TcR occupancy/little TcR 
clustering and high TcR occupancy/extensive TcR clustering (as determined by ligand affinity for 
TcR) cause positive selection, signals generated by these different interactions may not be 
equivalent. Additionally, there is no guarantee that signaling mechanisms involved in the positive 
selection of C04+ SP cells are identical to those of COS+ SP cells. This is supported by recent 
findings obtained from SID patients who are deficient in ZAP-70 activity (37). Somewhat 
unexpectedly, thymi taken from afflicted individuals were greatly depleted for COS+ SP cells, 
while there was no evident effect on the numbers of DP and C04+ SP cells. The defect in the 
production of CDS+ SP cells was also manifested in the periphery. CDS+ cells were absent in 
secondary lymphoid compartments but C04+ cells were easily detected, also indicating that a 
deficiency in ZAP-70 activity leads to the production of nonfunctional C04+ cells. Thus, these 
observations suggest that ZAP-70 activity is required for the OP to COS+ SP transition yet is 
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nonessential for the DP to CD4+ SP transition and that signals transduced in DP thymocytes 
following TcR-ligand interactions that induce positive selection of CD8+ SP cells are not identical 
to those that induce positive selection of CD4+ SP cells. The question of whether these potential 
differences are dictated by the specificity of the TcR alone or in a cell autonomous manner prior to 
TcR-ligand interaction cannot be answered at this time. 
Commitment to the Helper Versus Killer Lineage: Instructive Versus 
Stochastic/Selective Models 
It is not clear by what mechanism cells expressing class I or class IT-specific TcRs become 
CD4-CD8+ killer or CD4+cng- helper cell precursors, respectively. Two models have been 
proposed to explain CD4/CD8 lineage determination (203, 204). In the instructive model, 
coengagement of a class I molecule generates a different signal from class IT-restricted TcR/CD4 
and class II MHC interaction, thereby directing the differentiation into either killer or helper cell 
precursors. In the stochastic/selective model, commitment occurs stochastically by the random 
downregulation of either CD4 or CD8 surface expression, and cells with a complementary 
coreceptor combination, i.e., class !-restricted TcR plus CD8 or class IT-restricted TcR plus CD4, 
interacting with the appropriate MHC molecules would be selected for survival and maturation. In 
both cases, cells with mismatched TcR-coreceptor combinations are not selected and coreceptors 
play essential roles in positive selection. Evidence showing that CD4+CD8+ thymocytes 
upregulate TcR levels prior to downregulation of coreceptor support the instructive model of 
positive selection (205, 206) (the instructive model mandates that thymocytes expressing both 
coreceptors are the primary targets of positive selection). On the other hand, the existence of a 
significant population of CD4+ SP cells in class II-deficient mice that is intermediate in maturity 
between CD4+CD8+ and end-stage CD4+CD8- thymocytes as a result of having interacted with 
class I MHC (these cells are TcRhi CD69+ and have downregulated RAG-1 and TdT activities) 
implies that TcR-MHC engagement may provoke random downmodulation of either CD4 or CD8 
and a certain degree of differentiation, concepts consistent with the stochastic model (a reciprocal 
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intermediate population is found in class !-deficient mice) (207). Likewise, the rescue of ens+ 
cells in !32m-/- mice or in animals expressing a class IT-restricted TcR by overexpression of a CD4 
transgene (rescued cells express both CDS and transgenic Cn4, are class IT-restricted, and exhibit 
cytotoxic activity) (20S) suppon the notion that a two-step process is involved in thymocyte 
maturation in which initial TcR interaction with restricting MHC causes the stochastic 
downregulation of Cn4 or ens followed by selection based on compatible TcR and remaining 
coreceptor interaction with MHC. Additional studies will be required before it can be determined 
whether the instructive or stochastic/selective model more accurately describes the process of 
positive model more accurately describes the process of positive selection. Finally, neither of these 
models take into account whether commitment to the helper or killer lineage occurs prior to the nP 
stage, thus more information must be gathered in order to understand lineage commitment in the 
thymus. 
Extrathymic T -Cell Development 
The events and processes described up to this point have focused on the thymus-dependent 
generation of al3 and yo T cells. However, cells belonging to both lineage can be generated 
extrathymically. Mice bearing the nude (nu) mutation are unable to generate thymus-dependent 
subsets ofT cells due to defects associated with the thymic epithelium, but contain low numbers of 
CDS+ T cells which increases as the animal ages. Extrathymic ens+ cells can be distinguished 
from their thymus-processed counterpans by expression of CDSa-homodimers rather than CDSal3-
heterodimers and by the expression of a surface antigen encoded by the Ly-6 complex (126). A 
large portion of both extrathymically derived al3 and yS cells are associated with the gut and there is 
some evidence that the intestinal epithelium is the site where these subsets develop (209). 
Relatively little is known about the processes that control extrathymic T-cell development and 
whether T cells developing extrathymically are subject to any of the processes that control 
development ofT cells in the thymus. Recent fmdings have shown that T-lineage cells developing 
in the intestinal epithelium are subject to negative selection (210). In thymectomized radiation 
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chimeras reconstituted with fetal liver, T cells expressing potentially autoreactive TcRs were 
eliminated from the resulting donor T -cell population. It is still not clear if positive selection plays 
a role in shaping the extrathymic T -cell repertoire. 
Concluding Remarks 
In conclusion, all the information presented here indicates that the generation of functionally 
responsive T cells is highly dependent on a series of highly complex processes. On a descriptive 
level, much is known about the phenotypic states through which developing T -lineage cells 
progress while in the thymus. However, until recently, little was known about the molecular 
nature of interactions involved in specific transitions as hallmarked by specific phenotypic changes. 
The application of transgenic and targeted gene disruption techniques has provided a wealth of 
information, providing details of several crucial transitions on a molecular level. Even so, much 
work remains to produce a complete portrait ofT -cell development, as defined by both cellular and 
molecular interactions. 
Finally, based on data generated within the past two years, many of the cell surface and 
intracellular signaling components involved in mature T-cell activation are also utilized in pathways 
regulating specific transitions as immature T cells progress from one developmental stage to 
another. As in the development of any cell lineage, "naive" immature cells must acquire the 
capacity to execute specific genetic programs characteristic of the mature phenotype. With regard 
toT -cell development, one of these programs is the induction of ll...-2 gene expresion. As shown 
in vitro, induction of ll...-2 gene expression is a property exhibited by both immature TcR- and 
mature SP thymocytes (211), whereas cells in the immediate transition from the TN to DP stage as 
well as the majority of thymocytes represented by the DP/cortical population are refractory to 
signals that would otherwise be sufficient to induce ll...-2 gene expression in competent cells. The 
inability of cortical thymocytes to express the ll...-2 gene is manifested on a molecular level, since 
numerous transcription factors essential for transcriptional initiation of ll...-2 gene expression are 
apparently missing in DP cells (72). Thus, the ability to induce ll...-2 gene expression must be 
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"reacquired" as thymocytes progress from a functionally incompetent state to a mature/functionally 
competent one. This reacquisition process is not well understood. However, if ll...-2 is indeed 
expressed in the thymus in regions where developing T cells reside, this suggests that the thymic 
microenvironment is able to induce proper signaling pathways in immature thymocytes resulting in 
ll...-2 gene expression. Likewise, the induction of ll...-2 expression in developing thymocytes may 
be indicative of a commitment to function and/or of function reacquisition. Viewed in this light, 
tantalizing possibilities are raised with regard to whether ll...-2 gene expression is induced during 
any of the developmental transitions just described. Hence, identification of ll...-2 expressing cells 
in the thymus and characterization of interactions by which ll...-2 expression is controlled is of 
particular interest. This topic is the subject of Chapter 5. 
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Influence of activating stimulus on functional phenotype: 
Interleukin 2 mRNA accumulation differentially induced by 
ionophore and receptor ligands in subsets of murine T cells 
(ill situ hybridization/ RNA probe protoctlon/CD4, C08/antl-CD3) 
KATHLEEN L. McGUIRE*, JULIA A. YANG, AND ELLEN V. ROTHENBERG 
Division of B•ology. California Institute ofTechnoloa;y. Pasadena. CA 91125 
Communicar~d by Ray D. Ow~n. May 3/, 1988 (rec~iv~d for re"iew Novembtr 23 , 1987) 
ABSTRACT We have investigated the linkage between 
CD4 I CDS phenotype and programing for specific responses in 
primary T -cell populations. In silu hybridization has been used 
to determine the frequency of cells competent to express the 
interleukln 2 (IL-2) gene after sbort-term stimulation wlth 
various polyclonal activators. Tbe eft'ects of the T -cell receptor 
ligands Con A and anli-CDJ monoclonal antibody were com-
pared with those of a calcium ionophore that bypasses mem-
brane receptors altogether. Induction with a calcium ionophore 
and phorbol ester revealed that potential IL-2 producers not 
only constitute >85% or the cells with a CD4+ "helper/ 
inducer" phenotype but also constitute over balf of the cells 
with a cos• "killer/suppressor" phenotype. There Is no 
defect in the ability or these CDS+ cells to accumulate IL-2 
transcripts UDder these conditions. By contrast, in response to 
phorbol ester and either Con A or anti-CDJ, the CDS+ cells 
sbow an abortive IL-2 production response with rapid disap-
pearance of IL-2 mRNA. Tbls results In substantially lower 
yields of IL-2 per cell than Is made by CD4 + cells in response 
to the same stimuli. The extent to wbich these populations 
appear to have diverged in function thus depends on the 
stimulus used to trigger the response. The results suggest that 
dift'erences In signal transduction or posttranscriptional regu-
latory mechanisms, rather than effector gene inducibility ~r 
st, may initially underlie the commitment of CD4 + and CDS+ 
cells to distinct fuuctlonal roles. 
Mature T cells are functionally specialized in their responses 
to recognition of antigen. In general, T -cell lines that express 
the CD4 cell-surface glycoprotein are "helper" or "am-
plifier" cells that respond to the recognition of antigen by 
secreting iymphokines, often including the major T-cell 
growth factor intcrieukin 2 (IL-2) (1, 2). Cells that express 
CDS include most killer T cells and show little helper activity 
(3-6). This suggests that the constitutive CD4/CDS pheno-
types of T cells arc correlated with the inducibility of 
different. limited sets of functional response genes. Although 
the correlation is frequently observed in memory T cells and 
T -cell lines, it is not known how it is established during T -cell 
differentiation. When fresh CDS • cells arc activated and 
cloned, :s10% of the clones respond to stimulation by 
expression of IL-2 (5, 6). This would suggest an intrinsic 
difference between CDS • cells and CD4 • cells in programing 
for gene expression. However, in a variety of other studies, 
CDS • cells appear to make IL-2 as well as CD4 • cells (7-11). 
In the work reponed here, we used in situ hybridization and 
quantitative probe protection analyses to measure the accu-
mulation ofiL-2 mRNA in individual splenic T cells respond-
ing for the first time to different stimuli. We demonstrate that 
the majority of CD4 • and •50% of cos• splenocytes are 
The publication costs of this anicle were defrayed in pan by page charge 
payment. This article must therefore be hereby marked "odv~rtisrmrnt" 
in accordance with 18 U.S.C. §1734 solely to indicate this fact. 
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competent to accumulate similarly high levels of IL-2 mRNA 
when treated with calcium ionophore and phorbol ester. 
However, the two ceil types differ markedly in their kinetics 
of message accumulation when stimulated by means of the 
T-cell receptor with concanavalin A (Con A) or an anti-CD3 
monoclonal antibody (mAb). The results suggest that primary 
CD4 • and CDS • cells differ not so much in their intrinsic 
abilities to initiate IL-2 transcription but by a mechanism that 
limits IL-2 message accumulation in the CDS+ cells following 
stimulation by means of the T-cell receptor. 
MATERIALS AND METHODS 
Animals. C57BL/6 or C57BL/6-Tla" mice were bred in our 
facilities and used at 6-S weeks of age. 
Cell Preparation and Culture. Cell suspensions were pre-
pared from spleen, and CD4 - and CDS- populations were 
isolated as described (12). Cultures were incubated with or 
without 0.1 JLM A23187 (Sigma) and 17 nM phorbol 12-
myristatc 13-acctate (PMA). Where indicated, Con A (Phar-
macia) at 6 1-'g/ ml was used to replace A231S7 . The mAb 
against murine CD3, clone 145-2Cll (13), was kindly pro-
vided by Jeffrey Bluestone (University of Chicago, Chicago) 
via Linda Sherman (Research Institute of Scripps Clinic, La 
Jolla, CA) and was added to the cells as a I:10 dilution of 
hybridoma supernatant. Note that our culture medium con-
tains 10% fetal bovine serum and that under these conditions 
we (12) and others (14) find IL-2 RNA expression to be 
restricted to T cells. The amounts of IL-2 mRNA accumu-
lated per cell in these experiments are higher than we 
previously reponed, due, at least in part, to the use of a 
different lot of fetal calf serum, which supponed higher levels 
of IL-2 production by all T-cell populations tested (data not 
shown). Enriched T-cell populations were obtained by two 
rounds of panning using affinity-purified goat anti-mouse IgG 
(Boehringer Mannheim) as described (15). In our hands, 
nylon wool purification resulted in less B-cell contamination 
but with significant and biased losses of T cells (data not 
shown). 
In Silu Hybridization. Fixed splenocytes were hybridized 
with the "antisense" IL-2 probe as described (12). Grain 
counts were obtained from at least 500 cells per slide. The 
number of cells above background with only one grain was 
extremely variable between experiments and has not been 
included in the "positive" cell calculation. To analyze the 
distribution of IL-2 RNA in responding cells, grain counts 
from 0!:1-month exposures were used. Under these condi-
tions. most uninduccd cells still show no grains (12) and cells 
that fail to respond to induction account for most of the 
Abbreviations: IL-2, interleukin 2; mAb, monoclonal antibody; 
PMA. phorbol 12-myristate 13-acetate; nt, nucleotide. 
•Present address: Dana-Farber Cancer Institute , Jimmy Fund Build-
ing. 44 Binney Street, Boston, MA 02115. 
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zero-grain cells in an induced population (nl'). The observed 
percentage of cells in each grain count category in the 
induced population, n,. is the percentage of " true" respond-
ing cells, n;(corr), with specific hybridization above back-
ground, plus the percentage of residual nonresponding cells, 
with all grains due to background. Nonresponding cells are 
assumed to show the same grain distribution as uninduced 
cells (nu percent in the corresponding grain count category). 
Overall, they should constitute a fraction of the induced 
population, which, at most, is given by the ratio of the 
percentages of zero-grain cells in the induced and uninduced 
populations (n?/n~). Thus, for each grain count category, 
n,(corr) = n;- nu(n~ In~. Distributions of n,(corr) are plotted 
in Fig. 2. For the percentage of positive cells given in Table 
1 (column 0), the sum of all n,(corr) for grain count categories 
~2 was subjected to a further slight correction for potential 
nonspecific sticking of the probe to the induced cells , by 
subtracting the sum of n;(corr) obtained after hybridization 
with a "sense" strand probe. The sense strand probe gave a 
higher background than the antisense probe (although < 10% 
cells with s2 grains) but showed little difference between 
induced and uninduced samples. We have previously re-
ported the in situ hybridization technique to detect levels as 
low as 10 molecules per cell in our hands (12). 
Ribonuclease Probe Protection. Probe protection measure-
ments of IL-2 RNA have been described in detail elsewhere 
(12). For quantitation, the 400-nucleotide (nt) Hindlll- Acc I 
probe for the 3' half of the IL-2 mRNA was used as described. 
The integrity of the RNA was confirmed by electrophoresis 
in a 50% urea/ 5% polyacrylamide gel. The average number 
of molecules per cell was determined by liquid scintillation 
spectrometry of protected probe retained on DES1 paper by 
the following equation: pg of RNA (i.e., pg of probe pro-
tected) x (1 pmol/1.2 x lOS pg) (i.e., molecular weight of 
probe = 400 nt x 300 pg/ pmol of base) x (1/cell equiva-
lents) x (1 pmol/ 10 - 12 mol) x (6.03 x 1023 molecules per 
mol). The sensitivity of this technique is < 0.1 copy per cell 
in our hands (12) , and no IL-2 mRNA is ever detected in 
uninduced samples. To map the 5' end of the message as 
shown in Fig. 2, a 5' probe was derived from a genomic 
3.0-k.ilobase (kb) EcoRl-Hincll fragment from the 5' end of 
the IL-2 gene. This was cloned into pGEM-2, cleaved with 
Ace I, and transcribed to give the 220-nt antisense cRNA 
probe shown in Fig. 2. Riboprobe control template size 
markers (Promega Biotec, Madison, WO were used to de-
termine fragment sizes after electrophoresis. To determine 
the poly(A) sites used, the O.S-kb genomic EcoRl fragment 
Table L IL-2 mRNA accumulation by splenic T cells 
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including the fourth ex on of the IL-2 gene (16) was subcloned 
into pSP65 (T. J. Novak and E.V.R., unpublished results), 
digested with Rsa I. and transcribed with SP6 polymerase. 
The resulting 456-nt antisense transcript was used as a 3' 
probe (data not shown). 
RESULTS 
We previously demonstrated that mature splenic T cells 
accumulate large amounts of IL-2 mRNA when stimulated 
for 24 hr in the presence of the calcium ionophore A231S7 and 
PMA (12). The induction of IL-2 RNA expression in response 
to these stimuli is not influenced by the presence of accessory 
cells and is independent of antigenic stimulation (12, 17). 
Production of IL-2 mRNA is decreased by > 95% when all 
CD4 • and CDS • T cells are eliminated from the splenocyte 
population (12). Therefore, even with stimuli that do not 
require a functional T-cell receptor, IL-2 gene inducibility is 
aT-cell-specific response under these conditions. As shown 
in column D of Table 1, after 24 hr of treatment with A231S7 
and PMA, an average of20% of surviving spleen cells contain 
cytoplasmic IL-2 mRNA detectable by in situ hybridization 
analysis. The population of T cells in these splenocyte 
samples was initially 25-30% and usually declined slightly 
during culture, suggesting that the large majority of surviving 
T cells in unseparated splenic cell preparations can activate 
the IL-2 gene under these stimulation conditions. This 
interpretation was supported by two additional experiments 
analyzing responses of enriched splenic T cells. A population 
with 47% Thy-1 • cells (27% CD4 •, 16% CDS •) at the start 
of culture yielded 37% with IL-2 RNA and a population with 
7S% Thy-1 • cells (42% c04·, 27% cos•) responded to 
stimulation by IL-2 RNA expression in 47%. Quantitative 
RNase probe protection analysis demonstrated that splenic 
IL-2-producing cells accumulate, on average, about 650 IL-2 
transcripts per positive cell. 
To determine whether both CD4 • and CDS • cells partic-
ipated in this response, we used mAbs against CDS and CD4 
to mediate complement elimination of mature splenic T cells 
bearing these cell-surface markers. Over 90% of the suscep-
tible population was eliminated when cells were subjected to 
two rounds of elimination with the appropriate antibody. This 
treatment routinely allows recovery of - S5% of the expected 
number of total spleen cells in our hands. Additionally, after 
correcting for viability and total cell recovery, we calculate 
that > SO% of the input spleen cells scoring as IL-2 producers 
could be recovered in one or the other eliminated population. 
E F 
Viability % T cells in % T cells % positive cells Average no. of IL-2 Average no. of IL-2 G 
after cullUre, initial after for IL-2 RNA molecules per RNA molecules per IL-2, 
Spleen % input sample• culturet mRNAt viable cent positive cell, units/ mi ll 
Total 54 :!: 4 26 :!: 2 20-23 20 :!: 4 (3)•• 133 :!: 33 (5) 66S S30 
cos- 61 :!: 3 22 :!: o.s 13-!S 12.6 :!: 2 (3) 100 :!: 2S 794 670 
CD4- 61 :!: I IO.S :!: O.S 10-13 6.S:!: 0.7 33 :!: 3 48S 290 
All values are the average of two experiments with 24-hr stimulations by A231S7 and PMA. except where noted in parentheses. Standard 
deviations are given. · 
•As determined by now cytometry using the rat mAbs 3.1SS (anti-COS) and GKLS (anti-CD4) (IS) and fluorescein-conjugated anti-rat ~<-chain 
mAb MARIS.5 (Becton Dickinson) on an Ortho system SOH cytofluorograph with a S-W argon laser. 
t Determined by staining with anti-Thy-! antibody T24/ 31.7 (a gift ofR. Hyman. Salk Institute, La Jolla, CAJ using propidium iodide to exclude 
dead cells (R. J . Hill and E. V .R., unpubUshed results). CD4 and CDS antigens modulate after stimulation. 
t Determined by in situ hybridization analysis from 4-month exposures. 
IDetermined by quantitative RNase probe protection analysis. Quantitation is done by using a " P-Iabeled cRNA transcript (12) identical to that 
used for in situ hybridization, which exhibits a lower background than seen in Fig. I. Values given were derived from two or more independent 
RNA preparations as indicated. 
,Values in column E divided by those in column D. 
II Units of IL-2 per ml produced in 24 hr by 10" cells per ml of culture. 
••Two previously reported in situ hybridization experiments yielded 17% and 24% of total spleen positive for IL-2 mRNA at 4 weeks exposure 
(12), which included all cells with 2:1 grain above background. 
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The levels of IL-2 RNA accumulated by the eliminated 
populations similarly account for S5% of the IL-2 RNA 
expressed in the unfractionated spleen cells. Therefore, 
complement treatment does not appear to interfere with the 
ability of the surviving cells to express the IL-2 gene . 
Quantitative RNasc protection analysis (Fig. 1 A. and B) 
demonstrated that strikingly similar amounts of IL-2 RNA 
could be induced in eliminated splenocyte populations, 
whether the cells depleted were CDS+ or CD4 ... (compare 4 -
and g- in lanes marked A23187 + PMA). Table 1 (column E) 
shows that populations from which all CD4 ... cells had been 
removed accumulated only three times less IL-2 RNA than 
populations from which only cos~ cells were removed. As 
we have previously noted (12), removal of CD4 + and CDS + 
cells resulted in >95% loss of inducible IL-2 RNA expression 
under these conditions. Assuming that B cells and nonlym-
phoid cells survive equally in both eliminated populations, 
this implies that a significant fraction of the IL-2 RNA 
inducible in total spleen is present in CDS + cells. Indeed, 
both induced populations included significant fractions of 
cells with IL-2 transcripts detectable by in situ hybridization 
(Table 1, column D). In at least five experiments with 
eliminated or unfractionated populations, we have noted that 
CDS .. cells are slightly enriched and CD4 + cells are slightly 
depleted following stimulation (Table 1, column C, and 
unpublished results). Hence, the 12.6% positive cells in the 
CDS - population presumably reflect responses from among 
the 13-15% CD4 ... cells remaining, and the 6.S% positive 
cells in the CD4 - population were drawn from the 10-13% 
Cos• cells (Table 1, compare columns C and D). This 
suggests that at least 80% of CD4 + cells and about 50% of 
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The accumulation of IL-2 RNA in response to A231S7 and 
PMA was similar in individual CD4 .. and CDS+ cells. As 
demonstrated by the representative in situ hybridization 
analysis shown in Fig. 2, the grain distributions for 1L-2 
producers within the CD4 - and CDS - depleted populations 
were hardly distinguishable, except in the overall percentage 
of cells involved. This result agrees with calculations from 
the quantitative RNase protection analysis, which implied 
that Cos• IL-2 producers a_!:cumulate high levels of IL-2 
RNA (-500 molecules per cell) , although somewhat lower, 
on average, than individual CD4 + IL-2 producers (-800 
molecules per cell; Table 1, column F). As shown in column 
G of Table 1, IL-2 protein was secreted by all populations in 
relative amounts consistent with the amount of IL-2 RNA 
present at 24 hr (compare columns D and F). RNase mapping 
of the IL-2 RNA accumulated by these cells demonstrated 
that all three populations use identical 5' start and 3' poly(A) 
sites (Fig. 1 and data not shown), further indicating that the 
IL-2 RNA present is in the form of the mature, functional 
message. Taken together, these measurements indicate that 
about half of the surviving Cos• T-cell population can 
respond to A231S7 and PMA by accumulation of bona fide 
IL-2 mRNA to levels comparable to those in CD4 • cells. 
To test further whether such a high fraction of CDS .. cells 
is inducible, we have used two other sets of results to 
calculate the expected frequencies of potential IL-2 produc-
ers, x and y, in the CDS • and CD4 ... populations, respec-
tively. One set of results is that for total spleen (Table 1) in 
which about 23% of surviving cells after stimulation were T 
cells. The relative survival rates of CD4 + and CDS + cells 
(column C) imply that 10% were CDS + and 13% were CD4 +. 
The second set of results is from the analysis of enriched T 
cells described above, in which 42% of input cells were CD4 ... 
Anti·CD3 A23ta7 
+ PMA ~
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FIG. 1. Quantit.ation and mapping of S' ends of lL-2 mRNA accumulated by splenic T cells in response to various stimuli. (A) RNase 
protection of an Ace l-Hincll cRNA probe spanning the JL-2 cap site, using cytoplasmic RNA isolated after 24 hr in culture with A23187 or 
Con A and PMA. The migration of the fragment protected by RNA with the reported JL-2 cap site is marked as 101 nt. - or +, Probe incubated 
with 20 1'8 of yeast tRNA and carried through the analysis as described below without (-) or with ( +) RNase A and T1 treatment, respectively. 
E , 20 1'8 of RNA isolated from the thymic lymphoma EL4.E1, stimulated for 4 hr with 10 n8 of PMA per ml , as a positive control. T , Total 
spleen; 4-, CD4 - spleen; 8-, CDS - spleen. For all samples stimulated with A23187, S x JO" cell equivalents (16-211'1! of RNA) were used, 
and for the total, CD4-, and CDS- Con A-stimulated samples, 107 , 1.3 x 10'. and 9 x 10" ceU equivalents (20-28 1'8 of RNA) were used , 
respectively . The exposure time shown was 2 days . IL-2 RNA levels in these Con A-stimulated samples were measured to be 6 molecules per 
cell for total spleen. 2 molecules per cell for CDS- spleen, and 0.2 molecule per cell for CD4- spleen. (B) Total, CD4- , and CDS- splenocytes 
were stimulated for 24 hr with PMA and either A23187 or a 1:10 dilution of anti-CD3 bybridoma supernatant, and 1 x 107 cell equivalents of 
cytoplasmic RNA from each was used to protect the IL-2 probe. The exposure time was 20 hr. In these samples, the S' probe was used for 
quantitation. The levels of JL-2 RNA per cell were calculated to be 207, 173, and 206 molecules per cell for the total , cos- , and CD4- cells 
stimulated with A23187 and PMA. respectively, and 26, 23, and 1 molecule per cell for total, cos-, and CD4- cells stimulated with anti-CD3 
and PMA. respectively. (C) RNase protection as inA, using 2 x 107 cell equivalents (30-441'1!) of cytoplasmic RNA isolated from cells stimulated 
for 6 hr. This film was exposed for 6 days. The levels of lL-2 RNA quantitated in these samples were 10 molecules per cell for total spleen, 
S molecules per cell for cos- spleen, and 3 molecules per cell for CD4- spleen. 
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FtG. 2. Distribution of IL-2 mRNA accumulated in different 
classes of splenic IL-2 producers in response to A23187 and PMA. 
Total, CD4-eliminated, and COS-eliminated spleen cells were cul-
tured with or without inducers and probed for IL-2 RNA by in Jitu 
hybridization . The histograms plot the corrected percentages of cells 
in induced populations (n,(corr)]that exhibited the indicated numbers 
of grains in a representative experiment. Higher grain numbers are 
associated with higher numbers of transcripts per cell (12). The grain 
counts for each population, induced and uninduced . were determined 
from a 4-week exposure (29 days) of a representative experiment, 
and the corrected histograms were derived by subtracting back-
ground values. The similarity between the distributions ofiL-2 RNA 
among producing cells in all three populations was observed in three 
experiments. 
and 27% were cos•. Here, about 90% of the input cells were 
viable 24 hr after stimulation, suggesting only minor popu-
lation changes. At most, if all dying cells were CD4 • , the 
stimulated cells were 35% CD4 • and 30% CDS • . These 
values can be used to solve for x andy with two independent 
equations. (i) The fraction of cells positive by in situ hybrid-
ization is 
Fraction inducible = (CD4 ... poststimulation)y 
+ (Cos• poststimulation)x. (11 
(ii) As shown in Table 1, column E, CD4-eliminated spleen 
cells make one-third as much IL-2 RNA as COS-eliminated 
spleen cells (i.e., 33 ::!:: 3 vs. 100 ::!:: 2S). Then, if an average 
CDS • responder has 500 copies of IL-2 RNA and an average 
CD4... responder has SOO copies, it follows that (CDS ... 
poststimulation)(500x) = 1/3(CD4 ... poststimulation)(800y), 
or 
(COS • poststimulation)x = 
S/ 15 (CD4 • poststimulation)y. [2] 
In the total spleen analysis, the average fraction inducible 
is 0.2 (Table 1, column D). By using our estimates for CD4 + 
and CDS+ subsets after stimulation, y- 1.0 and x = 0. 7, with 
almost all CD4 + cells and over half of CDS+ cells respond-
ing. Similarly, in the experiment with enriched T cells, 0.47 
of the cells could express IL-2 RNA. Depending upon 
whether CD4 + cells are assumed to have died preferentially, 
values for y range from 0.73 to 0.9 and those for x range from 
0.54 to 0.61. These are in good agreement with the previous 
values and those estimated from CD4- or COS-eliminated 
populations (Table 1). Altogether, these calculations indicate 
the consistency of the in situ hybridization analyses and 
support the competence of at least half of splenic CDS+ cells 
to make IL-2. 
To test whether the mode of triggering influenced respon-
siveness, we replaced A231S7 with either of two polyclonal 
stimuli that could mimic more physiologic triggering by 
binding to the T -cell receptor-i.e., the lectin Con A or a mAb 
against the£ subunit ofCD3. In aU cases, PMA was added to 
67 
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obviate the requirement for accessory cells. RNase probe 
protection analysis demonstrated that 24 hr of culture with 6 
l'g of Con A per ml stimulated spleen cells to express lL-2 
mRNA, although at lower levels (by a factor of -10-20) than 
in cultures induced with A231S7 (Fig. 1 legend). Consistent 
with the levels of RNA detected, Con A-stimulated cultures 
also secrete, on average, fewer units of IL-2 activity per ml 
(by a factor of 10-30) than A23187-stimulated cultures (data 
not shown). However, the effects of Con A on CD4 + and 
cos+ cells were not the same. As shown in Fig. lA, probe 
protection analysis revealed that CD4- splenocytes ex-
pressed only about 1/ lOth as much IL-2 mRNA as cos-
cells after 24 hr of stimulation with Con A and PMA. They 
correspondingly secreted lower titers of IL-2 (by a factor of 
8-10) than CDS - splenocytes during the incubation (not 
shown). The poor IL-2 response of CDS ... cells did not result 
from an overall inability to respond to Con A and PMA, for 
CDS+ cells were fully activated to express IL-2 receptors 
(J .A.Y., data not shown). As shown in Fig. lB, CDS .. cells 
also expressed less IL-2 mRNA (by a factor of at least 10) 
than CD4 ... cells when stimulated for 24 hr with anti-CD3 and 
PMA. Thus. although many or most CDS ... cells can accu-
mulate IL-2 mRNA similarly to CD4 ... cells when stimulated 
with a calcium ionophore, they do not appear to do so when 
stimulated by Con A or by anti-CD3 . 
The differences in overall accumulation of IL-2 protein are 
consistent with a prolonged disparity between the levels of 
translatable IL-2 mRNA in CD4 + and CDS ... cells, but they 
do not rule out a brief response in the cos+ cells. This was 
of concern because time course analysis of IL-2 R.i'lA 
accumulation in total spleen revealed that the kinetics of the 
accumulation were different in response to Con A and PMA 
than for A231S7 and PMA (Fig. 3). In response to Con A, an 
initial peak was seen at 6 hr of stimulation, then a decline and 
a second peak at 24 hr, instead of the continued increase 
through 24 hr of stimulation induced by A231S7. This is 
consistent with previous reports of a peak in IL-2 mRNA 
expression ..,5 hr after induction with mitogen (9, 10, 19). To 
analyze the initial activation process, we compared the levels 
of IL-2 mRNA in splenic subpopulations after only 6 hr of 
stimulation with Con A (Fig. lC). In three experiments with 
either Con A or anti-CD3 stimulation, we found that cog+ 
cells contribute at least half as much accumulated IL-2 
mRNA as CD4 ... cells at this time point. This result suggests 
Con A + PMA A23187 + PMA 
6 12 18 24 30 6 12 18 24 30 
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FtG. 3. Time course of IL-2 mRNA production by total spleen 
cells in response to different stimuli. Cell cultures consistin& of 4 x 
107 cells supplemented with Con A and PMA and 2 x 107 cells 
supplemented with A23187 and PMA were incubated for the indi-
cated times (given in hours). One-half of the resulting cytoplasmic 
RNA isolated from each culture was blotted in descending 2-fold 
serial dilutions as described (12) . Viable cell equivalents ranged from 
13 to 20 x 10" cells for Con A and 6.5 to 10 x 10" cells for A23187. 
with the lowest numbers of viable cells in the 6-hr Con A and 24-hr 
A23187 cultures and the highest numbers in the uninduced controls. 
The autoradiograph shown is an overnight exposure of the filter 
hybridized with an IL-2 eDNA probe. 
Immunology: McGuire et a/. 
that CDS • T cells may initially activate the IL-2 gene when 
stimulated by means of the T -cell receptor for antigen. but 
that under these conditions , cos• and CD4 .. cells differen-
tially regulate subsequent IL-2 mRNA accumulation. 
DISCUSSION 
We have used in situ hybridization to measure the compe-
tence of individual splenocytes to express the IL-2 gene prior 
to any antigen-driven clonal expansion. This approach has 
revealed a strikingly broad phenotypic distribution of cells 
with intrinsic competence to make IL-2. for many or most 
CDS • cells as well as CD4 • cells are fully competent under 
certain stimulation conditions. A difference between CD4 • 
and cos• IL-2 producers emerged, however, in their re-
sponses to different polyclonal activators. Though the cal-
cium ionophore induced sustained IL-2 RNA accumulation in 
both , the membrane receptor ligands Con A and anti-CD3 
provoked a limited IL-2 production response in the cos• 
cells as compared to the CD4 .. cells. Thus, many cos• 
splenocytes appear to differ from CD4 • cells not so much in 
their potential to express the IL-2 gene as in their interpre-
tations of particular l!Ctivation stimuli. 
Previous work (9-11, 20, 21), using bulk culture and limiting 
dilution analysis. has established that some CDS • cells have the 
ability to secrete IL-2, but it did not reveal the prevalence of 
potential IL-2 producers in the cos• population that we 
observe upon stimulation with calcium ionophore and PMA. 
Several methodological differences may explain our findings . 
We have looked within the ftrst 24 hr of stimulation, which may 
be important for detecting IL-2 production by cos• cells (cf. 
refs. 20 and 21). In particular, in situ hybridization analysis 
allows us to look at the primary T -cell response prior to clonal 
expansion. Recent studies using the Pgp-1 marker to identify 
memory cells (22) support the interpretation that most (70%) of 
our splenic CDS • cells are indeed virgin T cells. By contrast, 
A231S7 and PMA do not induce IL-2 RNA in many long-term 
killer cell lines (f. J. Novak and E .V.R., unpublished data), 
suggesting either that CDS • cells may lose this capacity after 
exposure to antigen (20, 21), or that those that proliferate 
extensively in vitro come primarily from the noninducible 
fraction . In any case, the inducibility of!L-2 in about half of the 
cos· cells after stimulation with calcium ionophore and 
phorbol ester clearly shows that in virgin cos• cells the IL-2 
gene need not be locked in an inactive chromatin configuration. 
1be gene itself may always be competent to be expressed in 
mature primary T cells. 
Although there appears to be little difference between 
CD4 • and CDS • cells in the potential inducibility of their 
IL-2 genes by A231S7 and PMA, there is a clear difference in 
their abilities to accumulate IL-2 mRNA following prolonged 
stimulation with PMA and either Con A or mAb directed 
against CD3. Similarly, in response to antigen, IL-2 produc-
tion is apparently limited to certain responding T cells 
dominated by, though not restricted to, cells of the CD4• 
phenotype (4-6). Our results from the ~hr stimulation with 
T -cell receptor ligands, as well as previous reports in the 
literature (9, 10), support the hypothesis that transcription 
may initially be comparable in the two cell types but that 
RNA accumulation is limited at a later step in cos• cells. 
Such a mechanism might affect the accumulation of IL-2 
transcripts in individual cells or decrease the frequency of 
responding cells. Several laboratories have reported that 
cycloheximide , which blocks protein elongation, enhances 
the lectin-induced accumulation of IL-2 mRNA (9, 10, 23) 
without affecting the transcriptional activity of the gene (24). 
These data suggest that a protein product may be responsible 
for limiting IL-2 mRNA accumulation after stimulation with 
lectin. CD4• and Cos• T cells might differentially express 
this regulatory protein product, with its expression being 
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particularly prominent in Cos• lymphocytes. The accumu-
lation of high levels of!L-2 mRNA in both subpopulations of 
mature T cells and the kinetics of that response suggest that 
ionophore and phorbol ester may bypass this proposed 
regulatory mechanism altogether. Further work is required to 
test this possibility directly . However, the results presented 
here persuasively suggest that the difference between cells 
committed to "IL-2-producing" and "non-IL-2-producing" 
lineages may not be attributed either to the chromatin 
structure of the IL-2 gene or to the initial availability of 
specific transcription factors for IL-2. Particularly in these 
primary T -cell populations, signal transduction and/ or RNA 
stabilization mechanisms may play a vital role in regulating a 
surprisingly plastic set of functional responses. 
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Developmental and Anatomical Patterns of IL-2 Gene 
Expression In Vivo in the Murine Thymus 
JULlA A. YANG-SNYDER and ELLEN V. ROTHENBERG• 
Drvisron of Biology. 156-29. Californra Institute o{Ttehnology, Pasadena, California 91125 
Interleukin-2 (IL-2) is a potent growth factor that mature T lymphocytes synthesize and 
use as a proliferation signal. Much controversy has arisen concerning whether it is used 
to drive the extensive proliferation of immature pre-T cells in the thymus. Immature 
thymocytes acquire the competence to express IL-2 at an early stage, but it has remained 
uncertain whether they are activated to exercise this competence in vivo. Therefore, we 
have used in situ hybridization and immunohistochemistry on serial sections obtained 
from fetal and adult thymuses of normal C57BL/6 mice and of mice bearing the scid 
defect to determine where, when, and whether IL-2 is expressed in vivo. Our results 
show a striking spatial and temporal pattern of IL-2 expression in the normal fetal 
thymus. We detected a burst of IL-2 mRNA accumulation at day 14.5 of gestation, which 
rapidly decreased by day 15. At day 15, we observed maximal IL-2 protein production 
that subsequently decreased by day 16 of gestation. Both in situ hybridization and 
immunohistochemical staining revealed an unexpectedly strict localization of IL-2 
expressing cells to patches around the periphery of the fetal thymus, creating a 
previously unrecognized compartment of high IL-2 protein content. IL-2 production in 
the day-15 fetal thymus appeared to be unaffected by the scid mutation, indicating that 
this response is likely to be T-cell receptor (TcRJ-independent. Several features 
distinguish the IL-2 induction pattern in the adult thymus from that in the fetal thymus. 
In the normal adult thymus, IL-2-expressing cells are extremely rare (found at a 
frequency of 10' 7) , but they are reproducibly detectable as isolated cells in the outer 
cortex and subcapsular region of the thymus. Unlike the fetal thymic IL-2 producers. the 
IL-2 producers in the adult thymus are completely ehminated in mice homozygous for 
the scid mutation. This suggests that the IL-2-expressing cells in the normal adult 
thymus are of a more mature phenotype than the immature, TcR-negative cells that 
accumulate in the scid adult thymus. Thus, our work demonstrates that two 
developmentally distinct types of cell interactions induce IL-2 expression in vivo: one, a 
broadly localized interaction in day 14-15 fetal thymus that is unaffected by the scid 
mutation; the other, a rare event that occurs asynchronously from late fetal through 
adult life, but which is completely eliminated by the scid defect. These results imply that 
significant differences exist between the physiological processing of thymocytes in the 
fetal and postnatal thymic microenvironments. 
KEYWORDS: lnterleukin-2 (IL-2). interleukin-2 receptor (IL-2R), thymus, in situ hybridization, immunohistochemistry, severe 
combined immunodeficiency lscrd), T-cell receptor <TcR). 
INTRODUCTION 
T cells, unlike other cell types of the hemato-
poietic lineage, differentiate in the thymus, 
•corresponding author. 
85 
where differentiation is accompanied by exten-
sive proliferation, apparently triggered by 
mitotic signals from the thymic stroma. Thymus-
specific lymphostromal interactions are critical 
for driving T-cell development, yet both the 
nature of the signals and the molecular basis of 
their impact remain unknown. Among the 
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properties acquired and modulated as thymo-
cytes develop is the competence to express 
"response" genes that drive proliferation in 
mature T cells, such as the gene encoding the 
potent growth factor interleukin-2 {IL-2) 
(McGuire and Rothenberg, 1987; Howe and Mac-
Donald, 1988; Rothenberg et al., 1988; Tentori et 
al., 1988b; Fischer et al., 1991; Chen and Rothen-
berg, 1993). Although the inducibility of these 
genes at certain stages of differentiation is easily 
demonstrable under artificial conditions in vitro, 
it is not known whether intrathymic signals pro-
vide inductive stimuli for these genes in vivo. 
Thus, it is unclear to what extent growth factors 
such as IL-2 are normally available to contribute 
to the hormonal microenvironment of the thy-
mus. Similarly, it has remained uncertain 
whether the characteristic signaling pathways 
that activate IL-2 expression in vitro are utilized 
in normal thymocyte development in vivo. 
Recent gene-disruption experiments have for-
mally proven that IL-2 is not required for the 
generation of normal cell populations in the thy-
mus (Schorle et al., 1991). However, severe per-
turbations can be induced in thymocyte develop-
ment, in vivo or in organ culture, by anti-IL-2R 
antibody treatment (Jenkinson et al., 1987; Ten-
tori et al., 1988a; Zufliga-Pfliicker and Kruisbeek, 
1990; Zufliga-Pfliicker et al., 1990), by the 
addition of excess IL-2 (Skinner et al., 1987; Plum 
and de Smedt, 1988; Waanders and Boyd, 1990), 
or by the introduction of a transgenic IL-2Ra 
chain with inappropriate species specificity 
(Kroemer et al., 1991). Thus, the possibility 
remains that IL-2 production in vivo plays some 
developmental role. Furthermore, studies from 
our own laboratory and from others have shown 
that the intrinsic competence to express the IL-2 
gene is shared by both mature and immature thy-
mocytes (Howe and MacDonald, 1988; Rothen-
berg et al. , 1990; Fischer et al., 1991). However, it 
is unknown whether the thymic microenviron-
ment can actually provide signals to induce IL-2 
expression in either or both populations of thym-
ocytes. Therefore, IL-2 production (1) could 
potentially be induced at any of several stages in 
vivo and (2) might cause autocrine or paracrine 
effects, either early or late in T-cell development. 
These issues make it instructive to determine the 
conditions under which developing thymocytes 
actually exercise their competence to express IL-2 
in vivo. 
Several laboratories have analyzed cytokine 
expression during fetal thymocyte development 
in vivo as an approach to determine which factors 
might be present in the thymus during T-cell 
development. Von Boehmer and coworkers 
initially reported that IL-2 is secreted as fetal thy-
mocytes mature in organ culture (Kisielow et al., 
1985). Subsequent studies have shown that 
murine embryonic thymocytes harvested at dif-
ferent times during gestation express a variety of 
cytokine mRNAs, using either in situ hybridiz-
ation to cytocentrifuged preparations of freshly 
isolated cells (Carding et al., 1989, 1990; Zufliga-
Pfliicker et al., 1990) or reverse transcription/ 
polymerase chain reaction (rtPCR) analysis of 
total RNA samples obtained from fetal thymuses 
(Montgomery and Dallman, 1991). Most of these 
studies have focused exclusively on dissociated 
cell suspensions, making localization and identi-
fication of the IL-2-expressing cells within the 
thymus impossible. On a more general level, 
these studies have failed to distinguish between 
the developmental events involved in the fetal 
ontogeny of the thymus itself and those involved 
in the maturation ofT-cell precursors processed 
therein. In adult animals, thymocyte develop-
ment generates a different spectrum ofT-cell sub-
types than that generated during thymocyte 
development in the fetus (reviewed in Rothen-
berg, 1992). This could be attributable either to 
differences in the thymic environment or to the 
difference in hematopoietic origins between the 
precursors that seed the fetal and the postnatal 
thymus (lkuta et al., 1990). Thus, it is 
not clear whether IL-2 production is a universal 
feature of T-cell development or a peculiarity 
of the cell types present in the fetal 
thymus. 
In order to examine the spatial and temporal 
pattern of IL-2 gene expression as induced nat-
urally during T-cell ontogeny in vivo, we have 
used a combination of in situ hybridization and 
immunohistochemical staining of mouse thymus 
sections isolated at different stages of develop-
ment. Our findings show different and distinc-
tive patterns of IL-2 gene expression in fetal ver-
sus adult thymuses. Additionally, IL-2 gene 
expression appears to be normal in the fetal thy-
mus but perturbed in the adult thymus of ani-
mals that cannot generate mature T cells as a 
result of the severe combined immunodefficiency 
(scid) mutation. 
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RESULTS 
Developmental Pattern of IL-2 Gene 
Expression in the Fetal Thymus as Determined 
by In Situ Hybridization 
Figure 1 shows the patterns of IL-2-specific 
hybridization in the murine fetal thymus at dif-
ferent stages of gestation as defined using 590 nt 
antisense or sense riboprobes. At day 14, a few 
highly positive cells were found , mainly in the 
outer region of the thymus (Fig. 1A). At day 14.5, 
the outer region of the thymus contained a dra-
matically increased number of highly positive 
cells, clustered in distinctive, large patches of 
hybridization one cell deep that "outlined" the 
periphery of the tissue (Fig . 1C). At this stage of 
gestation, no corticomedullary boundary was 
observed in the thymus; cells appeared equally 
distributed throughout the organ (Figs. 1C and 
1D). Although the majority of sections of day 14.5 
fetal thymus did not include any regions of 
strong hybridization, every thymus examined 
contained sections exhibiting this striking localiz-
ation of highly positive cells. By day 15, the per-
centage of IL-2 mRNA positive cells decreased, 
and only an occasional highly positive cell was 
found (6-8 per half lobe equivalent; Fig. 1E). Iso-
lated positive cells were also observed later, at 
day 18 of gestation, and distinct cortical and 
medullary regions were identifiable by this time 
by DAPI staining (data not shown). The remain-
ing IL-2 mRNA positive cells in the fetal thymus 
at later stages of gestation were still restricted to 
the cortex and not to the medulla. Thus, highly 
positive IL-2 mRNA-expressing cells were pre-
sent at day 14 of gestation in the fetal thymus and 
some highly positive cells persisted through day 
18 of gestation. However, a dramatic peak of 
highly localized IL-2 gene expression was 
observed at day 14.5, which decreased abruptly 
by day 15. 
Pattern of IL-2 Expression in the Fetal Thymus 
at Different Stages of Development by 
Immunohistochemistry 
To confirm the pattern of IL-2 expression as 
determined from the in situ hybridization data, 
fetal thymuses isolated at various stages of ges-
tation were also stained with an anti-IL-2 mAb 
(Fig. 2). At day 14-14.5, weak immunoreactivity 
was observed (Fig. 2A; data not shown). At day 
15, strong staining appeared in the outer region 
of the tissue (Fig . 2C). This staining pattern was 
not seen when normal rat IgG was substituted for 
the anti-IL-2 mAb (Fig. 20); the IL-2 specificity of 
the staining reagent was further confirmed by 
control experiments with excess rmuiL-2 (see 
below). At day 16, immunoreactivity was still 
present around the periphery of the thymus, 
albeit at a reduced level (Fig. 2E), and at day 18, 
only isolated immunoreactive cells were found in 
the cortical region. A background of endogenous 
peroxidase-positive cells became detectable by 
day 18 (data not shown), but these cells could be 
distinguished from IL-2 immunoreactive cells by 
prior blocking and peroxidase quenching (for 
additional controls, see below). Nonetheless, 
based on these characteristics, the pattern of IL-2 
protein expression, detected by immunohistoch-
emistry, recapitulated the pattern of IL-2 mRNA 
accumulation as determined by in situ hybridiz-
ation. Additionally, maximum IL-2 protein 
expression was observed 12 hr following maxi-
mum IL-2 mRNA accumulation. 
Vr3 and CD16 Expression versus IL-2 
Expression in Day 15 Fetal Thymus as 
Determined by Immunohistochemistry 
IL-2 has been implicated in the growth of Vr3• T 
cells and natural killer (NK) cells from the fetal 
thymus in vitro (Skinner et a!., 1987; LeClerq et 
a!., 1990). Therefore, we were interested in 
determining whether intrathymic IL-2 was 
associated with the generation or expansion of 
particular subsets of T cells or NK cells in .the 
fetal thymus in vivo. By day 15 of g~stahon, 
almost all of the rare thymocytes expressmg sur-
face TcR specifically utilize the Vr3 segment in 
TcR gene rearrangements (Havran and Allison, 
1988). Likewise, the majority of cells in the fetal 
thymus at day 15 of gestation express CD16 
(FcRII/III; Rodewald et al., 1992), a marker that 
persists preferentially on pre-NK and NK ce~ls. 
We used a Vr3-specific (536) or CD16-spectftc 
(2.4G2) mAb along with the IL-2-specific mAb for 
immunohistochemical staining of adjacent serial 
sections of day 15 fetal thymus to determine ~he 
relative location of Vr3· and CD16• cells wtth 
respect to IL-2-producing cells (Fig. 3). A.t this 
stage of gestation, the majority of the cells m the 
fetal thymus were cytoplasmic CD3c• (data not 
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FIGURE 1. 
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shown)_ CD16. cells were detected in a hetero-
geneous distribution throughout the fetal thy-
mus. Vr3· cells were also detectable in a similar 
distribution (Fig. 3), but were substantially less 
abundant than CD16• cells. Neither cell type was 
concentrated in the peripheral region of the lobe. 
Thus, these results gave no clear evidence for 
colocalization of IL-2-producing cells with either 
Vr3 or CD16 expression (see Discussion). 
IL-2 Expression in the Scid Day 15 Fetal Thymus 
Mice homozygous for the scid mutation fail to 
rearrange their TcR genes normally, causing a 
developmental arrest that blocks the production 
of all classes of TcW thymocytes (Bosma and 
Carroll, 1991). In order to determine whether the 
scid defect affected IL-2 expression in the fetal 
thymus, we used immunohistochemistry to 
detect IL-2-producing cells in the scid day 15 fetal 
thymus (Figs. 2I to 2L). Scid day 15 fetal thy-
muses appeared normal in terms of the intensity 
and localization of IL-2 immunoreactivity (Fig. 
21). This staining was also shown to be IL-2-
specific. When an excess of exogenous recombi-
nant IL-2 was added, IL-2 immunoreactivity was 
abolished (Figs. 2K and 2L); as a control, addition 
of recombinant IL-4 had little effect (data not 
shown). Likewise, the gross architecture and size 
of the scid day 15 fetal thymus appeared to be 
normal in terms of cell density and number (data 
not shown). In situ hybridization of scid day 15 
fetal thymus sections revealed that a similar 
number of highly labeled IL-2 mRNA positive 
cells were present as compared to the normal 
counterpart (data not shown). Hence, at this 
stage of gestation, TcR rearrangement and 
expression are not prerequisites for IL-2 
expression in vivo. 
Analysis of IL-2Ra expression confirmed the 
lack of gross perturbation of thymocyte develop-
ment in scid mice at this age. When sections were 
stained with a rat anti-mouse IL-2Ra mAb, nor-
mal and scid day 15 fetal thymuses were similar 
with regard to the number and distribution of IL-
2Ra· cells in the thymus (Figs. 4A and 4B). By 
contrast, differences were readily apparent when 
comparing the IL-2Ra staining pattern of the nor-
mal versus scid adult thymus. The overwhelming 
majority of the cells in all regions of the scid adult 
thymus are IL-2Ra·, ·as compared with the 
irregular clusters of IL-2Ra• cells in the cortex of 
the normal tissue (Figs. 4C and 4D). This aberrant 
IL-2Ra staining pattern of the scid adult thymus 
convincingly showed the developmental arrest-
blocking progression beyond the IL-2Ra• imma-
ture stage. These staining results indicated that 
the scid mutation did not severely affect the con-
trol of IL-2 or IL-2Ra expression in the fetal thy-
mus, in spite of its severe developmental effects 
observed in the adult thymus. 
In Situ Hybridization of Normal Adult Thymus 
Sections 
In previous analyses of cytocentrifuged prep-
arations of adult thymus cell suspensions, we 
had failed to detect any cells expressing IL-2 
mRNA (McGuire and Rothenberg, 1987; Rothen-
berg et al., 1990). Ribonuclease protection assays 
failed to detect any IL-2 transcripts in samples of 
up to 100 pg of adult thymus total RNA, roughly 
equivalent to the amount of RNA isolated from 
half a thymic lobe (400 pg total RNA / thymus; 
data not shown). However, the results of four 
independent experiments confirmed the presence 
of extremely rare, highly labeled IL-2 mRNA-
positive cells in the thymus of 4-week-old mice. 
Approximately 160 sections hybridized alter-
nately with each strand of the 430-nt probe were 
analyzed per experiment (approximately 320 sec-
tions examined overall, corresponding to a thy-
mus lobe; i .e ., a half lobe equivalent for each 
probe). Highly labeled cells were found only in 
sections that had been hybridized with the anti-
sense riboprobe. These IL-2-positive cells were 
reproducibly found in the outer cortex and sub-
capsular region of the thymus (Fig. SA); the corti-
cal versus medullary regions of the thymus were 
distinguished by higher or lower cell density 
within the section, as shown by DAPI staining 
(Figs. 4A and 4B). Surprisingly, of all the IL-2-
FIGURE 1. (See Colour Plate VI at the back of this publication). In situ hybridization to sections of normal thymuses from days 
14 to 18 of gestation for IL-2 expression, using either a 3'5-labeled, 590-nt IL-2 antisense P.NA probe OL-2; Figs. lA, IC, IE, I G) or 
the complementary sense strand (NC; Figs. 1B, 10, IF, I H). Samples were counterstamed w1th DAPI and observed under dark 
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expressing cells detected, none was ever located 
in the medullary regions, where mature cells are 
expected to reside. 
The "intensity" of specific hybridization shown 
for the cortical IL-2 mRNA-positive cells was 
similar to that observed using the same probe in 
parallel to analyze EL4 thymoma cells that had 
been induced for 5 hr with calcium ionophore 
and phorbol ester to serve as a calibration 
standard I sensitivity control (data not shown). 
Roughly 70% of these cells accumulated IL-2 
mRNA following induction, and a positive cell 
contained approximately 220 IL-2 transcripts 
(Table 1). An average of 10 positive cells per half 
lobe was determined (Fig. 6) and , based on the 
assumption that an average thymic lobe con-
tained 1.5x108 cells (3x108 cells per thymus total, 
data not shown), the frequency of IL-2 mRNA 
positive cells among thymocytes was estimated 





roughly 200 IL-2 transcripts per positive cell in 
the thymus (based on the similarity to induced 
EL4 cells; data not shown and Table 1), the num-
ber of IL-2 transcripts per average cell in the 
adult thymus was calculated to be on the order of 
3xlo-s copies per cell, or a total of 2000 tran-
scripts in a 100 J.Jg RNA sample (equivalent to 
half a thymic lobe). This amount of RNA is two 
orders of magnitude lower than the threshold of 
detection for ribonuclease probe protection 
analysis under our conditions (see Materials and 
Methods). 
Immunohistochemical Staining of Normal 
Adult Thymus Sections Using Anti-IL-2 
Antibody 
The presence of rare IL-2 producers in the adult 
thymus was confirmed by immunohistochemical 
staining. Figure 7 A shows a typical, isolated IL-2 
FIGURE 3. (See Colour Plate VUI at the back of this publication). lmmunoperoxidase staining of normal day 15 fetal thymus, 
comparing localization of IL-2 producing cells, Vy3· and CD16" cells. Adjacent serial sections were stained with either S4B6 (anti· 
!L-2 mAb; F1g. 3A), 536 (anti·Vr3 mAb; Fig. 3B), 2.4G2 (anti..CD16/ FcRll mAb; Fig. 3C), or normal rat I~G (NC; F1g. 30>. The 
5486 sample was stained as in Fig. 2, and 536, 2.4G2, and NC samples were developed w1th ruckel/ cobalt·enhanced 
d1aminobenzidine. Arrowheads denote representative areas of immunoreactivity. 
77 
92 J.A. YANG-SNYDER AND E.V. ROTHENBERG 
immunoreactive cell found in the normal adult 
thymus. As for the IL-2 mRNA-positive cells 
detected by in situ hybridization, the IL-2 immu-
noreactive cells were exclusively restricted to the 
cortex. About 25-32 immunopositive cells were 
observed per half lobe (data not shown). Non-
specific, peroxidase-positive cells were present in 
the adult thymus (possibly macrophages or other 
bone marrow-derived cells), but this background 
was drastically reduced when sections were 
avidin-biotin blocked prior to staining and 
quenched for exogenous peroxidase activity. 
Under these conditions, sections stained with 
normal rat IgG did not contain immunoreactive 
cells (Fig. 7B). The staining seen in the thymus 
was similar in intensity to that observed in a 
positive staining control containing mature T 
cells activated in vivo (Fig. 70). Sections of lymph 
nodes isolated 8 days following immunization 
showed characteristic parafollicular staining with 
the anti-IL-2 mAb, in good agreement with the 
pattern of IL-2 immunoreactivity reported in the 
literature (Bogen et al., 1991 ). Addition of 
exogenous recombinant IL-2 abrogated the 
appearance of these immunoreactive cells (Fig. 
7C), confirming that reactivity seen with this 
mAb was IL-2-specific. 
IL-2 mRNA Positive Cells Are Absent in the 
Adult Thymus of Scid Mice 
Because the IL-2 mRNA-positive/immunoreac-
tive cells were restricted to a region in the adult 
thymus where rapidly proliferating immature 
cells are found, it was important to establish 
whether the IL-2 positive cells in the adult thy-
mus were immature. Therefore, we examined 
thymuses of adult scid mice that are enriched at 
FIGURE 4. (See Colour Plate IX at the back of this publication). Direct immunofluroescence staining of normal and scid thymus 
sections using a phycorerythrin·<:<mjugated rat anti-mouse CD25 (IURa) mAb. Figures 4A and 48 show day 15 fetal and young 
adult thymus sections obtained from normal mice, respectively, and Figs. 4C and 40 show comparable sections obtained from 
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TABLE I 
Titration of 430-nt 3"-IL-2 Probe by Ribonuclease A, Tl Pro tection Using Total RNA Isolated from Induced EL4 Cells 
% induced % lL-2 No. copies N o. cop ies No. copies No. copies 
EL4' m RNA' lL-2 IL-2 per I~-2 per IL-2 per 
by in situ• protected' avg . cen• induced cell' mRNA'cell' 
I 0.64 1.5xi O' 1.5 150 234 
2 1.4 2.9xl0' 2.9 145 207 
5 3.4 7.1xl 0' 7.1 140 206 
10 8.1 1.8x107 18 180 222 
20 13.9 3.3xl07 33 165 240 
50 35.0 7.9x107 79 160 229 
100 74.0 1.7x1o" 170 170 230 
The average number of copies IL-2 per IL-2 m RNA • cell=224±18 
"EU c~Us tndu~ for S hr wtth aloum aonophorr and phorbol estn Weft nuud wtth unmduced ELA cells at ttw ~tages md 1ated (a total of S)(JO' vuble cell 
equavalenb pft" w mplf') 
Total RNA wu n tru ted acrordmg to the method descn~ by ChomcZytUiu •nd S.ccht (1987) 
On4!'-ftfth o f each sample (or RNA from l • Hf «II equtnlmts) wu used prr prot«tton No protrction was obsorrved above bu kground ustng toUd RNA tso~ted from 
urundu~ EU cells 
.,dmhnl w mples of crlls Wft'f' pr<X'ftM'd as described i.n ~tt'rials and Mf'thods 1nd analyud by rn sttu hybndlUtiOn. Stgn.~ls from at lu st SOIX) cells w rre ~malyud per 
wmple. 
'No. coptts protected • convn$to n factor )C phosphor tmagrr value for prot«ted product 
cpm und 1gested probt used pn protect1on 
• ng f!Ob! uwd per prot«bon x 6 x 10"' moleculf'S mole 
molec W1 protected product peT 
wherr tlw conven1on factor • (bquJd sanbllahon cpm• detenru~ lo r know n amounts of unc:h gested probe 
phosphor unager value) 
• No coptes IL-2 prote-cted 
1 )( 10" 
, No. cop1es IL-2 P!"' avg. aU 
~ md EL4 • 10 1 
1 No cop1es ll-2 ~ tnd all • ::-::--:.,::...::'nd::::-7ue<d'!:::..::E:::IA:..__ 
~ll-2 mRNA. by 1n srtw 
least 100-fold for immature thymocytes at all 
stages leading up to the CD3·Co4-cDs- (TN) IL-
2Ra• stage of development (see Fig. 4) (Bosma 
and Carroll, 1991). If the IL-2 mRNA-
positive/ immunoreactive cells in the thymus of 
normal animals were of an immature phenotype, 
they should be present in greater numbers in the 
scid adult thymus than in the normal counterpart. 
On the other hand, if these cells had matured 
past the stage of TcR gene rearrangement, they 
should be depleted in the scid adult thymus. In 
situ hybridization revealed that IL-2 mRNA·posi-
tive cells were conspicuously absent from the scid 
adult thymus; both antisense and sense probes 
gave identical results in all sections analyzed 
(Figs. SD and SE). The absence of hybridization 
in the scid adult thymus samples was not due to 
artifactual degradation of probes hybridized to 
the scid thymus sections, because alternate sec-
tions hybridized with IL-2Ra antisense probes 
yielded strong signals (Fig. SF), consistent with 
the results obtained from direct immunofluoresc-
ent staining (Fig. 40). 
For direct quantitative comparison, hybridiz-
ation of scid thymus sections were carried out in 
parallel with hybridization of normal thymus 
sections (Fig. 6). On average, fewer sections per 
scid thymus were analyzed than per normal thy-
mus because scid adult thymuses were substan-
tially smaller than normal adult thymuses (scid 
thymuses, which lack all TcR• cell types, contain 
approximately 1/ 100 the number of viable cells 
found in normal thymuses; data not shown). Due 
to the reduced cell numbers in the scid adult thy-
mus, the frequency of IL-2-expressing cells could 
not be proven to be lower in the scid adult thy· 
mus than in the normal adult thymus on a ~ 
cell basis. Nonetheless, the depletion of IL-2 
mRNA·positive cells per lobe in the scid thymus 
was highly significant (Fig. 6). 
The absence of cells producing IL-2 protein in 
the scid adult thymus was difficult to confirm by 
immunohistochemistry due to a high back· 
ground of endogenous, peroxidase-positive cells 
that were "reactive" in the absence of specific 
antibody, even after extensive H20d peroxidase 
quenching (data not shown). Nevertheless, based 
on the unambiguous in situ hybridization data, it 
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Average Number of Sections Hybridized with Either Strand: Norma IE 162 
scid -= 80 
Average Number of Sections Analyze<! per Experiment: Normal:324 
scid •160 
FIGURE 6. Compiled data of in situ hybridization for IL-2 
expression in adult thymus from normal and scid mice. Adult 
thymus sections from normal and scid animals (open and 
shaded points, respectively) were analyzed by in situ 
hybridization with the 430-nt antisense or sense IL-2 RNA 
probe. Approximately half a thymic lobe was hybridized with 
each probe. The results using the antisense probe were 
compiled from four independent experiments. No signals were 
detected with the sense probe (data not shown). Normal and 
scid sections hybridized and analyzed in parallel are denoted 
with identical shapes (circles, diamonds). Positive cells were 
considered as having greater than 10 silver grains. The 
average, total numbers of sections analyzed per normal and 
scid thymus were 320 and 80, respectively, corresponding to 
complete thymic lobes. Slides were exposed for 21 days. 
appeared that IL-2 mRNA-positive cells in the 
normal adult thymus were very likely to be of a 
more mature phenotype than the developmen-
tally arrested thymocytes found in the scid adult 
thymus. 
DISCUSSION 
Our results show that IL-2 expression is induced 
in thymocytes by intrathymic signals in vivo. This 
expression is subject to complex developmental 
regulation that constrains the possible roles of IL-
2 as a mediator of signals. On the other hand, the 
induction of IL-2 itself serves as a probe for 
specific cell-cell interactions, which reveal sur-
prising differences between the fetal and adult 
thymus. 
Restricted Activation of IL-2 Expression in the 
Fetal Thymus 
Our results show that the day 15-16 fetal thymus 
includes distinct, substantial zones of low and 
high regional IL-2 protein concentration, in good 
agreement with the results of Waanders (1990) . 
Twelve hours prior to maximal protein pro-
duction, a burst of IL-2 message accumulation is 
observed in cells restricted to the identical area 
where IL-2 protein will be found, namely, the 
periphery of the fetal thymus. The combined in 
situ hybridization and immunohistochemical 
staining data reported here for day 14.5-15 fetal 
thymus show that only a minority of the cells in 
the fetal thymus were expressing IL-2 message or 
protein at the given time points. This interpret-
ation is not in complete agreement with that of 
Zuniga-Pflticker et a!. (1990), who reported that 
50-60% of fetal thymocytes expressed IL-2 
mRNA at day 15 gestation, based on in situ 
hybridization to cytocentrifuged samples. The 
disparity in percentage of IL-2 mRNA-positive 
cells could be due to any of several factors. 
Because the kinetics of IL-2 expression are clearly 
transient, our time points might have missed the 
true peak. Alternatively, the timing of the actual 
impregnation of the mice could be affected by the 
setting of the 12-hr light-dark cycle in the 
respective mouse colonies, leading to apparent 
shifts in kinetics. Also, in principle, there could 
be a lower threshold of detection for in situ 
hybridization to cytocentrifuged cell suspensions 
than to tissue sections. Finally, as Zuniga-
Pflticker eta!. (1990) did not subdivide categories 
of IL-2 mRNA-positive cells based on silver grain 
count, they might have included cells that we 
would not consider to be unequivocally IL-2-
positive. However, our immunohistochemical 
staining data support our in situ hybridization 
results, indicating that only a highly localized 
minority population express IL-2 protein that is 
detectable at days 15-16 of gestation. Thus, 
according to these staining results, if 50-60% of 
cells do express an IL-2 message at the time of 
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FIGURE 7. (See Colour Plate XI at the back of this publication). Immunoperoxidase staining of normal adult thymus and 
activated lymph node (removed 8 days after immunization) for IL-2 immunoreactivity. Figures 7A, 7B, and 7C show adjacent 
serial sections from a normal adult thymus. Figure 7 A shows a section containing an isolated immunoreactive cell located in the 
cortex following staining with the anti-IL-2 mAb, 5486. No immunoreactive cells were found in the same region in an adjacent 
section following staining with normal rat IgG (Fig. 7B). Specificity of staining was shown by staining the remaining adjacent 
section with anti-IL-2 mAb preincubated with rmuiL-2 (Fig. 7C; also see legend for Fig. 2) . Activated lymph node sample was 
counterstained with methyl green (Fig. 70). Magnification x200. 
maximal IL-2 mRNA accumulation in the fetal 
thymus, then only a fraction of those cells 
(corresponding to the highly positive cells we 
detect) ultimately synthesize IL-2 protein. 
IL-2 as an Effector: Constraints on the 
Intrathymic Role of IL-2 
The nonuniform distribution of IL-2 raises the 
possibility that the zones of high IL-2 expression 
may represent specific sites for expansion and 
differentiation of particular subsets of thymo-
cytes. Initial candidates for such IL-2-regulated 
subsets that we have considered here are the 
Vr3• subset of ro thymocytes and fetal thymic 
NK cells, both of which are highly responsive to 
IL-2 in vitro. The first wave of surface CD3• cells 
in the fetal thymus at day 15 of gestation specifi-
cally utilize the Vr3 gene segment in TcR r-chain 
gene rearrangement (Havran and Allison, 1988; 
Allison and Havran, 1991). These Vr3• cells leave 
the thymus soon afterwards and are undetectable 
in the thymus by the time of birth (Allison and 
Havran, 1991), and are exclusively found associ-
ated with the epidermis in postnatal mice 
(Havran and Allison, 1988). In vitro exposure of 
late fetal thymocytes to high concentrations of IL-
2 resulted in the preferential expansion of Vr3• 
cells relative to other TcR• lineages (LeCierq et 
al., 1990). IL-2 also influences the production of 
NK cells; recent findings revealed that cells exhi-
biting substantial NK activity can be generated in 
vitro from cultures of CD16• cells isolated from 
day "15.5'' fetal thymus (equivalent to day 14.5 in 
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our terminology) grown in moderate amounts of 
IL-2 (Rodewald et al., 1992). Furthermore, trans-
genic mice constitutively expressing IL-2 and IL-
2Ra chain show great preferential expansion of 
NK cells (Ishida et a!., 1989). Based on these data, 
the generation of either of these cell types in the 
fetal thymus in vivo could be positively regulated 
by the local concentration of IL-2. However, 
when we examined Vy3, CD16, and IL-2 
expression in the day 15 fetal thymus by 
immunohistochemical staining, we were unable 
to show a relationship between the localization of 
Vy3• or CD16• cells and IL-2 producers (Fig. 4). 
Although we cannot formally disprove the possi-
bility that Vy3- or CD16- precursors of either cell 
type respond to IL-2, these results make it 
unlikely that IL-2 is limiting for the generation of 
Vy3• T cells or CD16• cells (presumptive T I NK 
precursors) in the fetal thymus in vivo. The tar-
gets for the burst of fetal IL-2 production there-
fore remain undefined. 
In contrast to the results obtained from day 
14.5-15 fetal thymuses, IL-2-expressing cells are 
extremely rare in the adult thymus with a fre-
quency on the order of 10-7, as determined by 
both in situ hybridization and immunohisto-
chemical staining. Any cells responding to IL-2 in 
the adult thymus in vivo would most likely need 
to be in close proximity to these IL-2 producers, 
based on the minimal diffusion of IL-2 protein 
observed in the cortex. Unlike IL-2 production in 
the fetal thymus, no continuous zones of high IL-
2 concentration are found in the adult organ. Fur-
thermore, IL-2 may be available in these local 
sites for only a limited time. Our data suggest 
that the steady-state frequency of IL-2-expressing 
cells reflects the asynchronous activation of dif-
ferent rare cells. In the adult thymus, cells pro-
ducing IL-2 protein were detected at an approxi-
mately threefold higher frequency than cells 
expressing IL-2 mRNA at any one time. The IL-2 
mRNA is known to be labile (Shaw et al. , 1988; 
Lindsten et al., 1989), and our results with the 
fetal thymus indicate that IL-2 protein can persist 
in the thymus at least 1 day longer than IL-2 
mRNA. Thus, we interpret the excess of IL-2 
immunoreactive cells over IL-2 mRNA-positive 
cells as evidence that IL-2 gene induction in the 
adult thymus is also transient but asynchronous; 
that is, that most cells synthesizing IL-2 protein 
have already shut off synthesis of the short-lived 
IL-2 mRNA. When the resulting limited avail-
ability of IL-2 is compared with the 10-20% of 
thymocytes that are actively in cycle (Penit, 1986; 
Boyer et al., 1989), it is clear that thymocyte-
derived IL-2 is grossly inadequate to drive the 
extensive proliferation in this organ. 
Our results support the finding that transgenic 
mice homozygous for an IL-2 gene disruption 
did not make IL-2 and yet generated all major 
thymocyte populations in normal numbers 
(Schorle et al., 1991). However, the extreme rarity 
of IL-2-rich "niches" in the normal adult thymus 
raises a caveat about the interpretation of the 
gene disruption results. If IL-2 were normally 
required as a growth factor for a particular sub-
set of cells in the thymus, then its targets must 
represent a very minor fraction of cells in the cor-
tex, the deletion of which might not drastically 
affect thymocyte population dynamics as a 
whole. Thus, an effect of IL-2 on some minor or 
transient branch of the T-cell lineage cannot be 
ruled out. 
Developmental Significance of IL-2 Induction 
In Vivo: IL-2 as an Indicator of a Rare Activation 
Event 
What may be the most telling aspect of our data 
is the access they provide into the intrathymic 
activation events that are detected as the induc-
tion of IL-2 gene expression in the murine thy-
mus in vivo. These activation events depend both 
on the delivery of the appropriate signal from the 
thymic microenvironment and on the develop-
mental status of the responding thymocyte 
(Howe and MacDonald, 1988; Rothenberg et al., 
1990; Fischer et al., 1991). Little is known about 
the biochemical basis of thymic lymphostromal 
interactions, and key events in which activation 
signals are delivered have been more commonly 
inferred than demonstrated. On the other hand, 
the IL-2 induction response in vitro is relatively 
well characterized, both in terms of cytoplasmic 
signaling cascade and the transcription factors 
that are mobilized in the activated cells. Thus, 
our results provide strong evidence that this par-
ticular cascade of responses is indeed triggered in 
vivo in particular cells in the fetal and postnatal 
thymus. 
As both immature (TcR· ) and mature (TcRrugh) 
thymocytes can in principle make IL-2, the intra-
thymic IL-2 production observed could represent 
a response either of an immature cell, presum-
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ably to differentiating signals, or of a mature cell 
(possibly to antigen). We have utilized two 
complementary kinds of evidence to reach a pro-
visional conclusion. One is the intrathymic 
location of IL-2-expressing cells: In postnatal 
mice, the cortex is a zone of differentiation and 
precursor expansion, and the medulla is a 
domain where mature thymocytes accumulate 
and encounter circulating cells and antigen. The 
other relates to the effect of the scid mutation on 
intrathymic IL-2 expression. By preventing cor-
rect TcR gene rearrangement, this mutation 
blocks all TcR-expression-dependent events in T-
cell development while permitting those that 
precede TcR gene rearrangement. The results of 
our analysis suggest that both fetal and postnatal 
cells that make IL-2 in the thymus are responding 
to developmental signals, rather than environ-
mental antigen, but that distinct, nonequivalent 
cell types are responding to these signals in the 
fetal versus postnatal thymus. 
To elaborate, the fetal thymocytes that make 
IL-2 are unaffected by the scid mutation, even 
though the scid mutation effectively blocks the 
generation of fetal TcW thymocytes. Therefore, 
the activation signal that induces IL-2 expression 
in fetal thymocytes is likely to be delivered to 
cells at a stage upstream of the scid arrest point, 
that is, prior to TcR expression. This interpret-
ation is supported by the failure of IL-2-express-
ing cells to colocalize with TcR-expressing cells 
in the day 15 fetal thymus (i.e., Vy3• cells). By 
contrast, since the scid mutation does block the 
appearance of all IL-2-expressing cells in post-
natal thymus, it is probable that postnatal thymo-
cytes normally receive an IL-2-inducing signal 
downstream of the scid arrest point, as discussed 
further below. Thus, in the context of their own 
developmental lineage, the postnatal IL-2 
expressers are likely to be more advanced than 
the fetal IL-2 expressers. However, the cortical 
location of the postnatal IL-2 producers argues 
against any possibility that they have completed 
their intrathymic processing. Instead, the signal 
that induces IL-2 expression is apparently deliv-
ered while cells are still in the differentiative 
domain of the thymus. 
Successful induction of IL-2 expression in vivo 
indicates not only that thymocytes have the 
capacity to express IL-2 and that the thymic 
stroma has the capacity to deliver triggering sig-
nals, but also that the signal is matched to satisfy 
the activation requirements for the particular 
classes of thymocytes present. The failure of 
adult scid thymocytes to activate IL-2 expression 
could be caused by' defects in any of these 
aspects. However, our in vitro studies (Chen and 
Rothenberg, 1993; Rothenberg et al., submitted) 
clearly show that the scid thymus is significantly 
enriched for cells with the competence to express 
IL-2, provided that a certain set of triggering con-
ditions are used in vitro. Therefore, either a lack 
of inductive signal or a mismatch between the 
available signals and the requirements of the 
developmentally arrested cells seems to be impli-
cated. One possible explanation for the failure of 
cells in the scid adult thymus to express IL-2 in 
vivo would be that the scid thymic microenviron-
ment (i.e., the nonlymphoid component of the 
thymus) does not develop properly, due to the 
lack of feedback interactions from mature thymo-
cytes. Indeed, there is some evidence for architec-
tural abnormality of the scid thymus (Shores et 
al., 1990, 1991; van Ewijk, 1991). However, the 
main components reported to be reduced or 
absent in the scid thymus are medullary epi-
thelium, and as previously noted, the induction 
of IL-2 expression that we detect in the normal 
postnatal thymus is never associated with the 
medulla. Thus, another explanation for the 
inability of cells in the scid adult thymus to 
express IL-2 in vivo seems more plausible, 
namely, that the scid mutation directly prevents 
the maturation of thymocytes themselves to the 
stage where they can respond to those IL-2 
inductive signals generated by the postnatal thy-
mic cortex. In this case, responsiveness to IL-2-
inducing signals in the adult thymus in vivo 
would be at least indirectly dependent on suc-
cessful TcR gene rearrangement. Whether the 
TcR itself is implicated in the triggering event 
remains to be determined. We are currently in 
the process of defining the signals that induce IL-
2 gene expression in the postnatal thymus in vivo. 
Conclusions 
To summarize, our work shows that IL-2 is 
expressed in the fetal and adult thymus of nor-
mal mice in v ivo. Although the pattern of IL-2 
gene expression differs in the fetal versus adult 
thymus, IL-2 expression is highly localized dur-
ing both times in development. In the fetal thy-
mus, high expression of IL-2 is synchronous and 
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transient. Surprisingly, fetal thymic expression of 
IL-2 in vivo is not disrupted by the scid mutation, 
suggesting that normal TcR expression is not a 
requisite for IL-2 gene expression in the cell types 
present in the fetal thymus. On the other hand, 
IL-2 gene expression appears to be dependent 
upon TcR gene expression in the adult thymus, 
because the scid mutation abrogates the appear-
ance of IL-2-expressing cells in the adult thymus. 
Finally, our results indicate that IL-2 is available 
to cells in highly restricted areas of the thymus 
during development. Taken together, this work 
implies that TcR-independent and TcR-depen-
dent interactions are made within the thymus at 
different stages of development that, in turn, pro-
vide the proper inducing signal(s) in resident 
cells for IL-2 expression in vivo. Likewise, differ-
ences between the fetal and postnatal thymic 
microenvironments were clearly evident, both in 
terms of IL-2 protein content and in terms of the 
subsets of thymocytes induced to express IL-2 
therein. The nature of the responsive and 
responding cells, and the criteria by which they 
are distinguished from others in the same stage 
of differentiation are intriguing issues for further 
investigation. 
MATERIALS AND METHODS 
Mice 
C57BL/ 6 TJa• and C.B-17-scid animals were bred 
and maintained in our own facility. Thymuses 
from embryos at various stages of gestation were 
obtained from females using timed matings. The 
appearance of a vaginal plug was designated as 
day 0 and on this day the females were separated 
from the males. Young "adult" animals were 
used at 4 weeks of age. All scid animals were 
maintained in an Isotec flexible film isolater 
(Indianapolis, Indiana) without antibiotic treat-
ment, except those used for timed matings that 
were kept outside the isolator. 
Removal and Sectioning of Tissues 
Fetal thymuses were removed from embryos 
every 12 hr on and following day 14 of gestation 
(pregnant females were sacrificed at 10:00 A.M. 
and 10 P.M.) and were immediately embedded 
in Tissue-Tek O .C.T. compound (Miles Inc., 
Kankakee, Illinois). Thymuses removed from 
adult animals were frozen in n-pentane/ dry ice 
and stored at -70°C and embedded in O .C.T. 
prior to sectioning. For' in situ hybridization, 6-8-
pm serial cryosections were collected onto poly-
t-lysine-coated glass slides, dried briefly, fixed in 
freshly made 4% paraformaldehyde in PBS for 
1--4 min, rinsed in PBS and stored in 70% ethanol 
at 4°C. Alternatively, rinsed sections were stored 
with desiccant at -70°C and transferred to etha-
nol at 4°C , 3--7 days prior to hybridization. For 
sensitivity controls / hybridization standards, the 
murine thymoma EL4 was induced to express IL-
2 by culturing the cells in the presence of the cal-
cium ionophore A23187 (70 nM) and phorbol 
myristate acetate (PMA; 17 nM, 10 ng/ ml) for 
5 hr in RPMI 1640 (Irvine Scientific, Santa Ana, 
California) based complete medium sup-
plemented with 5% fetal bovine serum (v / v) as 
described elsewhere (Chen and Rothenberg, 
1993). Following induction, cells were harvested, 
mixed with uninduced cells at a known ratio of 
induced-to-uninduced cells, embedded in O .C.T., 
sectioned, fixed, and stored accordingly. For 
immunofluroescence and immunohistology, 6-8-
pm cryosections were collected onto 3-aminopro-
pyltriethoxysilane (Fluka, Ronkonkoma, New 
York) coated slides, air dried for approximately 
1 hr, fixed in cold acetone for 10 s and stored 
with desiccant at -20°C. For activated lymph 
node samples, adult mice (8-12 weeks) were 
immunized by hind foot pad injection using 
Freund's complete adjuvant. Popliteal, inguinal, 
and pericardia! lymph nodes were removed 8 
days after immunization and tissues were pro-
cessed as described before. 
Hybridization Probes 
All IL-2 probes used for in situ hybridization 
were IL-2 eDNA fragments cloned into the poly-
linker of the pGEM-1 and -2 plasmids (Promega, 
Madison, Wisconsin) using standard procedures. 
To ensure IL-2-specific hybridization, RNA 
probes did not include the CAG-repeat located in 
the 5'-region of the IL-2 eDNA. Two IL-2 RNA 
probes were used; a 590-nucleotide (nt) probe 
gave a strong signal, and a 430-nt AT-rich probe 
(contained within the 590-nt probe) gave 
extremely low backgrounds. For the 590 nt probe, 
a 750-base pair (bp) Pstl-Acci fragment derived 
from the full-length IL-2 eDNA (DNAX, Palo 
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Alto, California) was subcloned into pGEM-1 
and -2 (pCmiL2-1, -2). For the 430-nt probe, a 
430-bp Hindiii-Acci fragment derived from the 
same full-length eDNA clone was also subcloned 
into pGEM-1 and -2 (pmiL2.3-1 , -2; McGuire and 
Rothenberg, 1987). The pCmiL-2 plasmids were 
linearized with Pvull and the pmiL2.3 plasmids 
were linearized with Hindiii . The IL-2Ra probes 
were derived from two IL-2Ra eDNA fragments 
(Miller et al., 1985), a 5' 410-bp Pstl fragment and 
an internal 460-bp Taqi-Pvull fragment. Both 
were subcloned into pGEM-1 and were lin-
earized with Hindiii . 3-'5-labeled sense or anti-
sense transcripts were synthesized using T7 RNA 
polymerase as described previously (McGuire 
and Rothenberg, 1987; McGuire et al. , 1988). 
Transcription products were resuspended in 
200 JJI of 100 mM DTT and 0.1% SDS in 10 mM 
Tris, 1 mM EDT A, pH 7.4, and stored at -70°C 
prior to use. All steps in the procedure were car-
ried out using solutions made with diethylpyro-
carbonate-treated water and RNase-free glass-
and plasticware. 
In Situ Hybridization 
For each in situ hybridization experiment, alter-
nate serial sections were hybridized with anti-
sense and sense (negative control, "NC" in 
figures) riboprobes. Cells were only considered 
positive where the signal with the antisense 
probe clearly exceeded the sense-strand back-
ground. Hybridization was carried out with 
modifications to a protocol described previously 
(Rothenberg et al. , 1990). The hybridization 
buffer described previously was modified by the 
addition of 4 mM vanadyl ribonucleoside com-
plexes, and hybridization was carried out for 
8-12 hr. Following hybridization, cover slips 
were soaked off in 4xSSC. Unhybridized probe 
was removed with three washes in SO% formam-
ide, 2xSSC, 10 mM DTT, and 1% 2-ME at sooc 
(1 hr each). Slides were briefly rinsed in 2xSSC, 
transferred to digestion buffer (0.5 M NaCI, 
10 mM Tris-HCl, pH 7.4, 1 mM EDTA) containing 
40 JJg/ml RNase A and 40 U/ml RNase T1 and 
digested at 37°C for 30 min, after which slides 
were transferred to digestion buffer with 20 mM 
DTT and 1% 2-ME and incubated at 37°C for an 
additional 30 min. Slides were subsequently 
washed overnight in 50% formamide, 2xSSC, 
10 mM DTT, 1% 2-ME at 45°C and I or in 2xSSC, 
1 mM DTT, 1% 2-ME at 45°C for 30 min . In each 
case, the final wash was in 0.1 xSSC, 0.1% 2-ME at 
room temperature for 20 min. Slides were dehy-
drated in 30, so, 70, and 95% ethanol containing 
0.3 M ammonium acetate, dried for 1 hr and 
dipped in NTB-2 emulsion (Eastman Kodak Co., 
Rochester, New York) diluted at a ratio of 2 to 1 
with 0.9 M ammonium acetate. Slides were 
exposed for 12-21 days, developed at 13°C for 
3 min in GBX developer (Eastman Kodak Co.), 
briefly rinsed in 2% acetic acid, and fixed for 
7 min in Ektaflo fixer (Eastman Kodak Co.). 
Counterstaining was done with 250 JJg / ml 4,6-
diamidino-2-phenylindole (DAPI) at room tem-
perature for 1-2 hr or with hematoxylin and 
eosin for 2 min and cover slips were mounted 
using Permount (Fisher Scientific, Fair Lawn, 
New Jersey). Dual dark field and fluorescence 
microscopy were used for analysis. 
Antibodies 
The rat anti-mouse IL-2 mAb, S4B6, was obtained 
commercially at a concentration of 1 mg/ ml 
(Pharmingen, San Diego). Normal rat IgG was 
reconstituted at a concentration of 20 mg/ ml 
(Miles Inc., Kankakee, Illinois) . lmmunoselect 
phycoerythrin (PE)-conjugated rat anti-mouse 
CD25 was purchased from Gibco BRL 
(Gaithersburg, Maryland), and biotinylated ham-
ster anti-mouse CD3£ (145-2C11) and fluorescein 
(FITC)-conjugated Vf.' TcR (536) mAbs were pur-
chased from Pharmingen. Biotinylated rabbit 
anti-rat IgG or goat anti-hamster IgG (both 
mouse-absorbed) were obtained from Vector 
(Burlingame, California) or CALTAG Labora-
tories (San Francisco), respectively. The 
hybridoma 2.4G2 (rat anti-mouse CD16; 
FcRII/ III) was grown in Fetal Clone II (Hyclone 
Sterile Systems, Logan, Utah) and pooled culture 
supernatants were used neat for staining. 
Immunohistochemistry 
The immunohistochemical staining protocol was 
adapted from procedures described by Farr et al. 
(1990) and Bogen et al. (1991 ). Sections were 
warmed to room temperature, fixed in cold ace-
tone for an additional 2 min, transferred to 1% 
formaldehyde in PBS for 1 min, and washed in 
PBS for 5 min. Sections were blocked with 50 
,ug/ ml avidin in PBS, followed by treatment with 
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250 ,ug/ml D-biotin in PBS, each for 20 min. Sec-
tions were then washed in PBS/ 0.025% sodium 
azide (NaN3) and incubated with 2% normal 
mouse serum (Cappel/Organon Teknika Co., 
Durham, North Carolina) and 2% normal rabbit 
serum in PBS/1% BSA/ 0.025% NaN3 in a 
humidified chamber at room temperature for 
30 min. After every subsequent incubation, sec-
tions were washed with PBS/ NaN3. Following 
blocking steps, sections were incubated with 10 
,ug/ ml primary antibody or normal rat IgG in 
PBS / BSA/ NaNJ at room temperature for 1 hr. 
Sections were then incubated with 10 ,ug/ ml bio-
tinylated secondary staining reagent (mouse 
absorbed) in PBS/ BSA/ NaN3 at room tempera-
ture for an additional hour. Subsequently, sec-
tions were refixed in 2% paraformaldehyde in 
PBS for 10 min and quenched with 0.6% H 20 2 in 
methanol for 15 min . Following extensive wash-
ing in PBS, staining was detected using an 
avidin-biotin-horseradish peroxidase complex 
(Vectastain Elite ABC; Vector Laboratories) and 
diaminobenzidine (DAB) as the enzymatic sub-
strate (as described in the Vectastain protocol). 
Blocking experiments were performed using 
recombinant murine IL-2 or IL-4 purchased from 
Genzyme (Boston) and were carried out by pre-
incubating the primary antibody with an excess 
of recombinant lymphokine (1000 U/ml} at room 
te~perature for at least 1 hr prior to staining. 
Nickel/cobalt-enhanced staining was achieved 
using 30 mg NiCh and 30 mg CoCh per 10 ml 
DAB: H202 developing solution. 
Direct Immunofluorescence 
Staining procedure was modified from a protocol 
provided by Calbiochem (La Jolla, California). 
Sections were warmed to room temperature, 
fixed in cold acetone and briefly in 1 o/o formal-
dehyde in PBS, and washed in PBS. Sections were 
then blocked with 2% normal mouse serum in 
PBS/BSA/NaN3. Following a PBS/NaN3 wash, 
sections were incubated with 6-10 ,ug/ml pri-
mary antibody in PBS/BSA/NaN3 in a humidi-
fied chamber for 1 hr. Sections were washed 
again with PBS/Na azide. Stained sections were 
covered with 2-4 drops of Fluorosave Reagent 
(Calbiochem, La Jolla) and cover slips were 
mounted and sealed with clear nail polish. 
Ribonuclease Probe Protection 
Total RNA from samples containing known per-
centages of induced anti uninduced EL4 was iso-
lated using the technique published by Chom-
czynski and Sacchi (1987). Probe-protection 
measurements of IL-2 mRNA using the 430-nt IL-
2 probe have been described elsewhere (McGuire 
and Rothenberg, 1987; McGuire et al., 1988). The 
average number of molecules per cell was deter-
mined using a Phosphor Imager (Molecular 
Dynamics, Sunnyvale, California) and assuming 
complete recovery of protected products from 
each sample of 106 cell equivalents. The sensi-
tivity of this technique was 0.2 copies per cell (or 
a total of 1x105 copies per RNA sample isolated 
from 106 cells; data not shown), and no IL-2 
mRNA was detected in uninduced samples. 
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Title: Identification of IL-2 Expressing Cells in the Skin: A Potential Role of IL-2 in the 
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SUMMARY 
Upon activation by foreign antigen, a subset of mature T lymphocytes synthesize 
interleukin-2 (~-2), a potent T-cell growth factor. ~-2 is an important mediator of the primary 
immune response. It is responsible for pushing resting T cells into cycle, resulting in the clonal 
expansion of antigen-specific T cells. Although it is unlikely that ~-2 drives the extensive 
proliferation of immature pre-T cells in the thymus, it is not known whether ~-2 participates in 
the autocrine or paracrine expansion of certain cell types belonging to the T lineage to populate 
the tissues in which they are found. For example, in order for fetally-derived V 13+ yo TcR+ cells 
to populate the epidermis, the tissue with which they are associated, extensive extrathymic 
expansion is required. Several in vitro findings suggest that V13+ T cells may use ~-2 as a 
proliferative signal. We have used in situ hybridization and immunohistochemical staining on 
epidermal samples obtained from mice of different ages to determine the extent of ~-2 
expression in the skin. Our results revealed that maximal ~-2 mRNA and protein accumulation 
was observed in the epidermis at a time when the V 13+ population is still expanding. Cells that 
express ~-2 mRNA have a distinctive dendritic morphology, characteristic of resident T cells 
found associated with the skin. Likewise, striking similarities between the pattern of ~-2 
expression and distribution ofT cells exist at this point are no longer detectable in the epidermis, 
indicating that ~-2 expression in the skin is temporal and transient. ~-2 expression is absent in 
the epidermis of SCID mice. The SCID mutation also inhibits the appearance ofT cells in the 
skin. Taken together, the results obtained in SCID mice further reinforces the notion that ~-2 
expressing cells associated with the skin associated with the epidermis belong to the T lineage. 
In addition, ~-2 is expressed by aJ3+ T cells in the epidermis of aj3 TcR transgenic mice in which 
-yO TcR expression in the skin is suppressed, thereby indicating that ~-2 expression in the skin is 
not specified by TcR expression. The results presented here demonstrate that ~-2 may play a 
role in the post-thymic expansion of a particular population ofT cells in the absence of an active 
immune response. 
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The proliferation of antigen-specific cells is pivotal for the success of the vertebrate 
immune response. In a health animal, the frequency of any particular antigen-specific mature 
cell is low in lymphoid organs or in blood, thus clonal expansion of antigen reactive effector 
cells is necessary following immunologic challenge. This amplification process is regulated by 
the synthesis of specific lymphokines. One such factor that regulates antigen-induced T-cell 
proliferation is interleukin-2 (IL-2). The production of D...-2 is triggered in particular subsets ofT 
lymphocytes only upon activation as a result ofT-cell receptor (TcR) engagement with cognate 
MHC molecules and foreign antigen. IL-2 acts as a mediator to push resting T cells into cycle. 
Once T cells are stimulated to produce IL-2, the lymphokine is available to induce both autocrine 
and paracrine effects (1-3). IL-2 is clearly essential for antigen-driven T-cell proliferation in the 
primary immune response, but it remains largely unknown if IL-2 participates in the expansion 
ofT -cell populations in certain tissues that is not related to exposure to foreign antigen. 
Targeted disruption of the IL-2 gene in mice has shown that IL-2 is not essential for the 
generation of normal cell populations in the thymus, indicating that IL-2 is not required for 
driving the extensive proliferation of immature pre-T cells (4). However, even though IL-2 -/-
animals have normal numbers of T cells in lymphoid organs, these phenotypically mature cells 
were immunologically incompetent (4). Albeit that these studies reveal a great deal about the 
function of IL-2 in vivo, they do not disprove the possibility that IL-2 may play a role in the 
autocrine or paracrine expansion of particular T-cell subsets to populate the tissues in which they 
reside. 
One candidate for a target T-cell type that could potentially utilize IL-2 for expansion and 
maintenance of cell numbers in the periphery in vivo was initially chosen on a number of results 
obtained in vitro. To be specific, T cells of the gamma/delta ()'0) lineage that incorporate the Vy3 
gene segment in y-chain rearrangements (Vy3+ T cells) are generated during fetal ontogeny (5). 
Preferential expansion of V y3+ cells relative to other lineages has been observed upon culture of 
fetal thymic lobes (6) or cell suspensions of fetal thymocytes (7) in high concentrations of IL-2. 
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In normal mice, fetally-derived V 13+ cells comprise the vast majority ofT cells in the skin and 
are found nowhere else. In their target tissue site, V 13+ cells have a distinctive dendritic 
morphology and are often referred to as Thy-l+!fcR+ dendritic epidermal cells (DECs). In all 
likelihood, V 13+ cells recognize self-antigens expressed on keratinocytes. DEC clones can be 
activated by keratinocytes or fibroblasts treated with tryptic digests of keratinocytes to produce 
detectable amounts of IL-2 and IL-2 production is blocked by the addition of anti-CD3e or anti-
Vy3 mAbs.. Similarly, DEC clones can be stimulated to produce IL-2 and upregulate IL-2 
receptor (IL-2R) a-chain in response to the lectin, concanavalin A (ConA) or to CD3 
eros slinking (9). At the time in gestation when V 13+ cells are generated, the fetal thymus 
contains only about 0.5-1.0 x 105 cells. Hence, in order to populate the epidermis at a density of 
approximately 6-8 x 102 cells Jmm2 in the adult animal, extensive extrathymic expansion of 
V 13+ cells is required. As suggested by the findings described above, one growth factor that 
could potentially regulate this process is IL-2. 
To determine whether IL-2 is produced in the skin of normal mice, we have used a 
combination of in situ hybridization and immunohistochemical staining of epidermal samples 
obtained from mice of varying ages. Our findings reveal several striking features about IL-2 
gene expression in the skin. IL-2 mRNA and protein are easily detected in the epidermis at a 
time when the V 13+ cell population is expanding. Once V 13+ cells have reached steady-state 
numbers in the skin, IL-2 gene expression is downregulated. IL-2 producing cells are also found 
in the skin of mice expressing transgenic TeRn- and j3-chain genes in which ab T cells and no ..,.o+ 
cells are associated with the epidermis. Finally, the presence of IL-2 expressing cells in the skin 
is contingent upon the generation of mature T cells, since IL-2 expression is not detected in 
epidermis removed from mice that are unable to generate mature T cells as a result of the severe 
combined immunodeficiency (SCID) mutation. 
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MATERIALS AND METHODS 
Mice 
C57BL/6 Tia+, af3-TcR specific for H-2Ld transgenic (10, 11), and C.C.-17-SCID mice were 
bred and maintained in our own facility. al3-TcR transgenic animals were rederived to be virus-
free, backcrossed to either BIO (Jackson Laboratories, Bar Harbor, Maine) or B10.S (Charles 
River Laboratories, Willmington, MA) genetic backgrounds, and were kept on sterile food and 
bedding. All SCID animals were maintained in an Isotec flexible film isolator (Indianapolis, IN) 
without antibiotic treatment. Day 15 fetal thymuses were obtained from fetuses removed from 
pregnant BL/6 Tia+ and SCID mothers using timed matings. The appearance of a vaginal plug 
was designated as day 0. 
Removal and Processing of Tissues 
Mice were killed by cervical dislocation. For preparation of ear epidermal sheets, ears were 
collected and hair was removed by shaving with a single edge razor blade or by using a hair 
removal wax strip kit (Sally Hansen/Del Laboratories Inc., Farmingdale, NY). Shorn ears were 
then floated on 0.5 M ammonium thiocyanate (SIGMA, St. Louis, MO) in 0.1 M phosphate, pH 
6.8, outer surface not submerged, and incubated at 37°C for 10-15 min. The outer epidermis was 
separated from the underlying tissue and immediately washed in cold phosphate buffered saline 
(PBS). For in situ hybridization using 35S-probes, ear epidermal sheets were air dried onto 
poly-L-lysine coated slides, fixed in freshly made 4% paraformaldehyde in PBS for up to one 
hour on ice, rinsed in cold PBS and stored in 70% ethanol at 4°C. Samples were used within 
seven days after processing. For unmounted digoxygenin (dig) in situ hybridization, ear 
epidermal sheets were blotted dry on paper towels and fixed in 4% paraformaldehyde solution 
for up to one hour on ice, rinsed in cold PBS, dehydrated in graded ethanols and also stored in 
70% ethanol at 4 °C. For immunohistochemical and immunofluorescence staining, epidermal 
sheets were fixed in acetone for up to one hour at room temperature, after which they were 
rehydrated in PBS and stained on the same day. Activated lymph node and fetal thymus samples 
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were prepared as described in (12). Neonatal whole body samples for in situ hybridization were 
generated by quickly decapitating newborn pups, washing bodies in PBS and embedding 
immediately in Tissue-Tek O.C.T. (Miles Laboratories, Kankakee, ll...). 8 J.Lm sections were 
collected onto poly-L-lysine coated slides, briefly air dried, and fixed in 4% paraformaldehyde 
solution for 10 minutes on ice. Following a wash in cold PBS, slides were air dried completely 
and stored with desiccant at -80°C prior to hybridization. At least 12 hours before hybridizing, 
slides were thawed and transferred to 70% ethanol and kept at 4 °C. 
Hybridization Probes 
All probes used have been described previously (12). Details for the synthesis of 35S-labeled 
transcripts are given elsewhere (13, 14). In vitro transcription of labeled RNAs using dig-11-
UTP was carried out according to the manufacturer's specifications (Boehringer Mannheim 
Biochemicals, Indianapolis, IN; 15). Transcription products were resuspended in 200 J.Ll of 
100 mM DTT and 0.1% SDS at -80°C prior to use. 35S-labeled transcripts were used within a 
week, while dig-labeled probes were used up to six months after synthesis. 
In situ Hybridization 
Whole body section were hybridized to 35S-probes as given in (12). Ear epidermal sheets 
isolated from the same animal were used per single hybridization experiment, as one sheet was 
hybridized to a labeled ll...-2 antisense RNA and the other to the corresponding sense probe. 
Hybridization using 35S-probes was performed with slight modifications to a protocol described 
previously (12). Following rehydration of samples in PBS, epidermal sheets immobilized on 
glass slides were digested with 2 J.Lg/ml proteinase Kin PBS for 5-10 min. at room temperature. 
Digestion was stopped by transferring samples to 0.2% glycine in PBS for 2-3 min. Samples 
were rinsed in PBS, refixed in 4% paraformaldehyde in PBS for 20 min. at room temperature, 
and rerinsed in PBS. Prehybridization and hybridization treatment, removal of unhybridized 
probe and high stringency washes were carried out as detailed in (12). However, prior to RNase 
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digestion, hybridized samples were first washed in 2.5X SSe, 50 mM DTI, and 1% 2-ME for 
1-2 hours with gentle agitation, and then in 2.5X SSe for 30 min. at 37°e. For unmounted in 
situ hybridization using dig-labeled probes, a procedure was adapted from a published protocol 
(15). Briefly, fixed, unmounted epidermal sheets were rehydrated in graded ethanols, washed in 
PBST (PBS containing 0.1% Tween-20) and briefly digested in 2 ~g/ml proteinase K in PBS for 
2-4 min. at room temperature. Digestion was stopped upon transfer to 0.2% glycine in PBS for 
2-3 min. Samples were then rinsed in PBST, refixed in 4% paraformaldehyde solution for 20-30 
min., and rinsed again in PBST. Samples were acetylated with 0.3% acetic anhydride in 0.1 M 
triethanolamine, pH 7. Following another PBST wash, samples were soaked in 0.1 M Tris-
Glycine, pH 7.4 for 30 min. and transferred back into PBST. All steps following refizzation 
were performed at room temperature with agi tation. Samples were prehybridized in 
hybridization buffer without probe (50% deionized formamide, 10% PEG-8000, 600 mM Nael, 
20 mM Tris-Hel, pH 7.4, 5 mM EDTA, 500 ~g/ml yeast tRNA, 2X Denhardt' s, 0.1% Tween-20, 
0.1% CHAPS, and 10 mM vandyl ribonucleoside complexes) for 3-4 hours at 37°e. In the mean 
time, for every 1 ~g dig-labeled RNA used for hybridization, probes were hydrolyzed in 
carbonate buffer (60 mM Na2e02, 40 mM NaHe03, pH 10.2) for 2-3 min. at 60°e. Hydrolyzed 
probes were quickly transferred to an ice bath and neutralized with an equal volume of 200 mM 
sodium acetate, 1% acetic acid (v/v), pH 6.0. Probes were then precipitated and then 
resuspended in a solution of 20 mg/ml yeast tRNA (500 ~g tRNA per ~g probe). Nucleic acids 
were denatured by heating for 7-10 min. at 95°e and added directly to hybridization buffer. 
Following prehybridization, samples were washed briefly in PBST and transferred to 
hybridization buffer containing 0.05-0.1 nglml hydrolyzed probe. Hybridization was carried out 
for 12-15 hours at 42°C. The next day, samples were washed once in PBST at room temperature 
and once in PBST at 37°e , both for 30 min. with agitation. To remove unhybridized probe, 
samples were digested in 100 ~g/ml RNase A in PBS for 20 min. at 37°e . After RNase 
digestion, samples were washed in PBS at 37°e, IX SSe at 45°e, O.lX SSe at room 
temperature, and finally in PBST at room temperature, 30 min. per wash with agitation. For 
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detection, samples were blocked in 5% goat serum in PBST for 30-60 min. at room temperature 
and then incubated in PBST containing a 1:200 dilution of alkaline phosphatase conjugated anti-
dig Ab, Fab fragment (Boehringer Mannheim Biochemicals), 5% goat serum and 5% mouse 
serum for 1-3 hours. Samples were subsequently washed several times in PBST for at least 2 
hours, twice briefly in Tris buffered saline + 0.1% Tween-20 (TBST) and twice in alkaline 
phosphatase buffer (100 mM Tris-HCl, pH 9.5, 50 mM. MgCh, 0.1% Tween-20, 1 mM. 
levamisole). Stained samples were developed in alkaline phosphatase buffer containing 338 
JJ.g/ml nitro blue tetrazolium (NBT) and 175 JJ.g/ml 5-bromo-4-chloro-3-indolyl phosphate (X-
phosphatase), both purchased from Boehringer Mannheim Biochemicals, for 3-4 hours at room 
temperature in the dark. Colorimetric reactions were monitored periodically and stopped by 
transferring samples to PBST + 1 mM EDTA. Detection was highly dependent on the amount of 
time in which samples were developed. Overdeveloping led to a dramatic increase in 
background staining. Samples were finally dehydrated in graded ethanols, transferred to 2-
propanol, cleared in xylene, and mounted into glass slides under coverslips and observed under 
bright field microscopy. 
Antibodies 
Rat anti-mouse IL-2 mAb (S4B6), phycoerythrin (PE)-conjugated antimouse cxf3 TcR mAb 
(H57), and biotinylated hamster-anti mouse CD3e (500.AA2) and yo TcR (GL3) mAbs were 
purchased from Pharmingen (San Diego, CA). Normal rat IgG was reconstituted at a 
concentration of 20 JJ.g/ml (Miles Laboratories, Inc.). Fluorescein (FITC)-conjugated hamster 
anti-mouse CD3e (145-2C11) and PE- and biotinylated rat anti-mouse IL-2Rcx (AMT-13) were 
obtained from Boehringer Mannheim Biochemicals and GIBCO/BRL (Gaithersburg, MD), 
respectively. Lastly, biotinylated secondary reagents, rabbit anti-rat IgG was purchased from 
Vector Laboratories (Burlingame, CA) and goat anti-hamster IgG from CALTAG Laboratories 
(San Francisco, CA). 
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Immunohistochemistry and Direct Immunofluorescence Staining 
Protocols for immunohistochemical and immunofluorescence staining were essentially 
unchanged from those described in (12). It should be noted that for immunohistochemistry, the 
avidin-biotin blocking step was omitted, all antibody incubations were carried out overnight at 
4°C, and washes were increased in 1-2 hours at 4°C. Histochemical detection was performed 
using an avidin-biotin-horseradish peroxidase complex (Vectastain Elite ABC, Vector 
Laboratories) and metal enhanced diaminobenzidine (DAB+ 30 ~g/ml Ni- and CoCh). 
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RESULTS 
Developmental Pattern of IL-2 Gene Expression in the Mouse Epidermis as Determined by 
In Situ Hybridization. 
We initially identified IL-2 mRNA positive cells in the dermis following in situ 
hybridization to IL-2-specific 35S-labeled RNA probes (Figure 1). These positive cells were 
clearly llitl associated with the epidermal layer. However, the reproducible detection of IL-2 
mRNA positive cells associated with the dermis raised the possibility that these IL-2 mRNA 
expressing cells were perhaps migrating to the epidermis to populate the skin. Subsequent 
analysis of IL-2 mRNA accumulation in the epidermis of older mice revealed several interesting 
results (Figure 2). At three weeks of age several large areas of IL-2 expression was found in ear 
epidermal sheets (Figure 2A), as revealed by 35_S in situ hybridization. The high concentration 
of silver grains observed in 3-week old samples with the antisense strand were not detected in 
similar samples hybridized with the complementary sense control strand (Figure 2B). At this 
age, V 13+ cell populations are still expanding in the skin. In contrast, by 5 weeks of age when 
V13+ cell numbers have reached steady state (16, 17), zones of IL-2 expression were not 
observed (data not shown). Likewise, IL-2 expression was not detected in samples isolated from 
14-week old mice (data not shown). These results indicate that IL-2 expression is induced at 
stages in life when V 13+ cells are presumably still increasing, whereas once V 13+ cells are no 
longer proliferating, IL-2 expression appears to be downregulated. 
In the hope of increasing the sensitivity of detection, we employed a modified "whole 
mount" in situ hybridization procedure using dig-labeled probes to examine IL-2 message in 
unmounted, free-floating epidermal samples. In accord with the results described above, at 3 
weeks of age, extensive areas of IL-2 mRNA accumulation was observed using a dig-labeled 
IL-2 antisense RNA probe, as indicated by large zones of deep purple staining along with 
distinct, positively staining cells with dendritic morphology (Figure 2C). No significant staining 
was observed using a dig-labeled sense RNA probe (Figure 2D). Moreover, this pattern of 
expression was not detected in older animals, in good agreement with the hybridization results 
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generated using 35S-labeled probes (Figure 2E-H). A compilation of the hybridization data is 
given in Figure 3. The combined results indicate that IL-2 expression drops off and is 
undetectable by 5 weeks of age. Thus ll..,-2 mRNA expression in the skin is transient and may be 
correlated with the period during which V y3+ cell numbers are increasing to populate the skin. 
Distribution of IL-2 Expressing Cells in the Skin in Similar to that of CDJ+ Cells at 3 
Weeks of Age 
After having established the pattern of ll..,-2 expression in the skin, we were interested in 
defming the distribution of CD3e+ cells in the skin at a time when ll..,-2 was expressed therein. 
At 3 weeks of age, the pattern of ll..,-2 gene expression as revealed by dig-in situ hybridization 
was strikingly similar to that of CD3+ cells as shown by immunohistochemical staining (Figure 
4). Using both techniques on ear epidermal sheets isolated from the same animal, we found 
extensive reactivity associated with hair follicles as well as with scattered cells in the proximity 
of follicles at this age and the significance of the association will be discussed later. CD3e 
staining concentrated in follicles in ear epidermal sheets isolated from normal mice did not 
appear to be artifactual. Comparable staining was not seen in samples isolated from age matched 
SCID mice which do not have mature T cells populating peripheral tissues (see Figure 7 A) and 
hair follicles did not stain in samples taken from older wild-type animals; by 5 weeks of age, 
only a "confluent" distribution of scattered positively staining cells was observed (data not 
shown). A strong correlation between ll..,-2 expression and CD3e+ cells associated with hair 
follicles can be drawn, as shown in Figure 5. It is evident that CD3e+ cells were distributed 
throughout the skin in such a manner that closely reflected the distribution of areas where ll..,-2 
expressing cells were detected. The similarities between ll..,-2 expression and the distribution of 
CD3+ cells provides tantalizing circumstantial evidence that ll..,-2 expressing cells are indeed 
CD3e+. It should be mentioned that we could not detect high levels to -yO TcR expression at this 
time. Nevertheless, by 5 weeks of age, -yO cells were easily detected (see Figure 8C), hence it is 
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possible that these T-lineage cells are not expressing high levels of TcR at a time when they are 
proliferating. 
Pattern of IL-2 Protein Production in the Skin at Different Ages as Determined by 
Immunohistochemistry 
To confirm the pattern of ll...-2 expression as revealed by in situ hybridization, we stained 
ear epidermal sheets from age matched littermates with an anti-ll...-2 mAb (Figure 6). At 3 weeks 
of age, distinctive patches of ll...-2 reactivity were observed (Figure 6). Occasionally, isolated 
ll...-2 reactive cells were also detected (data not shown). These areas of immunohistochemical 
staining were similar in appearance to those revealed by in situ hybridization (compare Figure 1 
with Figure 5). Slight differences were noted between ll...-2 mRNA versus protein accumulation 
as a function of age. While ll...-2 mRNA accumulation in the skin was not observed beyond 5 
weeks of age, weakly staining zones of IL-2 reactivity associated with follicles were still 
detected (Figure 5C). However, by 5 weeks, there was an approximately five to tenfold 
reduction of ll...-2 positive zones compared to the number seen at 3 weeks (data not shown), and 
about 14 weeks, a twenty- to fiftyfold reduction relative to that seen at adolescence was observed 
(Figure 5E). Moreover, in younger animals, ll...-2 mRNA positive zones appeared to be slightly 
more prevalent than ll...-2 protein positive zones (1.5 to 2 times more abundant; data not shown). 
Thus in 3 week old mice, even though ll...-2 mRNA accumulation is apparently synchronous, this 
phenomenon may not be reflected at the level of protein production. It is also possible that 
detection of ll...-2 mRNA positive cells by dig- in situ hybridization is more sensitive than that of 
ll...-2 protein positive cells by immunohistochemistry. 
D..,-2 Expressing Cells Are Not Found in the Epidermis of SCID Mice 
Due to a defect that interferes with productive TcR gene rearrangement, mice 
homozygous for the SCID mutation are unable to produce mature T cells (18). Manifestation of 
the SCID defect is evident in the skin in which both CD3e andy() TcR+ cells are absent (Figure 
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7A, B; data not shown). To determine if the SCID mutation affects IL-2 expression in the skin, 
in situ hybridization and immunohistochemical staining were performed in parallel on ear 
epidermal sheets isolated from 3-week old SCID mice and epidermal sheets taken from age-
matched normal animals. The results obtained using SCID mice were significantly different than 
those obtained using normal animals. Whereas in situ hybridization of normal ear epidermal 
sheets to a dig-labeled antisense IL-2 RNA resulted in extensive zones of staining (as described 
in a previous section), no appreciable hybridization was detected above background in the SCID 
epidermis, i.e., there were no observable differences in hybridization patterns, using antisense or 
sense probes (Figure 7, C, D). Likewise, immunohistochemical staining of epidermal sheets 
isolated from 3-week old SCID mice yielded results that recapitulated those obtained by in situ 
hybridization (Figure 7, E, F). IL-2 protein in the epidermis was not detected in SCID animals at 
this age, nor was IL-2 protein detected in the skin of older animals (data not shown). The SCID 
mouse findings indicate that IL-2 expression in the skin requires the presence of CD3e+ cells 
therein, suggesting that either CD3e+!fcR+ cells themselves are producing IL-2 or that the 
induction of IL-2 expression in an unidentified cell type is dependent on the presence of CD3+ 
cells. 
Detection of IL-2 Protein in the Skin of a~-TcR Transgenic Mice 
Most T cells found in the skin express an invariant -yO TcR and are defined by the usage of 
the V y3 gene segment in y-chain gene rearrangements. It was recently reported that mice that do 
not generate yo T cells due to targeted disruption of at the o-chain gene locus still retain a small 
number of a~-TcR + cells associated with the epidermis (19). Although these rare a~ T cells 
found in the skin are detectable in wild-type animals, we were unable to detect this subset under 
our staining conditions (Figure 8A). Nevertheless, it was still of interest to establish whether 
there was a relationship between IL-2 expression in the epidermis and the expression of yo-
versus a~-TcR in resident T-lineage cells. Using mice expressing a transgenic a~ TcR (10, 11), 
ample number of a~+ T cells were detected in the skin (Figure 8B). There were no significant 
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differences observed in H-25 (nonselecting) versus H-2b (positively selecting) backgrounds (data 
not shown). Albeit that cells expressing yo TcR were detected in the thymus both 
immunohistochemical staining and fluorescence activated cell sorting analysis (data not shown), 
~ TcR+ cells were undetectable in the skin of ~ TcR transgenic mice, suggesting that the T cells 
observed here only use the cxJ3 TcR (Figure 80). In terms of CD3e expression (Figure 8E, F), 
IL-2 protein production (Figure 8G, H) the distribution of CD3e+ cells and the pattern of IL-2 
protein accumulation in the skin of TcR transgenic mice was indistinguishable compared to that 
seen in a wild-type littermate. Therefore, IL-2 is produced in the skin even in the apparent 
absence of ~Ny3 expressing cells, indicating that cxJ3 TcR+ T cells in the epidermis are capable 
of producing IL-2 and induction of IL-2 expression in the skin may not require a specific TcR-
antigen interaction. 
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DISCUSSION AND CONCLUSIONS 
The results presented here provide new insights into the potential function of ll...-2 in vivo 
in mediating the expansion of T -cell populations in the epidermis. In vitro findings suggest that 
ll...-2 influences the generation of V13+ cells (6, 7). Significantly, this lineage is found in strict 
association with the murine epidermis (~ T-cell development has been recently reviewed; 20, 
21). Moreover, ll...-2 is expressed in the fetal thymus at the point in gestation when V13+ cells are 
being generated (12). Although an absolute correlation between ll...-2 expression and Vy3 cells in 
the fetal thymus was not established (12), this is not the case in the postnatal skin. Even at birth, 
isolated ll...-2 expressing cells are reproducibly found in the dermis in a similar location to that in 
which CD3e+ cells are found (data not shown). By three weeks after birth, ll...-2 expressing cells 
are readily detected and ll...-2 and CD3e expression appear to colocalize. At this age, the majority 
of ll...-2 and CD3e expressing cells were found associated with hour follicles. A few individual 
ll...-2 mRNA positive cells not in direct contact with hair follicles were detected, but as a general 
rule, the number of ll...-2 expressing cells found in the skin was inversely proportional to the 
distance from particular hair follicles with which ll...-2 expressing cells were associated. The 
association of both ll...-2 and CD3e expressing cells with hair follicles is age dependent. By the 
time ll...-2 expression was no longer detected at 5 weeks of age, CD3e+ cells were no longer 
found associated with hair follicles and were evenly dispersed throughout the skin. Assuming 
that ll...-2 expressing cells are also CD3e+, we propose a dynamic model for the mechanism by 
which ll...-2 gene expression is induced in the skin at the time when T cells are still proliferating 
therein. Rare ll...-2 expressing CD3e+ cells move through the dermis and home to hair follicles. 
Following contact with follicles, ll...-2 expression is upregulated and CD3e+ cells proliferate in 
the basal layer. As CD3e+ cells migrate up through and away from hair follicles to populate the 
epidermis, ll...-2 expression is downregulated. This implies that an unidentified cell type found in 
hair follicles may be responsible for upregulating ll...-2 gene expression in this particular T-cell 
population. Once T cells are no longer in contact with resident cells in the follicle, T-lineage 
cells do not receive the necessary stimulus to induce ll...-2 gene expression. 
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a-2 protein is also detected in the skin at three weeks of age, showing that IL-2 is 
available to resident cells to use as a proliferation signal. A slight discrepancy between the 
distribution of a-2 mRNA positive zones and a-2 protein rich areas in the skin was noted. 
Extensive areas of a-2 reactivity associated with follicles were detected, but unlike the pattern 
of staining obtained by dig-in situ of epidermal sheets taken from 3-week old mice showing 
individual a-2 mRNA positive cells in between areas of high a-2 mRNA expression, rare, 
individual cells producing a-2 protein not in direct association with follicles were detected. 
This suggests that the immunohistochemical staining method employed may no have been 
sensitive enough to stain individual cells producing a-2 protein and that areas in which a gross 
excess of a-2 protein was being synthesized were reactive under these staining conditions. 
Another possibility exists to account for the variation in expression patterns generated by in situ 
hybridization and immunohistochemical staining. The individual a-2 mRNA positive cells not 
in direct contact with hair follicles could be migrating away from follicles to populate the 
epidermis and the a-2 message detected in migrant cells may represent residual accumulated 
mRNA that was synthesized during the period in which a-2 inducible cells were in contact with 
follicles. Like most cytokine messages, a-2 mRNA is unstable (22), therefore upon dissociation 
from follicles, a-2 inducible cells would no longer be receiving stimulus to transcribe the a-2 
gene and the remaining a-2 transcripts could be rapidly degraded prior to translocation into 
protein. Additionally, this explanation would also account for the transcience of a-2 gene 
expression observed in the skin. 
The generation of mature T cells and their presence in the skin appears to be essential for 
a-2 gene expression observed therein. In SCID mice, neither CD3e+ cells not a-2 expressing 
cells were found associated with the epidermis, strengthening the notion that a-2 expressing 
cells in the skin are also CD3e+ T cells. We cannot formally dismiss the possibility that an 
unknown non-T lineage cells type is induced by T cells to produce a-2, but based on the cell-
type specificity of IL-2 gene expression that only cells of the T lineage are inducible for IL-2 
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gene expression, and on studies showing that Thy-l/CD3e+ DECs are inducible for IL-2 gene 
expression in vitro (8, 9), we regard this explanation to be unlikely. 
In terms of signals involved in inducing IL-2 gene expression in the skin, our findings in 
~ TcR transgenic mice indicate that IL-2 expression in the skin does not absolutely depend on 
the expression of V 13+ -yO TcR per se. Previous studies have demonstrated that V 13 expression 
was not requisite for the generation of T cells in the skin, since introduction of an irrelevant 
transgenic ...,0 TcR has no obvious effects on the development of -yO T cells associated with the 
epidermis (2, 5). Indeed our studies using ~ TcR transgenic mice indicate that T cells were still 
found associated with the skin, though they expressed a~ rather than "fO TcRs. It is unclear 
whether the a~ T cells in the a~ TcR transgenic animals are actually cells of the -yO lineage that 
expressed al3 TcR in lieu of endogenous "fO TcR or whether CD3e+ DECs in these mice 
represented an expanded population of bona fide a~ T-lineage cells. Irrespective of the 
origin/lineage of a~+ DECs cells in a~ TcR transgenic mice, resident cells were still induced to 
express IL-2, suggesting that IL-2 is expressed by T cells in the skin independent of~ or ...,0 TcR 
expression and that induction of IL-2 gene expression in the skin may not be specified by 
engagement of a particular TcR (in this case V13-containing ...,0 TcRs) with an undislased ligand. 
Since the evidence indicates that DECs expressing proper V y3+ yo-TcRs or 
"inappropriate" a~-TcRs can be induced to express IL-2 independent of TcR specificity in vivo, 
this raises important questions with regard to the activation of DECs resulting in the induction of 
IL-2 gene expression in the apparent absence of an overt inflammatory/primary immune 
response. Several provisional pieces of evidence suggest that under normal circumstances, cells 
in the V13+ lineage may not be expressing multisubunit form of high affinity IL-2R at a stage 
when they are proliferating in response to IL-2. Both fetal thymic organ and fetal thymocyte 
suspension culture showed preferential expansion of V 13+ subsets only in high doses of IL-2. If 
V 13+ cells at this stage were expressing high affinity receptors for IL-2, they should have 
expanded in vitro in response to much lower concentrations of IL-2. Likewise, while IL-2 is 
abundantly expressed in the skin at 3 weeks of age, little high affinity IL-2R expression was 
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detected as evinced by the lack of staining by an anti-ll..-2Ra mAb (Figure 9A). As a positive 
staining control, fetal thymus sections were subjected to immunohistochemical staining for ll..-2 
and ll..-2Ra expression (Figure 9B). ll..-2Ra was readily detected in these samples (Figure 9B). 
No good staining reagents exist for the rapid identification of moderate affinity ll..-2R, thus we 
cannot unequivocally show that DECs are expressing functional ll..-2R at a time when ll..-2 
expression in the skin is maximal. Nevertheless, induction of IL2Ra is indicative of the 
activation of mature T cells to foreign antigen. ll..-2Ra expression is crucial for the formation of 
the high affmity ll..-2R that mediates the rapid clonotypic expansion of antigen-specific T cells 
that is vital for the success of the vertebrate immune response. The lack of ll..-2Ra expression 
while ll..-2 itself is expressed in the skin indicates a potential uncoupling of high affinity receptor 
and ligand expression. This implies that high affinity ll..-2Ra expression may not be involved in 
the gradual, ll..-2 driven expansion ofT-cell populations in the tissues where they reside, as 
demonstrated by the differential regulation of IL-2 and ll..-2Ra in DECs during a period in which 
this population is still expanding in the skin. 
In conclusion, we have shown that ll..-2 is expressed in the epidermis of mice at a time 
when resident T cells are still expanding. ll..-2 expression appears to be induced in the absence 
of an immune response against antigen and ll..-2 may participate in the post-thymic expansion of 
T-cell subsets in vivo in the absence of acute inflammation. Although ll..-2 is not necessary for 
the expansion of pre-T cells in the thymus, ll..-2 may function as a general growth factor forT 
cells in the periphery. ll..-2 may be required for achieving and maintaining steady-state numbers 
ofT cells in peripheral tissues. In ll..-2 -1- mice, defects were observed in peripheral lymphoid 
organs in which high numbers ofT cells are normally found as manifested as a decrease in 
cellularity, implying that ll..-2 may be involved in T-cell homeostasis of the nonactivated 
immune system (23). Finally, our studies using normal and SCID mice strongly suggest that 
ll..-2 expressing cells in the skin belong to the T lineage. Up to this point, little is known about 
the regulation of ll..-2 expression in DECs. NF AT, an inducible transcription factor in T cells, is 
absolutely required for transcriptional activation of the ll..-2 gene. A recent study using an 
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oligomerized NFAT binding site to drive SV40 T-antigen expression in transgenic mice revealed 
that constitutive NFAT binding activity present in the skin (24). Phenotypic analysis of the cells 
in the epidermis displaying this characteristic was not performed, but a tantalizing possibility 
exists that DECs cells in their resident tissue may be constitutively expressing high levels of 
functional NFAT and this may facilitate the coordinate induction of IL-2 gene expression in 
DECs as they proliferate in the skin, contribute to the regulation of IL-2 expression in DECs. 
Likewise, potential constitutive NFAT binding activity in DECs may be peculiar to this lineage. 
Identification of additional cell types able to induce IL-2 expression in DECs and detailed 
examination of the molecular mechanisms involved in controlling IL-2 gene expression in this T-
cell subset will provide new avenues for further research and increase understanding of the 
function, role and regulation of IL-2 expression in vivo. 
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FIGURE LEGENDS 
FIGURE 1. Identification of ll...-2 mRNA positive cells in the dennis of neonatal mice following 
in situ hybridization of whole body mouse sections to a 410 nt IL-2 specific 35S-labeled 
antisense RNA probe. Representative field showing an isolated IL-2 mRNA positive cell. 
Highly positive cells were not detected in serial sections hybridized to the complementary sense-
strand RNA (data not shown). Hair follicle (fol). 
(A): Bright field, 200X. 




FIGURE 2. In situ hybridization of ear epidermal sheets to 410 nt ll..,-2 specific 35S- or 
digoxygenin-labeled RNA probes. (A) and (B) hybridized to 35S-labeled antisense and negative 
control sense-strand RNAs, respectively. (C), (E), and (G) hybridized to digoxygenin-labeled 
antisense RNA probes; (D), (F), and (H) to negative control sense-strand RNAs. Representative 
fields shown. Arrows indicate representative hair follicles. 
(A), (B), (C), and (D): Epidermal sheets isolated from 3-week old mice. 
(E) and (F): Epidermal sheets isolated from 5-week old mice. 
(G) and (H): Epidermal sheets isolated from 14-week old mice. 
Bright field, 200X. 
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FIGURE 3. Compilation of 35s- and digoxygenin in situ hybridization data using 410 nt ll...-2 
specific RNA probes to show the development progression of ll...-2 gene expression associated 
with hair follicles in the epidermis. Hybridization to follicles was not detected when epidermal 
sheets were hybridized to negative control sense-strand RNAs. 
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FIGURE 4. Comparative dioxygenin-in situ hybridization using 410 nt ll..-2 specific RNA 
probes and immunohistochemical staining for CD3E expression in epidermal sheets isolated from 
3-week old mice. Smaller arrows indicate individual positive cells with dendritic morphology; 
larger arrows indicate representative hair follicles. 
(A): In situ hybridization to the antisense RNA probe. 
(B): In situ hybridization to negative control sense-strand RNAs. 
(C): Immunohistochemical staining for CD3E expression. 
(D): Negative control staining, determined by omission of primary antibody. 
Bright field, 200X. 
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FIGURE 5. Diagram demonstrating the correlation between ll...-2 mRNA positive hair follicles 
detected by digoxygenin in situ hybridization and CD3e+ stained follicles detected by 
immunohistochemical staining of ear epidermal sheets isolated from 3-, 5- and 14-week old 
normal mice and 3-week old SCID mutant mice. Multiple random fields at 100X magnification 
were analyzed to reduce bias to positively staining regions and an average number of 600 


































































































































































FIGURE 6. Immunohistochemical staining for IL-2 protein in ear epidermal sheets isolated from 
mice of different ages. (A). (C). and (E) stained with a rat anti-mouse IL-2 mAb. (B). (D). and 
(F) stained with normal rat IgG. Specificity of the primary antibody was shown previously (12). 
Arrows indicate reactive follicles positive for IL-2 protein. 
(A) and (B): Epidermal sheets isolated from 3-week old littermates of mice shown in Figure 
2C-D. 
(C) and (D): Epidermal sheets isolated from 5-week old littermates of mice shown in Figure 
2E-F. 
(E) and (F): Epidermal sheets isolated from 14-week old littermates of mice shown in Figure 
2G-H. 
Bright field, 200X. 
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FIGURE 7. Absence of CD3e-specific staining, ll..--2 mRNA positive areas, and ll..--2 protein 
production in ear epidermal sheets isolated from 3-week old SCID mutant mice. Data were 
generated in parallel with those shown in Figure 4. Arrows indicate representative hair follicles. 
(A): Immunohistochemical staining for CD3e expression. 
(B): Negative staining control. 
(C): Digoxygenin-in situ hybridization for a 410 nt ll..--2 specific antisense RNA probe. 
(D): Hybridization to negative control410 nt IL-2 sense-strand RNAs. 
(E): Immunohistochemical staining for ll..--2 protein. 
(F): Rat IgG negative staining control. 






E F ' 
131 
FIGURE 8. Comparative staining for af3-TcR, ~ TcR, CD3e expression and IL-2 protein of ear 
epidermal sheets isolated from normal and aj3-TcR transgenic mice. Negative controls are not 
shown. 
(A): Direct immunofluorescence staining for c:xj3-TcR expression in an epidermal sheet isolated 
from a 5-week old wild-type littermate. 
(B): Direct immunofluorescence staining for af3-TcR expression in an epidermal sheet isolated 
from a 5-week old a~-TcR transgenic mouse. 
(C): Immunohistochemical staining for -yO-TcR expression in an epidermal sheet isolated from 
the same wild-type mouse shown in (A). 
(D): Immunohistochemical staining for yo-TcR expression in an epidermal sheet isolated from 
the same transgenic shown in (B). 
(E): Immunohistochemical staining for CD3e expression in an epidermal sheet isolated from a 3-
week old littermate. 
(F): Immunohistochemical staining for CD3e expression in an epidermal sheet isolated from a 3-
week old ab-TcR transgenic mouse. 
(G): Immunohistochemical staining for IL-2 protein in an epidermal sheet isolated from the 
same wild-type mouse shown in (E). 
(H): Immunohistochemical staining for IL-2 protein in the epidermal sheet isolated from the 
same transgenic mouse shown in (F). 
(A) and (B): Fluorescence microscopy, 200X. 
(C) - (H): Bright field, 200X. 
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FIGURE 9. Immunohistochemical staining for IL-2 protein and IL-2Ra expression in ear 
epidermal sheets isolated from normal 3-week old mice and in 8 ~m day 15 fetal thymus 
sections. 
(A), left to right: Staining for IL-2, IL-2Ra, and rat IgG control in ear epidermal sheets isolated 
from 3-week old mice. 
Bright field, 200X 
(B), left to right: Staining for IL-2, IL-2Ra, and rat IgG control in day 15 fetal thymus sections 
(positive staining control). 
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Detection of ll..-2 Expressing Cells in the Gut of Normal Mice: 
Evidence that IL-2 is Involved in Controlling Dysfunction in the Mucosal Immune System 
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SUMMARY 
Interleuk:in-2 (ll..-2) is a potent growth factor that mature T lymphocytes produce upon 
activation by foreign antigen and is used as a proliferation signal, resulting in the clonal 
expansion of antigen-specific T cells. Analysis of thymocyte populations in ll...-2 deficient mice 
indicated that ll...-2 is not necessary for the generation of the major subsets of pre-T cells in the 
thymus. On the other hand, ll...-2 appears to play a role in suppressing detrimental immune 
responses to intestinal microflora, since the absence of ll...-2 causes a disease state resembling 
ulcerative colitis in humans. Although highly informative, these findings provide only 
circumstantial evidence that ll...-2 is expressed in the gut of healthy animals. We have used in 
situ hybridization and immunohistochemical staining to identify ll...-2 expressing cells in the gut 
of normal mice at various ages. Initially, ll...-2 mRNA positive cells were detected in the neonatal 
gut. Subsequent analysis of ll...-2 protein accumulation revealed that numerous ll...-2 producing 
ells were found associated with the gut of newborn animals. ll...-2 producing cells were also 
detected in the lamina propria of the small and large intestine but not in Peyer's patches or 
intestinal epithelium of older mice and IL -2 production appeared to persist throughout life. 
Differential distribution of IL-2 producing cells in the small and large intestine was observed, 
indicating that IL-2 producers in the gut may be involved in regional specialization of the 
mucosal immune system. Gut-associated IL-2 expressing cells were not found in mice 
homozygous for the SCID mutation, demonstrating that the generation of IL-2 producing cells is 
contingent on the generation of mature T and B cells. Finally, a substantial number of IL-2 
producers were present in the prenatal gut, hence a large portion of gut-associated IL-2 
producing cells are generated during fetal life. Examination of fetal tissues that may be potential 
sources of IL-2 producing cells in the gut revealed that IL-2 protein positive cells were not found 
exclusively in the thymus, but were also abundant in the fetal liver and omentum at a stage in 
gestation when gut-associated IL-2 producing cells were scarce. These data suggest that a 
subpopulation of intestinal IL-2 producing cells may be extrathymic in origin and raise the 
possibility that cells other than those belonging to the T lineage may express IL-2 in fetal tissues, 
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including the gut. Taken altogether, the work we describe here demonstrates that IL-2 
expression is indeed induced in the intestine of healthy animals and supports the notion that IL-2 
producing cells are available to participate in the prevention of inflammatory bowel disease 
(ffiD). 
KEYWORDS: lnterleukin-2 (IL-2), T cells, Peyer's patch associated lymphocytes (PPLs), 
lamina propria associated lymphocytes (LPLs), intestinal epithelial lymphocytes (IELs), severe 
combined immunodeficiency (SCID), targeted gene disruption, fetal liver, fetal omentum, 
inflammatory bowel disease (IBD). 
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INTRODUCTION 
The gut can be considered the only region in an organism that is under constant antigenic 
stimulus. The gastrointestinal tract is extensively populated by T lymphocytes. Not only are T 
cells found in gut associated lymphoid tissues (Peyer's patches in the small intestine and 
lymphoid aggregates in the large), butT-lineage cells are also disseminated all along the mucosa 
and are located in both the lamina propria and the epithelium. T lymphocytes from the Peyer's 
patches or lymphoid aggregates (PPLs!LALs), in the lamina propria (LPLs) and within the 
intestinal epithelium (IELs) represent three distinct populations which differ in origin, cellular 
composition, and functional properties. In terms of ontogeny, the generation of PPLs is 
generally thymus dependent. On the other hand, development of the majority of IELs is believed 
to be thymus independent (1, 2), while, the LPL population may be a composite of thymus-
dependent and independent cell types (3). Phenotypically, detailed analysis of PPL/LAL, LPL 
and small and large intestine IEL populations showed that the subsets contained within these 
populations are not equivalent (4). Finally, with regard to function, PPLs and LPLs are thought 
to regulate B-cell isotype responses by producing lymphokines, whereas in addition to being able 
to produce lymphokines, IEL exhibit cytotoxic activity. 
Lymphok:ine production by gut associated T cells has been chiefly characterized using 
purified T lymphocyte populations in vitro. Far less is known about the regulation of 
lymphokine production by different T-cell populations in the gut and how this contributes to 
mucosal immunity and immunologic balance of relevant cells therein in normal animals. The 
immunobiology of gut-associated T cells and the role of specific lymphokines in vivo have been 
examined indirectly by characterization of several pathologic states of disease in humans (5-8) 
• 
and by genetic analyses of mutant mice rendered deficient in lymphokine production by targeted 
gene disruption (9, 10). 
The absence of interleuk:in-2 (IL-2) has striking effects on the regulation of the mucosal 
immune response to intestinal microflora in humans (6, 11) and mice (9). IL-2 is a major 
mediator of the vertebrate immune response (12, 13). It is a potent T-cell growth factor that 
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particular subsets of mature T cells produce upon antigenic stimulation. IL-2 mediated events 
are controlled by interaction of the lymphokine with its cognate multichain receptor (14). IL-2 
also participates in B-cell differentiation (15) and promotes macrophage, NK and LAK cell 
activation. Mice homozygous for a disrupted IL-2 gene, while being immunocompetent, develop 
normally for the first 3-4 weeks of age, and produce all major populations of thymocytes and 
have apparently normal proportions ofT cells in peripheral lymphoid tissues (16). However, 
profound defects are observed in older animals (9). Shortly after one month of age, roughly half 
of IL-2 -/- mice become severely compromised, as manifested by splenomegaly, 
lymphoadenopathy, and severe anemia, and die within 9 weeks of age. The remaining animals 
contract inflammatory bowel disease (ffiD) resembling ulcerative colitis in humans with 100% 
penetrance. Characteristics of the disease state include spurious activation of T and B cells, 
elevated immunoglobulin secretion, and production of anti-colon antibodies. Hence, IL-2 may 
play a role in suppressing an abnormal immune response to a normal antigenic stimulus in the 
gut. 
Although the results obtained using the ll...-2 -/- mice are highly informative, they do not 
conclusively demonstrate that IL-2 is expressed in normal healthy animals. Likewise, as with 
regard to whether IL-2 is expressed in the gut, little is known about the distribution of expressing 
cells therein. Therefore, we have used both in situ hybridization to and immunohistochemical 
staining of gut sections obtained from appropriate tissues of normal and T -cell deficient mice of 
various ages. Our findings reveal numerous striking features with regard to IL-2 gene expression 
in the gut. IL-2 mRNA positive cells were first identified in the gut by in situ hybridization of 
neonatal "whole body" sections to an ll...-2 specific probe. Additionally, ll...-2 protein is readily 
detected in the newborn gut. IL-2 protein production persists in older animals; IL-2 producing 
cells were observed in 3-week and 3-month old animals. In older animals, there was 
conspicuous regional specialization of IL-2 producing cells in the lamina propria of the small and 
large intestine, and few IL-2 producing cells were found in Peyer's patches, lymphoid 
aggregates, and in the intestinal epithelium. were reportedly localized in the colon (9), ll...-2 
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producing cells were more prevalent in the small intestine of healthy animals. a-2 expression in 
the gut is contingent upon the development of mature T cells, since a-2 expression was not 
detectable in gut tissues taken from mice that cannot generate mature T and B cells as a result of 
the combined immunodeficiency (SCID) mutation. Finally, a-2 producing cells are abundant in 
the gut prior to birth, indicating that a high proportion of a-2 producing cells may be generated 
during fetal life. Prior to extensive population of the fetal gut with a-2 expressing cells, a-2 
expression is detected in the fetal thymus and, surprisingly, throughout the fetal liver, the major 
site of hematopoiesis, and in the fetal omentum. Considering that the induction of a-2 
expression may be a hallmark of future function of cells derived from these particular tissues, 
these observations suggest that the generation of a-2 producing cells in the fetal gut may be 
predominantly thymus-independent and raise the possibility that cell types other than those 
belonging to the T lineage may express a-2 in the gut. 
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MATERIALS AND METHODS 
Mice 
C57BL/6 Tia+ and C.B.-17-SCID mice were bred and maintained in our own facility. All SCID 
animals were maintained in an Isotec flexible film isolator (Indianapolis, IN) without antibiotic 
treatment. Regular monitoring of our colony verified that animals used were pathogen-free (data 
not shown). Neonatal animals were taken within 12 hours after birth. Fetal tissues were taken 
from fetuses removed from pregnant Bl./6 Tia+ and SCID mothers using timed matings. The 
appearance of a vaginal plug was designated as day 0. "Germ free" normal animals were weaned 
from mothers bred under conventional housing and were kept on sterile bedding and food for at 
least 8 weeks. 
Removal and Processing of Tissues 
Pre- and neonatal mice were killed by decapitation. Older animals were killed by cervical 
dislocation. For in situ hybridization, whole bodies or separated tissues were washed thoroughly 
in cold phosphate buffered saline (PBS), blotted dry and immediately embedded in Tissue-Tek 
O.C.T. compound (Miles Laboratories, Kankakee, IL). 8 J.Lm cryosections were collected and 
processed according to a published procedure (17). Fixed and washed sections were air dried 
and stored with desiccant at -80°C prior to use. At least 12 hours before hybridizing, sections 
were thawed and transferred to 70% ethanol at 4°C. For combined IL-2 and cell surface staining 
of sections generated from tissues of older animals, pieces of intestine approximately 0.5 em in 
length were extensively flushed with cold PBS to remove debris. Flushed segments were cut in 
half; one half was directly embedded in O.C.T., and the other was fixed in freshly made 4% 
paraformaldehyde in PBS overnight at 4°C. The following day, fixed tissues were washed in 
cold PBS for at least 2 hours and then saturated in 30% sucrose in PBS at 4 °C. Once saturated 
(samples descended to the bottom in solution), processed tissues were embedded in O.C.T. 
Following cryosectioning, both fixed and unfixed samples were soaked in acetone for 20-30 min. 
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at room temperature. Fixed/refixed sections were air dried and stored with desiccant at -80°C 
prior to use. 
In Situ Hybridization 
All probes used have been described previously (17). Either 410 or 590 nucleotide (nt) ll..-2 
antisense or sense 35S-labeled RNA probes were used. Hybridization was performed essentially 
as described previously (18). Hybridized sections were dehydrated in graded ethanols containing 
0.3 M ammonium acetate, dipped twice in NT -2B Nuclear Track Photography Emulsion 
(Eastman Kodak, Rochester, NY), and were air dried in a light-tight box. Slides were then 
transferred to slide boxes containing drierite, sealed with parafllm, wrapped twice in aluminum 
foil and exposed for 14-21 days. Slides were developed at 12-13°C, coverglasses were mounted, 
and sections were counterstained with hematoxylin and eosin and analyzed by bright and dark 
field microscopy. 
Antibodies and Staining Reagents 
Rat anti-mouse IL-2 mAb (S4B6), and biotinylated hamster-mAbs mouse against CD3e (145-
2Cll) and yo TcR (GL3) were obtained commercially (Pharmingen, San Diego, CA). 
Biotinylated rat anti-mouse CD4 (H129.19) was purchased from GIBCO/BRL (Gaithersburg, 
MD) and biotinylated rat anti-mouse CD8o. from Becton-Dickinson (Mountain View, CA). 
Normal rat Ig was reconstituted at a concentration of 20 Jl.g/ml (Miles Laboratories, Inc.). 
Biotinylated secondary reagents, rabbit anti-rat IgG and goat anti-hamster IgG, both mouse 
absorbed, were obtained from Vector Laboratories (Burlingame, CA) and CAL TAG Laboratories 




Protocol for immunohistochemical staining of non-prefixed sections was similar to that described 
in (17) except that the avidin-biotin blocking step was omitted, all antibody incubations were 
carried out for 16-20 hours at 4°C, and washes were increased to 1-2 hours at 4°. For staining of 
prefixed sections to detect ll...-2 protein, several modifications were adapted. Prefixed sections 
were thawed to room temperature and rehydrated in PBS. Following a brief refix in 1% 
formaldehyde in PBS (1-2 min.), sections were washed in PBS. Prior to blocking in PBS/1% 
BSA Fraction V/NaN3 at 4°C, sections were soaked in PBS+ 0.1% Tween-20 (PBST) for 30 
min. at room temperature. Blocked sections were incubated in 2-5 J.!g/ml anti-ll...-2 mAb for 16-
20 hours at 4°C. For the remaining staining steps, prefixed sections were treated identically to 
non-prefixed sections. Histochemical detection was carried out using an avidin-biotin-
horseradish peroxidase complex (Vectastain Elite ABC, Vector Laboratories) and metal-
enhanced diaminobenzidine (600 J.lg/ml DAB + 30 J.lg/ml 1:1 NiCl2 and CoCl2). For blocking 
experiments, the primary antibody was incubated with an excess of recombinant mouse ll...-2 for 
at least 12 hours at 4°C before use in staining. Potential aggregates were cleared from the 
solution by centrifugation. 
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RESULTS 
Identification of IL-2 mRNA positive Cells in the Gut by In Situ hybridization of Neonatal 
Whole Body Sections to an IL-2 Specific Probe 
To understand the overall pattern of ll...-2 gene expression in the mouse, we generated neonatal 
whole body mouse sections and hybridized these sections to ll...-2 specific RNA probes (Figure 
1). Most tissues wre consistently negative for ll...-2 expression, including heart, lung, stomach, 
bladder, kidney, liver, esophagus, spinal cord, and brain (tissues were considered as being 
negative when no significant hybridization to the ll...-2 antisense RNA probe was observed above 
background as determined by hybridization to the corresponding sense probe). However, we 
reproducibly found highly positive ll...-2 expressing cells in the dermis (Figure 1) and in the gut 
(Figure 1). IL-2 mRNA positive cells in the gut were predominantly located in the small 
intestine and associated with villi (Figure lJ-M). These results indicated that ll...-2 expressing 
cells were detectable in the gut of very young postnatal animals. 
IL-2 Protein is Readily Detected in the Gut of Neonatal Animals 
To reinforce the finding obtained in in situ hybridization showing the presence of ll...-2 mRNA 
positive cells in the neonatal gut, we stained sections of isolated neonatal guts with an anti-ll...-2 
mAb. The results are shown in Figure 2. In our initial attempts to identify ll...-2 protein in the 
neonatal gut, we used acetone fixed sections generated from fresh frozen tissues. This treatment 
of sections was routinely used for the detection of cell surface antigens. We were unable to 
reproducibly detect ll...-2 protein in the gut when tissue sections were treated in the manner just 
described (data not shown). However, when immunohistochemical staining was performed on 
sections obtained from tissues prefixed in 4% paraformaldehyde, IL-2 protein was readily 
detected without an increase in nonspecific staining using rat lgG in lieu of rat anti-mouse ll...-2 
mAb (Figure 2). Again, ll...-2 producing cells were mostly confined to the villi of the small 
intestine, but scattered ll...-2 reactive cells were also found in the large intestine (data not shown). 
Finally, the cells expressing ll...-2 were characteristically large in size. 
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When in situ hybridization and immunohistochemical staining were carried out in parallel 
on tissue sections of intestines removed from neonatal littermates, the ll...-2 protein producing 
cells outnumbered ll...-2 mRNA positive cells by a factor of at least 20 (data not shown). We can 
account for this discrepancy in several ways. First, IL-2 mRNA accumulation may be 
asynchronous relative to IL-2 protein production. The asynchrony in ll...-2 message versus 
protein accumulation was observed in the day 14-15 fetal thymus in which maximal IL-2 mRNA 
accumulation was observed 12 hours prior to maximal IL-2 production and in the adult thymus 
where ll...-2 protein positive cells are more prevalent than IL-2 message positive cells (17). 
Another explanation for the difference in numbers between IL-2 mRNA versus IL-2 positive 
cells focuses on stability of IL-2 mRNA relative to IL-2 protein in vivo. It is well documented 
that the IL-2 message, like many other cytokine mRNAs, is highly unstable (ti/2 = 1-2 hours; 
19). Therefore, IL-2 message may be degraded rapidly while IL-2 protein may not, resulting on 
a net decrease in detectable IL-2 mRNA positive cells. This how the number of mRNA positive 
and protein positive cells sould differ by twentyfold in steady state (i.e., for every cell tht is 
degrading IL-2 mRNA, another is accumulating message). In addition, this in equivalency is also 
observed in lymph nodes activated by foreign antigen in which IL-2 mRNA accumulation is not 
readily apparent but IL-2 protein production is (20). Finally, a rather mundane account for the 
elevated numbers of IL-2 protein positive cells relative to IL-2 mRNA positive cells is that, in 
our hands, immunohistochemical staining is more sensitive than in situ hybridization in detecting 
positive cells. Nevertheless, the combined observations made following analysis of in situ 
hybridization and immunohistochemical staining of neonatal gut samples examining IL-2 gene 
expression indicate that IL-2 is expressed in the intestine of newborn animals and IL-2 protein is 
present therein. 
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IL-2 Protein Production in the Gut of Older Mice: Restriction of IL-2 Producing Cells to 
the Lamina Propria 
We were interested in determining whether IL-2 protein was present in the gut of older animals. 
Therefore, we generated small and large intestine sections treated for immunohistochemical 
detection of IL-2 protein obtained from tissues of normal 3-week and 3-month old BL/6 Tia+ 
mice. Since the morphology of the gut was better defined in tissue sections taken from older 
animals, it was clear that IL-2 producing cells were restricted to the lamina propria (Figure 3, left 
panels). Very rare IL-2 reactive cells were found in gut-associated lymphoid tissues or within 
the epithelium. In general, IL-2 producing cells appeared to be smaller than those observed in 
the neonatal gut. As a control to demonstrate the specificity of staining, the anti-IL-2 mAb was 
preincubated with an excess of recombinant IL-2 prior to use. This resulted in a marked decrease 
in IL-2 reactivity (Figure 3, right panels). 
Percentages of IL-2 protein positive cells in the small and large intestine for 3-week and 
3-month old animals are given in Table I. At three weeks of age, IL-2 reactive cells represent 
2.3% of all the cells in the small intestine villi and 1.2% in the large. By 3 months of age, IL-2 
producing cells in the small intestine had doubled, while the number of IL-2 producing cells in 
the colon remained unchanged. Hence, IL-2 producing cells represent a detectable and defined 
population in intestinal villi, especially in the small intestine. It was somewhat unexpected that 
the number of IL-2 producing cells in the small intestine was approximately two- to fourfold 
greater than that in the large intestine, given that the colon and .!lQ1 the small intestine is largely 
affected in IL-2 -/- animals (9). 
For comparison, the percentages of IL-2 reactive cells found in Peyer's patches and 
mesenteric lymph nodes are included in Table I. IL-2 producers represent a small subset of cells 
in these lymphoid tissues. Moreover, IL-2 producing cells were at least 5 times more prevalent 
in the villi of the small intestine than in Peyer' s patches. It should be noted that the percentage 
ofiL-2 producing cells in the small intestine villi represents a lower boundary figure, because the 
data listed in Table I was based on the number of IL-2 producers detected by 
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immunohistochemical staining relative to all cells in the villi (this would include a substantial 
number of epithelial cells). Thus, if cells contained only in the lamina propria were used in these 
calculations, the number of IL-2 producing cells in the LPL population would be significantly 
higher. The difference between the number of IL-2 reactive cells in the Peyer's patches and in 
the lamina propria could reflect the regulation of B-cell lg production in the gut. It is possible 
that the decreased number of IL-2 producers in Peyer's patches is an indication that IL-4 
expressing cells rather than IL-2 expressing cells predominate in Peyer's patches in which B cells 
would be chiefly producing lgA and IgG1. On the other hand, increased numbers of IL-2 
expressing cells associated with the lamina propria suggest that IL-2 propria suggest that IL-2 
producers may participate in the primary line of defense in the immune response in the mucosa. 
To correlate the frequency of IL-2 producing cells relative to defined subpopulations of 
cells in the gut, we performed parallel immunohistochemical staining on sections generated from 
the same animal to detect IL-2 production and surface expression of CD3e, CD4, CD8a. and yS T-
cell receptor (TcR). A comparison between IL-2 and CD3e expression in the small and large 
intestine of a 3-month old animal is shown in Figure 4. The distribution of IL-2 producing cells 
in regions of intestine where they reside was highly similar to of the distribution of CD3e+ cells 
in a comparable area. A high concentration of CD3e+ cells was found associated with the lamina 
propria and CD3e+ cells were distributed therein in a pattern highly reminiscent to that of ll.r2 
producing cells in the small and large intestine (Figure 4). CD3e+ cells outnumbered IL-2 
producing cells (Table II), thus if IL-2 producing cells express CD3e, they are only a subset of all 
CD3e-expressing cells in the gut. Although these observations do not conclusively show that 
IL-2 expressing cells also express CD3e, these combined staining results do reveal that IL-2 
producing cells can be found in areas of the gut where CD3e+ cells are located. 
A compilation of staining results to determine the frequencies of different subsets of T 
cells is given in Table II. As shown previously by fluorescence activated cell sorting analysis of 
isolated small and large intestinal IELs ( 4 ), our immunohistochemical staining data also 
indicated that the composition of the T-lymphocyte pool in the small and large intestine is not 
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identical. Additionally, we were able to distinguish between IEL, LPL and PPL/LAL 
populations (data not shown). In general, CD8a+cells represented a higher percentage of CD3£+ 
cells in the small intestine compared to the large intestine. On the other hand, CD4+ cells are 
more highly represented in the large intestine CD3£+ population. y5 T cells are also less 
prevalent in the large intestine versus the small intestine. Unfortunately, we did not determine 
the frequency of B cells in our analysis of gut-associated lymphocyte populations, thus it is not 
certain if CD3£+ cells represent a higher proportion of all lymphocytes in the small intestine. 
With regard to IL-2 producing cells and the expression ofT-cell surface markers in the small 
intestine, IL-2 producers cannot be accounted for by the CD4+ population alone, since 5-6 times 
as many IL-2 producing cells are found associated with villi compared to CD4+ cells (4.5% 
versus 0.8%). This provisionally suggests that other T-cell subsets (CDS+ and ')'OTcR+ cells) may 
produce IL-2 in the small intestine. In contrast, the frequency of IL-2 producing cells in the large 
intestine was roughly equivalent to that of CD4+ cells, thus it is possible that IL-2 producers are 
also CD4+ in the large intestine. Without double staining forT-cell markers in conjuction with 
IL-2 protein production, no definitive conclusions can be drawn with respect to IL-2 production 
and T-cell subsets in the gut. Nevertheless, the nonequivalent distribution ofT-cell populations 
in the small and large intestine as determined by immunohistochemistry supports the notion that 
regional specialization ofT-cell function may exist in the mucosal immune system (4). 
IL-2 Expressing Cells are Absent in Mutant Mice That Do Not Generate Mature T and B 
Cells 
Mice homozygous for the SCID mutation are unable to productively rearrange their TcR and Ig 
genes, resulting in a failure to generate mature T and B cells. The results from simultaneous in 
situ hybridization in isolated neonatal gut sections obtained from the tissues of normal and SCID 
mouse pups are shown in Figure 5A-D. As described above, in normal neonatal animals, IL-2 
mRNA positive cells were consistently found in the gut following hybridization of tissue sections 
to an IL-2 specific antisense RNA probe (Figure 5A). In contrast, no hybridization above 
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to an IL-2 specific antisense RNA probe (Figure 5A). In contrast. no hybridization above 
background was observed in sections of SCID neonatal gut (Figure 5B). In addition, the 
morphology of SCID neonatal gut appeared to be slightly disorganized as a result of a decrease 
in cellularity (compare Figure 5A with 5B). Hence, IL-2 mRNA positive cells were not 
detectable in the gut of newborn mice that do not generate functional T and B lymphocytes. 
To strengthen the fmdings obtained by in situ hybridization, immunohistochemical 
staining was carried out on prefixed normal and SCID neonatal gut sections (Figures 5C, D). 
Staining of identically treated SCID neonatal gut sections revealed that IL-2 producing cells were 
conspicuously missing in the SCID neonatal gut (Figure 5D, H). It is evident that these staining 
results were in good agreement with the in situ hybridization results. Taken together, these data 
support the conclusion that IL-2 producers associated with the gut are absent in SCID neonatal 
animals, thereby indicating that the SCID defect affects IL-2 expression in the gut. 
In general, we were unable to achieve satisfactory staining for CD3e in neonatal gut 
sections regardless of the source of tissue, hence we could not verify that T cells were missing in 
the SCID neonatal gut. To demonstrate that CD3e+ cells were indeed absent in the SCID gut, we 
stained 3-week old SCID small and large intestine sections for IL-2 protein production and CD3e 
expression. Neither CD3e staining (data not shown) nor IL-2 staining (Figure 6) were observed 
on the older SCID gut sections, indicating that IL-2 production in the gut was undetectable in the 
gut when gut-associated T cells were also absent. At this point, we cannot formally disprove that 
the SCID mutation affects some unidentified non-T IL-2 producing cell type which is dependent 
on T cells for its development or for the induction to produce IL-2. Likewise, we cannot 
completely dismiss the possibility that B cells make IL-2 in the gut, since SCID mice exhibit a 
deficiency in the production of both T and B lymphocytes (the possibility that B cells are able to 
produce IL-2 will be discussed later). Nevertheless, the staining results indicate that there is a 
correlation between IL-2 expression in the small and large intestine and the presence of gut-
associated T cells. 
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IL-2 Producing Cells are Found in the Fetal Gut 
With regard to expression in the neonatal gut, it was possible that IL-2 expression was induced 
upon feeding in neonatal mouse pups. To explore this possibility, we sacrificed pregnant mice to 
obtain prenatal tissues to look for IL-2 protein production in the day 20 fetal gut (Figure 7). IL-2 
producing cells were easily observed in the prenatal gut (Figure 7A). Similar to IL-2 producers in 
the neonatal gut, IL-2 reactive cells in the prenatal gut appeared to be large blast cells. 
Interestingly, "nests" of IL-2 reactive cells were found in the lamina propria. This observation 
suggests that IL-2 producers may be using IL-2 as a proliferation signal (experiments are under 
progress to determine whether IL-2 producing cells express IL-2 receptor). The identification of 
IL-2 producing cells in the prenatal gut demonstrates that IL-2 expression is not induced upon 
nursing and that a very high proportion of IL-2 producing cells arise during fetal life. 
Additionally, this prenatal result suggests that IL-2 expression in the gut is induced by exposure 
to an unknown self antigen and not to ingested stimuli. 
The findings in the prenatal gut led us to examine at what point n gestation is IL-2 
production first detected in the fetal gut. In the day 16 fetal gut, we detected occasional IL-2 
reactive cells by immunohistochemical staining (Figure 7B). IL-2 producing cells were ten times 
less abundant in the day 16 fetal gut compared to the prenatal gut (3.3% IL-2 reactive cells 
versus 0.3% positive cells, respectively). Therefore, between days 16 and 20-21 of gestation, 
there is a dramatic increase in IL-2 producing cells in the fetal gut. It is still undetermined 
whether the increase in IL-2 producers associated with the gut is due to expansion of cells in situ 
or to immigration of cells coming from a source outside the fetal gut. 
Subsequently, we were interested in determining the potential origin(s) of gut-associated 
IL-2 producers in the developing fetus. Considering that induction of IL-2 expression during the 
development of a particular cell type may be indicative of future function as an IL-2 producing 
cell, sites at which IL-2 expression is induced can be regarded as a potential source of IL-2 
producers. We examined three embryonic sites at which development ofT cells or blood cells 
takes place during ontogeny, the fetal thymus, the fetal liver and the fetal omentum, for IL-2 
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expression by immunohistochemical staining, the results of which are shown in Figure 8. With 
increased detection of IL-2 protein by staining prefixed sections, our staining results revealed 
two populations of IL-2 producers in the day 15 fetal thymus (Figure 8A). The first subset was 
restricted to the subcapsular region of the organ. This subset was also observed in the SCID fetal 
thymus, indicating that induction of IL-2 expression in this population does not require 
productive TcR gene rearrangement and expression (17). On the other hand, a second subset of 
IL-2 producers were found in the interior of the normal fetal thymus. These intrathymic IL-2 
expressors were also detected by in situ hybridization (17; data not shown). However, this 
subpopulation ofiL-2 expressors was not found in the SCID fetal thymus, as determined by both 
in situ hybridization and immunohistochemical staining (data not shown). Hence a SCID-
sensitive population of IL-2 expressing cells were defined in the fetal thymus and the appearance 
of this subset in the fetal thymus is contingent upon TcR expression. It should be noted that at 
this stage of gestation, T cells expressing a specific invariant TcR are being generated that home 
exclusively to the skin (21). Ergo, we do not know for certain which fetal lineage ofT cells is 
induced. This T-cell type represents the major lineage developing in the day 15 fetal thymus, it 
is unlikely that it is the sole cell type of T-lineage developing therein to express IL-2 
intrathymically at this point in gestation. The uncertainty about lineage and IL-2 expression not 
withstanding, the fetal thymus must still be considered a source of IL-2 expressing cells that 
could migrate to the fetal gut. Additionally, at day 15 of gestation, the fetal thymus contains 
only one 5 x lQS cells. Therefore, in order for a thymus-derived IL-2 producing cell to seed the 
gut, further expansion of this cell type in the gut would be required. 
Immunohistochemical staining of day 15 fetal omentum and liver for the presence of IL-2 
protein yielded unexpected results (Figure 8B, C). IL-2 protein was abundant in both these 
tissues. Specificity of staining was demonstrated by preincubating the anti-IL-2 mAb in an 
excess of recombinant murine IL-2 prior to staining. This blocking treatment totally inhibited 
IL-2 reactivity in fetal omentum and liver samples. In addition, the immunohistochemical 
staining results in the fetal liver were reconfirmed by in situ hybridization. Similar to the 
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staining results, ll...-2 mRNA positive cells were found throughout the day 15-16 fetal liver (data 
not shown). This finding is in good agreement with other published results (25). However, in 
the earlier published accounts of ll...-2 expression in the fetal liver, only IL-2 mRNA 
accumulation was examined. Here, we verify that not only is the ll...-2 gene being transcribed in 
the fetal liver, but ll...-2 protein is present and available to resident cells in the fetal liver. Finally, 
the fmdings just described suggest not only that ll...-2 producers associated with the gut may be 
extrathymic in origin, but they also raise the possibility that a cell type other than that belonging 
to the T lineage may be producing ll...-2 in the gut. The fetal liver is the primary site of B-cell 
development during embryonic life and the omentum is a documented source for a specialized 
population of B cells. Viewed in this light, B cells in particular may also express ll...-2 within and 
outside the fetal liver and omentum. 
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DISCUSSION AND CONCLUSIONS 
Our results presented here show that IL-2 is indeed expressed in the gut of normal mice. IL-2 
mRNA and protein are detected in the neonatal gut and IL-2 producers persist in the small and 
large intestine apparently throughout life. In newborn mice, IL-2 producing cells appeared to be 
blast cells, since these cells are distinctively large and round in shape. This blasted appearance 
suggests that neonatal IL-2 producers may still be dividing. In older animals, IL-2 producing 
cells were smaller in size than their neonatal counterparts and clearly restricted to the lamina 
propria of the small and large intestine. It is not known whether IL-2 producing cells in older 
mice are the progeny of neonatal IL-2 producers or represent an independent population in the 
gut. 
In the small intestine, IL-2 producers were reproducibly 2-4 times more prevalent than 
IL-2 producers in the large intestine. This finding was surprising taken in the context of results 
obtained with IL-2 -/-mice (9). In IL-2 -/-animals, no profound effects were seen in the small 
intestine, while pronounced abnormalities were observed in the large intestine. The defects in 
the large intestine of IL-2 -/-deficient mice reflected a generalized deregulation ofT- and B-cell 
responses. Again, these results are significant, but the pattern of IL-2 gene expression in the gut 
of wild-type mice was never defined. We can reconcile our results with the IL-2 -/-results in 
one of two ways. First, IL-2 producers in the small intestine may influence responses 
downstream in the large intestine that would normally be suppressed, hence the absence of IL-2 
production in the gut, especially in the small intestine, may result in indesirable immune 
responses in the large intestine which cause IBD. On the other hand, IL-2 producers in the small 
intestine may be dispensable to terms of regulating the immune response to intestinal microflora 
(11), whereas those in the large intestine are absolutely required for the suppression of harmful 
activation of the mucosal immune system. This second account also takes into consideration the 
potential segregation of gut-associated lymphocyte function, especially in terms of IL-2 
expression. At this point, neither our studies nor the IL-2 -/- studies can distinguish between 
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these two explanations. Regardless. we establish that IL-2 is prodqced in the gut and a lack of 
IL-2 protein in the gut presumably results in ffiD. 
The difference between the number of IL-2 reactive cells in the lamina propria and 
Peyer's patches may reflect how Ig production by B cells is regulated in the gut. It is possible 
that the decreased number of IL-2 producers in Peyer's patches is an indication that IL-4 
expressing cells rather than IL-2 expressing cells predominate therein. hence Peyer's patch B 
cells would chiefly produce IgA and IgGl. On the other hand, an increased number of IL-2 
expressing cells associated with the lamina propria suggests that IL-2 producers may participate 
in the primary line of defense in the mucosal immune response against foreign antigen. 
Experiments to determine the pattern of IL-4 production in the gut relative to that of IL-2 
production are in progress. 
With regard to observations made from the study of IL-2 -/-mice kept under GF or SPF 
conditions. it is not likely that keeping animals in such a manner would have affected IL-2 
production per se. as demonstrated by our findings on IL-2 production in normal animals kept in 
GF conditions. Perhaps keeping IL-2 deficient animals under controlled conditions affects T-
and B-cell activation as a result of a commensurate decrease in intestinal microflora. thereby 
eliminating the need for IL-2 dependent control of the mucosal immune response. Hence in 
conventionally housed animals. IL-2 may play a role in suppressing responses to normally 
nonpathogenic microflora. On the other hand, when intestinal microflora is controlled or limited 
under GF and SPF conditions. IL-2-related suppression of the mucosal immune response may be 
redundant, as indicated by the studies of IL-2 -/-animals in which mutant mice do not contract 
mD when housed under GF or SPF conditions. 
Data on the identification of IL-2 producing cells in the lamina propria in vivo are in good 
agreement with recent findings obtained in vitro with regard to the characterization of cell types 
present in the LPL population. It has been shown that freshly isolated LPLs produced substantial 
amounts of IL-2. IL-4 and IFN-y. but decreased levels of IL-5 (22). Likewise. CD4+ lines 
established from LPLs secreted IL-2. IL-4. IFN-y upon stimulation using anti-CD3 mAb ·and 
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phorbol myristate acetate (22). These data indicate that CD4+ ll...-2 producers are contained 
within the LPL pool, and this subset may represent a population induced to express ll...-2 in the 
gut in vivo. 
Production of ll...-2 per se may not be sufficient to protect animals from mo. As 
demonstrated by the studies using IL-2 -1- mice, IL-2 appears to be necessary for the 
maintenance of nonreactivity of resident lympyhocytes to endogenous microflora in the intestine. 
However, injection of CD4+ purified T cells that produce ll...-2 and IFNy and little ll...-4 induced 
ffiD in congenic SCID mice (23). On the other hand, identical treatment with a detmed 
population of CD4+ cells that produces both IL-2 and IL-4 did not cause immune related 
pathology (24). Significantly, wasting disease and colitis was prevented when both CD4+ 
populations were cotransferred into immunodeficient animals (24). These studies show that ll...-2 
alone cannot protect animals susceptible to mo and that the coordinate interactions of cytokines 
is important for the maintenance of immunologic balance in the mucosa. Any disruption of these 
interactions cause lethal inflammatory responses that, under normal circumstances, would be 
held in check. Disruption of ll...-10 gene expression also led to chronic enterocolitis in mutant 
mice (10). ll...-10 has been classically defined as a negative regulator of ll...-2 expression, thus 
putative deregulation of ll...-2 production in the gut is likewise detrimental. The ll...-10 -/- studies 
further support the notion that the proper regulation of cytokine expression is vital for preventing 
mo and any perturbation in the balance between regulatory pathways dictated by cytokine 
production has pathologic consequences. 
The studies demonstrating that peripheral T -cell subsets cause or prevent colitis in SCID 
mice show that mature splenic T cells can home to the gut and infiltrate the colon. This indicates 
that thymus-dependent T cells can migrate to the gut and contribute to immune regulatory 
interactions therein. Additionally, phenotypic characterization of lymphocytes obtained from 
congenic parabionts revealed that peripheral T cells home rapidly to the Peyer's patches and 
lamina propria but not to the intestinal epithelium (3). Therefore, at least a subset of ll...-2 
producers in the gut may be initially thymic in origin. Nevertheless, not allll..-2 producers in the 
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gut may require on the thymus for their development. Analysis of fetal liver radiation chimeras 
using adult thymectomized recipients revealed that T cells of donor origin were found in both the 
intestinal epithelium and lamina propria and were absent in secondary lymphoid tissues such as 
the spleen and Peyer's patches (3). Subsequently, it was postulated that extrathymic 
development of T cells occurs in the intestinal epithelium, after which phenotypically mature T 
cells migrate to the lamina propria. Thus, the LPL population is heterogeneous, composed of 
both thymic-dependent and -independent T-cell types. It is possible that both lineages ofT cells 
contribute to the IL-2 producing pool in the lamina propria. It would be informative to determine 
if IL-2 producing cells appear in the donor population of mature T cells in the lamina propria of 
thymectomized irradiation chimeras reconstituted with fetal liver. 
Our results analyzing IL-2 production in the fetal gut revealed that a significant 
population of IL-2 producers is present therein gut prior to birth. It is not known whether a 
comparable population of gut-associated IL-2 producers exist in humans. Regardless, several 
questions remain unanswered with regard to the development of IL-2 producers associated with 
the fetal gut. Immunohistochemical staining of the fetal liver and omentum for the presence of 
IL-2 protein revealed that IL-2 producers in the fetal gut may be derived from either of these 
sources of IL-2 producing cells. As discussed above, fetal liver is able to give rise to LPL 
lymphocytes in the absence of thymus-dependent T-cell development. In addition, rearranged r-
and &-chain TcR gene rearrangements can be detected in the fetal liver (25), suggesting that T 
and B lymphopoiesis occurs in the fetal liver. These observations strengthen the notion that 
fetal-gut associated IL-2 producing cells may be generated directly from progenitors in the fetal 
liver. Albeit that the fetal liver cells can populate the LPL compartment, it may not be the sole 
contributor of lymphocytes (and potential IL-2 producers) in the gut. The close association of 
IL-2 producing cells in the fetal omentum with the gut at day 15 of gestation is provocative in 
terms of raising the possibility that IL-2 producers in the fetal gut may also be derived from the 
omentum. The fetal omentum is a highly specialized hematopoietic tissue. Not only is the fetal 
omentum an embryonic source ofT and B lymphocytes in the mouse (26), it is the principal 
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tissue from which Lyl+JCD5lo B cells arise (27). Lyl+/CD5lo B cells represent a separate 
lineage that can be distinguished from conventional B cells with regard to several characteristics 
(28-32). Lyl+ B cells are derived only from fetal tissues (33) but not adult bone marrow, and are 
associated with the peritoneal and plural activities of normal adult mice (34, 35). More 
importantly, fetal omentum has been shown to give rise to IgA-producing cells in the gut (27). 
Due to the marked production of IL-2 in the omentum, we cannot overlook the likelihood that B 
cells (especially those of the Lyl + lineage) may express and/or utilize IL-2 during their 
development. Likewise, the fetal omentum is able to contribute to the lymphocyte pool 
associated with the gut and may also be a putative source of intestinal IL-2 producers. We are 
currently in the process of determining whether the SCID mutation affects IL-2 expression in 
fetal tissues. Since IL-2 expressing cells are not detected in the SCID neonatal gut, it is likely 
that the SCID mutation may also affect processes that influence the development of fetally-
derived, gut-associated IL-2 producers, one of which may be IL-2 expression at these 
extrathymic sites. 
Examination of SCID mice revealed that IL-2 producing cells are not detected in neonatal 
and adult mutant animals. SCID mice cannot generate mature T and B cells (36) and are not 
susceptible to IDD. It is apparent that animals in which both T and B-cell development is 
disrupted do not contract IDD (37) and that IBD is induced only following alterations that affect 
T-or B-cell function. With regard to gut-associated IL-2 production, the SCID results do not 
clarify whether cells belonging to the Tor B lineage or both produce IL-2 in the small and large 
intestine. Based solely on the information described here, we cannot determine the exact identity 
of IL-2 producing cells in vivo. Importantly, mice that are unable to produce T cells as a result of 
targeted disruption of TcR genes develop IDD (37). In these immunodeficient mouse strains, B-
cell development is unperturbed. Analysis of gut-associated IL-2 production in TcRa -,~-and~­
xy-chain mutant mice would clearly demonstrate whether T cells and/or B cells synthesize IL-2 
in the small and large intestine. 
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It was observed that when IL-2 defici~nt mice are kept under germ-free conditions (GF) 
or in a defined microbial (specific-pathogen free/SPF) environment, they do not contract disease 
or that symptoms of mD were delayed significantly (9). We were interested in examining how 
IL-2 production in the gut is affected when animals are kept under GF conditions. Analysis of 
IL-2 production in gut tissues of mice kept on sterile bedding, food and water and showed that 
there was essentially no difference in the number of IL-2 producing cells in the small and large 
intestine or the distribution of IL-2 producers associated with the lamina propria therein of 
animals kept under GF conditions (n=4) and littermates kept in conventional housing (data not 
shown). However, a tenfold increase in IL-2 producing cells was observed in Peyer's patches 
taken from animals kept under GF conditions compared to conventionally housed mice (2.6% 
versus 0.2% IL-2 producing cells, respectively; see Figure 9). These results suggest that IL-2 
producers are responding to ingested antigenic and raise the possibility that IL-2 producers are 
stimulated by endogenous antigen found in the intestine. Indeed, the response of potential IL-2 
producers in the Peyer's patches may be inhibited by ingested antigen. In addition, the results 
obtained using mice maintained under GF conditions demonstrated that the lack of IL-2 
expression in the gut of SCID mice was not due to the manner by which immunodeficient 
animals were housed. 
In conclusion, the results presented here provide new insights into how a deficiency in 
IL-2 production contributes to dysfunction of the mucosal immune system resulting in ffiD. 
Additional work is still required to determine if IL- 2-producing cells are absent in IL-2 -/-
animals or if potential IL-2 producing cells are still present in the gut but are simply 
nonfunctional. Although mD in humans is a disease of multi genic etiology, some cases of ffiD 
are related to IL-2 deficiency. The identification of cells associated with the gut that produce 
IL-2 in vivo will undoubtedly increase understanding of the pathologic mechanisms involved in 
initiating and perpetuating mD as a result of IL-2 deficiency. Further characterization of IL-2 
producing cells in normal mice would provide information on cell types that could prevent ffiD 
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in a -2 -/- mice, thereby aiding in the development of new approaches to the prevention and 
therapeutic intervention offfiD caused by a defect in a-2 gene expression. 
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TABLE 1. Frequencies of IL-2 reactive cells detected by immunohistochemical staining 
of normal small and large intestine sections. 
Number Number Percentage 
Sample IL-2+ Cells Nuclei Counted IL-2+ Cells 
Small 
Intestine 220 9544 2.3 
3 weeks 
Large 
Intestine 112 9451 1.2 
3 weeks 
Small 
Intestine 429 9629 4.5 
3 months 
Large 
Intestine 121 9378 1.3 
3 months 
Peyer' s 
Patch 47 5883 0.7 
3 months 
Mesenteric 
Lymph node 22 3505 0.6 
3 months 
Following immunohistochemical staining, sections were counterstained with DAPI. Nuclei were 
visualized under fluorescence microscopy. Random fields at 200X magnification were analyzed 
to remove bias toward positively staining areas. For small intestine analysis, villi were 
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predominantly analyzed. Immunoreactive cells were not observed in negative control stainings 
of serial sections. 
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TABLE II. Frequencies of CD3e, CD4, CD8a and yO-TcR positive cells determined by 
immunohistochemical staining of small and large intestine sections (3-month 
old animals) 
SMALL INTESTINE 
Number Number Percentage 
Positive Nuclei Positive 
Anti~en Cells Counted Cells 
CD3e 510 6951 7.3 
CD4 73 9036 0.8 
CD8a 321 6256 5.1 
')6-TcR 208 7646 2.7 
LARGE INTESTINE 
CD3e 360 10398 3.5 
CD4 144 11002 1.3 
CD8a 192 10769 1.8 
')6-TcR 102 12031 0.8 
Analysis was carried out as described in legend for Table I. Samples stained in this experiment 
were identical to those stained in Figure 4. 
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FIGURE LEGENDS 
FIGURE 1. 35S-in situ hybridization of longitudinal neonatal whole body and saggital head 
sections to a 410 nt IL-2 specific antisense RNA probe. Representative fields were taken from 3 
separate hybridization experiments. Extensive hybridization was not detected in any region in 
serial sections hybridized to the complementary sense-strand RNA (data not shown). 
Counterstained with hematoxylin or alcian blue. Bright and dark fields shown. 
(A): Valves of the heart, 40X. 
(B): Lung, 40X. 
(C): Liver (LI), ans stomach (S, lumen), 40X. 
(D): Bladder, lOOX. 
(E): Spine, spinal cord, 40X. 
(F): Midbrain, 100X. 
(G): Right ventricle, 40X. 
(H): Left olfactory bulb, 40X. 
(1): Thymus, 40X. 
(J): Dermis (D), epidermis, lOOX. Arrow points to positive cells. 
(K): Small intestine, 40X. 
















FIGURE 2. Immunohistochemical staining for IL-2 protein in the neonatal gut. Bright field, 
280X. 
(A): Staining using a rat anti-mouse IL-2 mAb. 





FIGURE 3. Immunohistochemical staining for IL-2 protein in small and large intestine sections 
generated from tissues of normal mice and demonstration of staining specificity. Left panels 
show staining pattern using a rat anti-mouse IL-2 mAb. Right panels show staining pattern using 
the same antibody preincubated with lOOOu of recombinant mouse IL-2. Bright field, 200X. 
(A): Small intestine, 3 weeks of age. 
(B): Large intestine, 3 weeks of age. 
(C): Small intestine, 3 months of age. 
(D): Large intestine, 3 months of age. 
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FIGURE 4. Parallel immunohistochemical staining of normal small and large intestine sections 
generated form tissues taken from 3-month old mice. Left panels show experimental staining, 
right panels show negative control staining. Bright field, 200X. 
(A): Small intestine, ~-2 staining plus negative control. 
(B): Small intestine, CD3e staining plus negative control. 
(C): Large intestine, ~-2 staining plus negative control. 
(D): Large intestine, CD3e staining plus negative control. 
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FIGURE 5. Comparison of ll..-2 gene expression and protein production in the normal versus 
SCID neonatal gut. Panels included in (A) and (B) show in situ hybridization of neonatal gut 
sections hybridized to a 25S-labeled 410 nt ll..-2 specific antisense RNA probe. No appreciable 
hybridization was detected in adjacent serial sections hybridized to the negative contol sense-
strand RNA (data not shown). Sections were counterstained with hematoxylin and eosin. (C) 
and (D) show immunohistochemical staining of comparable sections. Normal and SCID sections 
were collected onto the same slides. 200X magnification. 
(A): Normal neonatal gut section hybridized to a radiolabeled ll..-2 specific antigense RNA 
probe, bright and dark field. 
(B): SCID neonatal gut section hybridized to the same probe in (A), bright and dark field. 
(C): Normal neonatal gut section stained for ll..-2 protein production (left panel) and negative 
control staining (right panel). 
(D): SCID neonatal gut section stained for ll..-2 protein production (left panel) and negative 
control staining (right panel). 
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FIGURE 6. Immunohistochemical staining for IL-2 protein production in SCID 3-week old 
small and large intestine. Bright field, 230X. 
(A): Small intestine section stained with anti-IL-2 mAb (left panel) or negative control staining 
(right panel). 




FIGURE 7. Immunohistochemical staining for ll...-2 protein production in prenatal and day 16 
fetal gut of normal mice. Bright field, 230X. 
(A): Prenatal gut (day 19-20 of gestation) section stained with anti-ll...-2 mAb (left panel) or 
negative control staining (right panel). 











FIGURE 8. Pattern of IL-2 protein production in day 15 fetal tissues. Specificity of staining 
observed in (B) and (C) was demonstrated by preincubation of primary mAb with 1000u 
recombinant mouse IL-2 prior to use in staining. Bright field, 40X. 
(A): Fetal thymus section stained with anti-IL-2 mAb (left panel) or negative control staining 
(right panel). Sections were counterstained with methyl green. 
(B): Fetal omentum section stained with anti-IL-2 mAb (left panel) or mAb preincubated with 
recombinant IL-2 (right panel). 
(C): Fetal liver section stained with anti-IL-2 mAb (left panel) or mAb preincubated with 





FIGURE 9. Comparison of IL-2 protein production in Peyer's patches of mice kept under germ-
free conditions and littermates maintained in conventional housing. Bright field, 140X. 
(A) Peyer' s patch section generated from a mouse kept under GF conditions stained with anti-
IL-2mAb. 
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CHAPTERS 
INDUCTION OF IL-2 GENE EXPRESSION IN THE MURINE THYMUS: 
EXERCISE OF FUNCTIONAL COMPETENCE IN IMMATURE T CELLS AS 
REVEALED BY INTRA THYMIC IL-2 PROTEIN PRODUCTION IS 
DEPENDENT ON FUNCTIONAL TcR EXPRESSION 
188 
ABSTRACT 
Induction of interleukin-2 (ll.,-2) gene expression resulting in ll.,-2 protein synthesis is a 
functional response that a major subset ofT lymphocytes must exercise following contact with 
foreign antigen. Although a great deal is known about the regulation of ll.,-2 gene expression in 
the mature T -cell population in vivo and in vitro, proportionally less is known about events and 
interactions controlling induction of ll.,-2 gene expression in developing T cells. In vitro studies 
have shown that the competence to express ll.,-2 is acquired early on in T-cell development, 
before surface expression of the T-cell receptor (TcR). However, once cell surface TcR is 
detectable, immature T cells lose the capacity to induce ll...-2 gene expression and this capability 
must be regained prior to the completion of the maturation process. Previous work demonstrated 
that induction of ll.,-2 gene expression represents a rare activation event in the murine thymus. 
Additional examination of intrathymic induction of IL-2 gene expression in mutant mice 
exhibiting a block in T -cell development resulting in the enrichment of immature TcR cells in the 
thymus revealed that immature T cells which are inducible for ll.,-2 gene expression in vitro do 
not exercise the competence to express ll.,-2 in vivo. Hence the stage in development when 
competence to induce ll.,-2 gene expression is initially acquired and that when competence is 
exercised intrathymically are most certainly !lQ1 equivalent. Using an improved staining method 
to detect ll.,-2 protein in the thymus as a function of the induction of ll.,-2 gene expression 
therein, we report the following. First, intra thymic ll.,-2 is synthesized by both immature ~ and 
,.0-TcR+ cells as shown by detailed analysis of ll...-2 protein accumulation in the thymus of mice 
deficient in the expression of a single chain of the TcR. In the cxJ3 lineage, intrathymic ll.,-2 
production is dependent on cxJ3 TcR-heterodimer expression, since TcRJ3-chain expression alone 
is insufficient to induce ll.,-2 gene expression/protein production. Finally, increased IL-2 protein 
synthesis in the thymus was not observed in cxJ3-TcR transgenic animals for which a bias toward 
positive selection was displayed. Taken together, the demonstration of functional competence 
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and responsiveness as indicated by intrathymic production of ll...-2 protein in developing T cells 
in vivo occurs after TcR-heterodimer expression and before export into the medulla. 
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INTRODUCTION 
T (thymus-derived) lymphocytes play pivotal roles in the vertebrate immune system and 
in the regulation of cell growth and differentiation in numerous hematopoietic lineages. The 
coupling of specific antigen recognition with a diverse array of effector functions is integral to 
cells in the T lineage. The processes by which developing T cells gain functional responsiveness 
in conjunction with recognition specificity have been under the scrutiny of cell, developmental 
and molecular biologists for many years ( 1 ). As immature T cells progress from one 
developmental state to another, transitions are accompanied by well-documented changes in cell-
surface phenotype. In contrast, relatively little is known with regard to the cellular and 
molecular events that control and influence the majority of these transitions. However, 
enormous strides are being made in understanding the regulation of many important transitions in 
T-cell development. This has been greatly facilitated by the use of naturally occurring mouse 
mutants and genetically engineered animals with the aid of transgenic and targeted gene 
disruption technologies. 
Although much is being revealed about how particular events determine the progression 
to a defined phenotypic state, it is not clear how these events may or may not influence the 
acquisition, "reacquisition" or maintenance of functional responsiveness during T -cell 
development. In addition, a great deal of uncertainty exists with respect to the possibility that 
cells, once having acquired functional responsiveness, exercise this capacity prior to leaving the 
thymus. For example, induction of interleukin-2 (ll..,-2) gene expression in the mature T-cell 
population, resulting in the synthesis of ll..,-2, is vital for mediating the clonal expansion of 
antigen-specific T cells during the vertebrate immune response. As demonstrated in vitro, the 
competence to induce ll..,-2 gene expression is acquired early on in T-cell development (2-4). 
However, as immature cells develop, they lose this competence as indicated by an inability to 
induce ll..,-2 gene expression under conditions that are otherwise sufficient to induce IL-2 
expression in competent cells. The ability to induce ll..,-2 gene expression is reacquired by the 
time developing T cells display a mature cell surface phenotype. Up to this point, it is not known 
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if immature T cells display the competence to express the IL-2 gene in vivo and if this is true, 
whether signals produced during specific transitions in development are adequate to induce IL-2 
gene expression in developing T cells. 
It is widely accepted that IL-2 is not essential for the generation of mature T cells, as 
demonstrated by the production of normal numbers and proportions of thymocyte subsets in the 
thymus of IL-2-deficient mice (5). Nevertheless, mature T cells generated in these mutant 
animals are not completely functional, since they cannot produce IL-2. From a technical 
standpoint, it is virtually impossible to study the exercise of functional competence in developing 
T cells in vivo, as evinced by the actual intrathymic induction of IL-2 gene expression in mice 
incapable of demonstrating functional competence by synthesizing IL-2. Thus the results 
obtained from the study of IL-2 -/- mice are informative, but they provide little information as to 
whether IL-2 gene expression is induced in immature T-cell populations in vivo, the significance 
of which has already been explained. 
In a previous report, we have shown that IL-2 is induced in a minority population in the 
postnatal thymus of normal mice (6). Not only was IL-2 mRNA detected reproducibly in the 
thymus, but IL-2 protein was also present therein. The absence of IL-2 expressing cells in the 
thymus of mice homozygous for the SCID mutation indicated that induction of IL-2 gene 
expression requires functional T-cell receptor (TcR) gene rearrangement and expression (6). 
Importantly, the localization of IL-2 expressing cells predominantly in the subcapsular region 
and cortex indicated that cells induced to express the IL-2 gene have not completed their 
intrathymic processing. In order to further characterize IL-2 expressing cells in the thymus and 
the intrathymic interactions required for the induction of IL-2 gene expression, we examined 
IL-2 expression as indicated by IL-2 protein synthesis by employing an improved 
immunohistochemical staining technique on thymus sections generated from mice in which 
surface expression of TcR components has been specifically perturbed (7, 8) or positive selection 
can be manipulated (9, 10). Our results reconfirmed that IL-2 expression in the thymus of 
normal mice was found throughout the cortex but not in the medulla. In mice rendered deficient 
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for expression of a particular chain of the TcR, we demonstrate that cells belonging to both the 
af3 and -yO lineage were induced to express ll...-2 in the thymus. Significantly, IL-2 expressing 
cells of the yo lineage were restricted to the outer cortex and those of the al3 lineage were 
relegated to the inner cortex and corticomedullary junction. Induction of IL-2 gene expression in 
the thymus appears to be dependent on bonafide al3 or -yO TcR expression, since ll...-2 expression 
was not readily detected in the thymus for which only rearranged TcRj3-chain was expressed 
(11). Finally, in terms of positive selection, ll...-2 expressing cells were llQ1 enriched in a~TcR 
transgenic animals bred onto a positively selecting background, implying that should ll...-2 
expression be correlated with positive selection, positive selection "niches" are perhaps already 
saturated (12). Taken altogether, these results show that induction of ll...-2 gene expression in the 
thymus is strictly contingent upon functional TcR gene rearrangement and/or heterodimer 
expression and suggest that the exercise of functional responsiveness in vivo does not occur prior 
to TcR surface expression. 
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Materials and Methods 
Mice 
Pathogen-free C57BV6 Tia+, B6PLThy1A/Cy, al3-TcR transgenic mice specific for H-2Ld, and 
C.B.-17-SCID animals were bred and maintained in our own facility. al3-TcR transgenic mice 
were rederived by embryo transfer and kept on sterile bedding and food. For positive selection 
and "nonselection,. in vivo , transgenic mice were backcrossed to B10. (Jackson Laboratories, 
Bar Harbor, ME) and BlO.S (Charles River Laboratories, Inc., Wilmington, MA) genetic 
backgrounds, respectively. All SCID mice were maintained in an Isotec flexible film isolator 
(Indianapolis, IN) without antibiotic treatment. 
Treatment and Sectioning of Tissues 
Thymuses were removed from 3-5 week old animals. For detection of cell surface antigens, 
organs were immediately embedded in Tissue-Tek O.C.T. compound (Miles Laboratories, Inc., 
Kankakee, IL). For detection of IL-2 protein, thymuses were fixed in freshly made 4% 
paraformaldehyde in phosphate buffered saline (PBS) for 12-16 hours at 4°C. Following 
fixation, organs were thoroughly washed in PBS at 4°C, saturated in 30% sucrose in PBS, and 
embedded in O.C.T. If samples were not sectioned immediately, they were stored at -80°C. 8 
IJ.IIl serial cryosections collected onto poly-L-lysine plus glutaraldehyde coated slides. Sections 
were air-dried, dehydrated in acetone for 20-30 min. at room temperature and stored with 
desiccant at -80°C prior to staining. 
Antibodies and Staining Reagents 
The rat anti-mouse ll...-2 mAb, S4B6, was purchased from Pharmingen (San Diego, CA) at a 
concentration of 0.5 mg/ml. Biotinylated hamster anti-mouse CD3e and "(0 TcR or rat anti-mouse 
CD4 and CD8 antibodies were also purchased from either Pharmingen, Gibco-BRL 
(Gaithersburg, MD) or Becton-Dickinson Immunocytometry (Mansfield, MA). Normal rat IgG 
was reconstituted at a concentration of 20 mg/ml (Miles Laboratories, Inc.) and normal mouse 
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serum at 60 mg/ml (CappeVOrganon Teknika Corp., West Chester, PA). Biotinylated secondary 
staining reagents (rabbit anti-rat or goat anti-hamster IgG, mouse-absorbed) were obtained from 
Vector (Burlingame, CA) or CALTAG Laboratories (San Francisco, CA) and recombinant 
mouse IL-2 from Genzyme (Cambridge, MA). Antigen-antibody-biotin complexes were 
detected using an avidin-biotin-horseradish peroxidase complex (Vectastain Elite~ Vector 
Laboratories). 
Immunohistochemistry 
Sections were thawed and rehydrated in PBS and briefly post-fixed in 1% formaldehyde in PBS 
for 1-2 min. at room temperature. For detection of IL-2 protein, sections were washed in PBS 
and incubated in PBS+ 0.1% Tween-20 for 30 min at room temperature (this step was omitted 
for detection of cell surface antigens). Sections were blocked in PBS/1% BSA, Fraction V/0.1% 
NaN3 for 1-2 hours at 4°C, after which they were incubated with primary antibody at a 
concentration of 2-20 ~g/ml in PBS/BSA/NaN3 for 18-20 hours at 4°C in humidified chambers. 
Following a PBS/0.1% NaN3 wash, sections were treated with a secondary staining reagent (5-10 
~g/ml) in a similar manner and rinsed again in PBS/NaN3 at 4°C. Samples were then fixed in 
2% paraformaldehyde in PBS for 20-30 min., and washed in PBS only. Endogenous peroxidase 
activity was quenched using 1% H202 in methanol for 40-50 min. Detection of antibody-biotin 
complexes were detected as specified by the manufacturer (Vector Laboratories). Treated 
sections were developed with diaminobenzi-(0.6 mg/ml) with 0.002% NiCl2 and CoCl2 in 50 
mM Tris-HCl, pH 7.5, and were counterstained with methyl green. Sections were cleared in 
xylenes and coverglasses were mounted onto slides. 
Analysis and Quantitation 
Sections stained with relevant primary antibody, equivalent to half a thymus lobe were analyzed 
under 100X magnification. Every experimental section was examined to exclude any bias to 
195 
non-random distribution of positively staining regions. Unique staining regions as determined 
after analysis of all sections were counted once. 
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RESULTS 
Pattern of ll..-2 Expression in the Normal Postnatal Mouse Thymus as Determined by ll..-2 
Protein Accumulation 
With the prefixation of tissues prior to sectioning, we were able to increase the sensitivity of the 
immunohistochemical staining technique for the detection of IL-2 protein (Figure 1). Whereas a 
single IL-2 protein positive cells were observed in sections taken from fresh frozen tissues 
(Figure 1A, 1B), extensive zones of IL-2 expression were readily detected in thymus sections 
generated from prefixed samples (Figure lC, lD). Treatment of tissues prior to sectioning may 
have prevented the diffusion of IL-2 protein away from the local in which it was produced once 
sections were generated and stained. Zones of IL-2 reactivity in prefixed tissue sections 
localized exclusively to regions where IL-2 producing cells in tissue sections from thymi that 
were not pretreated (Figure 1, data not shown). As demonstrated by previous staining results 
obtained from sections of freshly isolated thymi (6), regions of IL-2 staining in tissue sections 
generated from prefixed organs were relegated to the cortex and subcapsular region and not to 
the medulla (Figure 2A). Comparing the data generated by both tissue treatments, we 
determined that the number of unique IL-2 reactive zones observed in prefixed tissue sections 
was equivalent to the number of IL-2 producing cells detected in fresh frozen tissue sections 
(data not shown). This correlation suggests that a ~ IL-2 producing cell contributes to a 
particular IL-2 protein-rich area. Specificity of staining in pretreated tissue sections in shown in 
Figure 2B. Preincubation of the primary antibody with an excel of recombinant mouse IL-2 
(1000u) totally abolished IL-2 staining, thus the increased reactivity observed in pretreated tissue 
sections was indeed ll..-2 specific. 
ll..-2 Expression is Still Not Observed in the SCID Adult Thymus Under Improved Staining 
Conditions 
Due to a generalized defect in DNA repair of double-strand breaks, mice bearing the severe 
combined immunodeficiency (SCID) mutation cannot productively rearrange TcR or 
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immunoglobulin chain genes, resulting in the accumulation of immature T and B cells arrested at 
a stage in development prior to TcR and Ig chain gene rearrangement (13). As demonstrated 
previously, IL-2 mRNA expressing cells were not found in the SCID postnatal thymus (6). 
However, the absence of IL-2 protein in the SCID postnatal thymus was not confirmed, since 
detection of IL-2 protein was hampered by a high background of endogenous, peroxidase 
positive cells in sections collected from freshly isolated tissues (6). Significantly, with 
prefixation treatment not only was detection of IL-2 protein enhanced, but background 
peroxidase activity was decreased dramatically (data not shown). Therefore, to verify that IL-2 
protein was absent in the SCID postnatal thymus, we stained prefixed SCID thymus sections for 
the presence of IL-2 protein therein. The results are shown in Figure 3. No significant IL-2 
reactivity was observed in the SCID thymus (Figure 3). However, nonspecific crossreactivity to 
vessels in the SCID thymus was detected. Nonspecific staining of vessels by this particular rat 
anti-mouse IL-2 mAb has also been observed in other independent studies (15). Additionally, 
recombinant IL-2 was unable to abrogate crossreactive staining of vessels, showing that IL-2 
protein was not responsible for the residual staining seen in SCID thymus sections. More 
importantly, these results reveal that even with improved detection methodology, IL-2 expression 
was absent in the SCID thymus. Hence functional TcR rearrangement and surface expression is 
an absolute requirement for the induction of IL-2 expression in the postnatal thymus. 
Patterns of Intrathymic IL-2 Protein Accumulation in TcR-Mutant Mice 
To investigate whether cells belonging to the a.~ or yB lineage are responsible for IL-2 protein 
synthesis in the thymus, we examined IL-2 protein accumulation in thymi taken from mice 
carrying different mutant-TcR genes (Figure 4). Detection of intrathymic IL-2 protein 
accumulation in these animals permitted analysis of IL-2 gene expression in the thymus when 
either a.~ or yB T -cell development is specifically inhibited. The deletion of a particular TcR 
chain is sufficient to block development of cells belonging to the relevant lineage (7, 8). In 
TcRa.- or TcR~-deficient mice, IL-2 protein was still detected in the thymus. Since the 
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development of yo T cells does not depend on TcRa- or TcRJ3-expression (7) and viewed in the 
context of the SCID data indicating that IL-2 protein is observed in the thymus only when 
functional TcR rearrangement occurs, the intrathymic IL-2 staining results obtained from TcRa 
and TcRJ3 -/- animals imply that IL-2 producing cells in these mutant thymic belong to the yo 
lineage. In af3-lineage mice, IL-2 reactivity in the thymus was constrained to the cortex and 
subcapsular region; this is dramatically demonstrated by the IL-2 protein staining pattern 
observed in the thymus of TcRf3-deficient mice (Figure 4C). 
In comparable staining studies to examine intrathymic IL-2 protein accumulation in the 
thymus of mice rendered TcRO-deficient by targeted gene disruption, IL-2 protein was also 
detected. Again, the generation of af3 T cells is independent of yo T -cell development (8), cells 
induced to express IL-2 in the TeReS-/- thymus must belong to the af3 lineage. Surprisingly, the 
pattern of IL-2 protein accumulation in the TeReS -/- thymus revealed that IL-2 protein was 
limited to the inner cortex and cortical-medullary junction (Figure 4E). Thus, the patterns of 
IL-2 protein accumulation in the thymus of a f3- and yo-lineage mice are apparently 
nonoverlapping. The combined intrathymic IL-2 staining data from TcRa-, TcRJ3-, and TcRO-
deficient mice are given in Table I and Figure 5. These results indicate that the intrathymic 
pattern of IL-2 staining in normal mice is a composite of patterns generated in af3 TcR- and 
ycSTcR- animals. This finding is completely consistent, since the normal thymus contains both af3 
and yo lineages. In detail, the number of intrathymic IL-2 reactive zones in TcR-deficient mice 
was routinely smaller than that in wild-type animals (Table I). However, when added together, 
the number of IL-2 protein-rich areas in TcRaf3- and TcRyo- mice was generally equal to the 
number of unique reactive zones in wild-type mice in which both af3- and yo lineages are 
generated (Figure 5). As a control, IL-2 protein was not detected in TcRf3!fcRO-double mutants, 
confmning that IL-2 expression in the thymus is dependent on expression of either af3 and yeS 
TcR. These combined data demonstrate that the intrathymic IL-2 expressing population contains 
both af3 and yeS TcR+ cells. 
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TcRJ3-Expression Alone is Insufficient to Induce IL-2 Gene Expression in the Thymus 
Although the results from the study of intrathymic IL-2 protein accumulation in TcR~ 
deficient mice indicate that cells of the lineage are inducible for IL-2 gene expression in the 
thymus, it was not possible to determine whether TcRcxJ3-expression or TcRJ3-expression alone 
induces intrathymic ll...-2 protein synthesis. To address this issue, IL-2 protein accumulation was 
analyzed in RAG-2-deficient mice expressing a TcRJ3-chain transgene (16). Animals deficient in 
recombination activating gene (RAG) activity cannot initiate V (D)J rearrangement ( 17, 18). The 
RAG-2 -/-block in T-cell development is comparable to that observed in SCID mice. However, 
the expression of a functional TcRb-transgene in the RAG-2 mutant background allows cells to 
progress from a TcR-CD4-CD8- state to a CD4+CD8+ state (16). This transition is presumably 
regulated by the interaction ofTcRJ3 and its "pre-TcRcx" partner, gp33 (19). However, these cells 
are never subject to conventional positive or negative selection because they never express a 
complete TcRcxl3 heterodimer. As expected, IL-2 protein was not detected in the RAG-2 -/-
thymus (Figure 6A). More importantly, IL-2 staining was not observed in the TcRJ3+, RAG-2 -/-
thymus (Figure 6C). Thus, these findings reveal that signals transduced by TcRJ3/gp33 cannot 
induce ll...-2 gene expression in vivo, and that intrathymic IL-2 gene expression is induced cells of 
the cxJ3 lineage upon cxl3-TcR surface expression. 
Induction of IL-2 Gene Expression in cxf3-TcR Transgenic Thymus Bred Onto Positively 
Selecting and Nonselecting Backgrounds 
The dependence of intrathymic IL-2 gene expression on cxf3-TcR expression raises the 
possibility that intrathymic ll...-2 gene expression in developing cxl3-TcR+ cells is linked to a gain 
in function, induced by the process of positive selection. Therefore, the pattern of intrathymic 
IL-2 protein accumulation was determined in animals expressing a transgenic cxl3-TcR specific 
for H-2Ld bred onto H-2B (positively selecting) and H-2S (nonselecting) genetic backgrounds (9, 
10). The representative staining patterns are shown in Figure 7. IL-2 protein was detected in the 
cxf3-TcR transgenic/H-2B thymus (Figure 7A), but was also detected in the cxl3-TcR transgenic/H-
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2S thymus (Figure 7B). Likewise, the number of unique IL-2 reactive zones was similar in both 
cases (data not shown). These results show that background and frequency of positive selection 
do not appear to affect the frequency ofiL-2 protein producers in the thymus. 
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DISCUSSION 
In this study, we examined the effects of particular TcR mutations and positive selection 
on the induction of ll..,-2 gene expression in the thymus, as monitored by the accumulation of 
ll..,-2 protein therein. These new findings help resolve several issues with regard to the identity of 
cells induced intrathymically to express the ll..,-2 gene and the nature of the interactions that 
induce ll..,-2 gene expression in the ll..,-2 expressing cell population. In addition, the data 
presented here open new possibilities with regard to mechanisms by which developing T cells 
acquire functional competence and respond to fate-determining intrathymic signals. 
By using an enhanced immunohistochemical staining technique, we were able to improve 
detection of ll..,-2 protein accumulation in the thymus. As mentioned previously, the comparison 
between the frequency of individual ll..,-2 producing cells detected in sections generated from 
fresh frozen tissues was comparable to that of unique ll..,-2 reactive zones seen in sections of 
prefixed tissue, supporting the notion that ll..,-2 protein synthesized in a specific area can be 
attributed to a single ll....-2 producer. Additionally, earlier in situ hybridization data revealed that 
cells induced to express ll..,-2 mRNA in the postnatal thymus were found at relatively the same 
frequency as single ll..,-2 producing cells (6) and were highly ll..,-2 mRNA+; qualitatively, the 
amount of accumulated ll..,-2 mRNA in intrathymically induced ll..,-2 expressors was comparable 
to that routinely observed in EL4 cells, a high ll....-2 producing thymoma cell line, stimulated to 
express ll..,-2 with calcium ionophore and phorbol ester (6). Thus, it is likely that ll..,-2 producing 
cells in the thymus are synthesizing large amounts of protein. Finally, with regard to the location 
of ll..,-2 production in the thymus, the are in which an intrathymically induced cell produces ll..,-2 
protein may llQ1 be identical to that in which the cell was initially induced to express ll..,-2 
mRNA. In general, maximal ll..,-2 mRNA expression precedes maximal ll..,-2 protein synthesis 
by 10-12 hours (6). Hence, ll..,-2 producing cells restricted to a particular "zone," especially at 
the cortical-medullary junction, may have originally been induced to express IL-2 mRNA 
elsewhere and migrated to the site of protein production. 
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Our studies using immunocompromised mice to identify interactions essential for the 
induction of IL-2 gene expression leading to IL-2 protein synthesis in the thymus demonstrated 
that there are three independent ways to perturb TcR expression which result in the elimination 
of intrathymic IL-2 producing cells. Our data show that the disruption of TcR expression by 
targeted gene disruption, introduction of SCID mutation, or deficiency in RAG-2 activity results 
in either the partial or complete abrogation of IL-2 protein production in the thymus. 
Consequently, we can rule out any basis for blocking IL-2 expression/protein production in the 
thymus other than the absence of TcR expression and the cells on which TcRs are expressed. 
Induction of IL-2 gene expression in the thymus is contingent upon TcR surface 
expression. Mutations that block TcR gene rearrangements or interfere with ex~ .a.n..d. yo TcR 
surface expression inhibit intrathymic IL-2 gene expression. This is supported by results 
demonstrating that intrathymic accumulation of IL-2 protein was not detected in SCID mice and 
animals deficient in RAG-2 activity of TcRp along with TcRo chain expression. However, 
expression of a rearranged TcR~-chain is insufficient to induce IL-2 gene expression in 
thymocytes in vivo. It has been shown that TcR chain can be expressed on the cell surface of 
immature thymocytes in the absence of TcRcx-chain expression (19-21). Prior to TcRcx-chain 
surface expression in conjunction with TcR~-chain, TcR~-chain is disulfide linked to a newly 
identified polypeptide, gp33 (19). TcR~/gp33 dimers apparently associate with CD3y, o, and e, 
but only weakly with CD3~ (16, 19). Expression of gp33 may be developmentally regulated; 
once functional TcRcx-chain is expressed, TcR~-chains preferentially associate with TcRcx-chains 
and TcRMgp33 dimers are no longer detectable (19). Partial characterization of intracellular 
signals transduced by TcR~/gp33 revealed that TcRMgp33 crosslinking leads to a rapid calcium 
flux (21). Altogether, the signals transduced by TcR~/gp33 with its undisclosed ligand(s) are 
able to initiate the explosive expansion of cell numbers, expression of CD4 and CD8 coreceptors, 
and suppress further TcR~-chain gene rearrangement (22). Presumably, activation of the src-
family protein tyrosine kinase, Lck, is involved in TcRMgp33-mediated signaling, since 
upregulation of Lck mediates immature thymocyte proliferation and suppresses TcR~-chain gene 
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rearrangement (23, 24). A recent report details that Lck is directly involved in regulating these 
events (25). Thus, many of the signals transduced by TcRJ3fgp33 in immature thymocytes are 
shared with those transduced by a.~ TcR in mature T cells. Nevertheless, TcR~/gp33 interactions 
cannot induce intrathymic IL-2 protein production, indicating that signal transduction pathways 
mediated by TcRMgp33 interactions may be quantitatively and qualitatively different than those 
mediated by a.l3 TcR. 
Although results obtained in SCID mice demonstrate that induction of IL-2 gene 
expression resulting in IL-2 protein synthesis in the thymus relies on productive TcR gene 
rearrangement and expression, they provide little information on whether cells induced 
intrathymically for IL-2 gene expression belong to the a.l3 or yo lineage. Detailed analysis of the 
intrathymic patterns of IL-2 protein accumulation in TcRa. -/-, TcRI3 -/-, TcRo -/-, and TcRI3 -/-&-
/- mice yielded evidence indicating that both a.l3 TcR+ and yo TcR+ cells are included in the 
thymocyte population inducible for IL-2 gene expression in vivo. A multitude of studies in vitro 
and in vivo have demonstrated that subsets mature a.l3 and yo TcR+ cells can be induced to 
express IL-2, thus induction of IL-2 gene expression is a functional response that subsets of both 
a.l3 and yo lineage T cells must possess and acquire during development. Should induction of 
IL-2 gene expression in the thymus be regarded as the exercise of functional competence, then, 
according to prediction, intrathymic induction of IL-2 gene expression would be detected in both 
lineages, and this is indeed the case. Interestingly, the partitioning of IL-2 inducible cells 
belonging to the a.l3 and yo lineages in the thymus suggests that demonstration of functional 
competence may occur in different regions in the thymus and perhaps at different times 
following bona fide TcR expression in immature a.l3 TcR+ versus yo TcR+ cells. On the other 
hand, based on arguments presented earlier, the apportionment of IL-2 producers belonging to 
the a.l3- or .,.0 lineage to specific sites of IL-2 protein production may be somewhat artificial. 
The correlation between functional TcR expression and induction of IL-2 gene expression 
in the thymus alludes to the possibility that intrathymic induction of IL-2 gene expression may be 
coupled to the process of positive selection. It is common knowledge that positive selection is 
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involved in detennining specificity and function of the at3 TcR repertoire, yet less is known with 
respect to whether positive selection shapes the yo TcR repertoire. Nevertheless, aspects of 
positive selection in the development of cells in the at3 lineage provide clues into the unanswered 
question regarding the role that positive selection might play in inducing ll..-2 gene expression in 
thymocytes in vivo. Recent studies have demonstrated that cognate peptide for a specific 
transgenic af3 TcR can induce both positive and negative selection (26 27). The decision as to 
whether positive or negative selection is induced in the presence of peptide is highly dose 
dependent. These studies show that several participants in cell-surface interactions detennining 
negative selection, positive selection, and mature T -cell activation are more or less identical-
TcR, peptide, and MHC molecules in particular. Although the signals transduced by these 
processes are most likely nonequivalent, since the net result of TcR engagement under these sets 
of circumstances are death, survival, and induction of effector functions, respectively, it is still 
tantalizing to speculate that TcR-specific interactions in immature T cells may be sufficient to 
induce genetic programs characteristic of the functionally mature state. In terms of induction of 
ll..-2 gene expression manifested by the production of ll..-2 protein and positive selection in the 
thymus, no direct correlation could be drawn. Regardless, this does not formally disprove that 
intrathymic induction of ll..-2 gene expression may be coupled to positive selection. 
We did not observe an increase in the number intrathymic ll..-2 producers represented by 
unique zones of ll..-2 reactivity in animals for which positively selected T cells is enriched. 
These results can be accounted for in numerous ways. First, yo T -cell development is not 
suppressed in these transgenic animals, since yo TcR+ cells were detected in af3-TcR transgenic 
animals, since yo TcR+ cells were detected in a f3-TcR transgenic thymi as determined 
fluorescence activated cell sorting analysis (data not shown). Hence ll..-2 protein production in 
the af3-TcR transgenic/nonselecting thymus may be due to intrathymic induction of ll..-2 gene 
expression in yo TcR+ cells. On the other hand, cells induced to express IL-2 in the 
transgenic/nonselecting thymus could belong to the af3 lineage, but may express nonidiotypic, 
endogenous TcR a-chains coupled with transgenic TcRf3-chains. In addition, kinetic studies of 
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thymocyte population dynamics in a.l3-TcR transgenic mice have shown that there may be a 
limiting number of selecting "niches" available to immature thymocytes (12). Therefore, it is not 
entirely unexpected that an enrichment of IL-2 inducible cells in an a.l3-TcR transgenic/positively 
selecting thymus, since the process of positive selection in itself may be rate limiting. Finally, an 
increase in IL-2 production may not have been observed using this ab-TcR transgenic system 
because positive selection is biased toward the generation of CDS+ /class I MHC-restricted T 
cells. Canonically, CDS+ T cells exhibit a "killer" functional phenotype and participate directly 
in cell-mediated cytotoxicity. The generation of CD4+ T "helper" cells that respond to foreign 
antigen by producing lymphokines, including IL-2, is perturbed in mice expressing transgenic ab 
TcRs with class I specificity (S, 10, 2S, 29). Hence the failure to detect on an increase in 
intrathymic IL-2 production in positively selecting class !-restricted a.l3 TcR transgenic mice may 
have resulted from a failure to bias positive selection toward the generation of CD4+ helper cells. 
In conclusion, induction of IL-2 gene expression in the thymus can be regarded as an 
exhibition of functional responsiveness that occurs as developing thymocytes mature. It remains 
to be proven or disproven that this inductive event is linked to positive selection, the process by 
which immature T cells are "chosen" to mature, based on recognition specificity. Likewise, the 
dependence of intrathymic induction of IL-2 gene expression on functional TcR expression 
suggests that there is a coupling between the exercise of functional competence and recognition 
specificity within the thymus. However, additional research is necessary to show that this is true. 
Finally, intrathymic induction of IL-2 gene expression as hallmarked by intrathymic IL-2 protein 
production is a rare activation event which may occur independent of the positive selection 
process. These issues, along with further characterization of precise interactions involved in 
inducing IL-2 gene expression in the thymus, provide continued interest and expanded areas of 
research in the processes involved in the generation of functionally responsive T cells. 
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TABLE 1: Regions of IL-2 Staining in Thymus Lobes of Different TcR-Mutant Mice 
No. of Discrete ll...-2 Staining Zones in: 
No. Sections Corti co- Total No. 
Genotype Examined Outer Cortex Inner Cortex Medullary +Regions 
TcRa -/-, #1 136 11 11 1 23 
TcRa -/-, #2 126 13 15 0 28 
TcR(3 -/-, #1 72 13 5 0 18 
TcR(3 -/-, #2 72 8 10 0 18 
TcRf3 -/-, #3 74 7 10 0 17 
TcRo -/-, #1 126 2 17 22 41 
TcRo -/-, #2 126 2 22 16 40 
TcRJ3-/-&-/- 62 0 0 0 0 
TcRa+/- 136 13 18 18 49 
TcRf3+/+ w.t. 132 12 19 20 51 
Total number of sections examined for each sample represents half a thymic lobe in each case. 
ll...-2 staining regions identified by immunohistochemistry of serial sections, and corrected for 
regions detected in more than one section. No staining was observed in the medulla proper. 
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FIGURE LEGENDS 
FIGURE 1. Fresh frozen versus prefixed tissue sections of normal thymuses generated from 4-5 
week old mice stained with a rat antimouse n....-2 mAb. Tissues prefixed prior to sectioning were 
incubated in 4% paraformaldehyde/PBS for 16-18 hours, washed thoroughly in PBS, saturated in 
30% sucrose/PBS and then embedded in O.C.T. Negative control stainings were carried out 
using normal rat IgG in lieu of the primary antibody. No apprecial reactivity was observed in 
negative control samples (data not shown). Bright field, 200X. Medulla (M). 
(A): n....-2 reactive cell associated with cortex (arrow) in fresh frozen thymus section. 
(B): IL-2 reactive cell associated with cortical-medullary junction (arrow) in fresh frozen 
thymus section. 
(C): Zone of n....-2 reactivity associated with cortex in prefixed thymus section. 





FIGURE 2: Blocking experiment to demonstrate specificity of staining in prefixed normal 
mouse thymus sections. Blocking treatment is described in Materials and Methods. Arrows 
point to "islands" of cortex in the medulla. Counterstained with methyl green. Bright field, 
Upper panels 15X, lower panels 30X. Bar= 1 mm. 
(A): Stained with anti-IL-2 mAb. 




FIGURE 3. Prefixed thymus sections taken from 4-5 week old SCID mice stained for IL-2 
protein accumulation. Counterstained with methyl green. Bright field, 15X. Bar= 1 mm. 
(A): Stained with anti-ll..-2 mAb. 







FIGURE 4. Staining of prefixed thymus sections generated from TcR-deficient mutant mice for 
IL-2 protein accumulation. Counterstained with methyl green. Bright field, 15X. Left panels: 
staining with primary antibody. Right panels: Negative control staining. Bar = 1 mm. 
(A): TeRn -/- thymus sections. 
(B): TcR~ -/- thymus sections. 
(C): TcRy -/- thymus sections. 
(D): TcR~-/-&-/- thymus sections. 
Medulla is identified by less intensely stained areas following visualization by counterstaining. 





FIGURE 5. Bar graph showing frequency and distribution of unique a-2 reactive zones in the 
thymus of TcRa. -/-, f3 -/-, o -/-, f3 -/- o -/-, and wild-type mice. Analysis was performed on thymi 

















































































































































FIGURE 6: Expression of TcRf3 does not restore intrathymic IL-2 production in rearrangement-
deficient mice. Left panels: staining using anti-IL-2 mAb. Right panels: negative control 
staining. Positive control staining (normal thymus sections) are not shown. Counterstained with 
methyl green. Bright field, 15X. 
(A): Prefixed thymus sections generated from 4-week old RAG-2 -1- mice. 




FIGURE 7 : Staining of prefixed tissue sections generated from 3-5 week old ex~-TcR transgenic 
mice using a rat anti-mouse ll...-2 rnA b. Left panels: staining with primary antibody. Right 
panels: negative control staining. Counterstained with methyl green. Arrows indicate 
correponding regions of cortex in negative control staining that are immunoreactive in the 
adjacent serial section. Bright field, 25X. Bar = 1 mm. 
(A): H-2B cx~-TcR transgenic thymus. 








The body of work presented here sheds new light on several aspects of ll..--2 gene 
expression in vivo. First, ll..--2 expression is detected in the thymus, the paramount site ofT-cell 
development. Cells induced to express ll..--2 intrathymically can be separated into two main 
groups as defined by the dependence of ll..--2 expression on functional TcR rearrangement and 
surface expression. One subset is found in the day 14-15 fetal thymus. ll..--2 expressing cells 
belonging to this subset are restricted to the periphery of the fetal thymus. Peak IL-2 mRNA 
accumulation in this fetal thymic ll..--2 expressing cells is detected at a day 14.5 of gestation and 
maximal protein synthesis is observed 12 hours later. Induction of ll..--2 gene expression in this 
subset is extremely transient; extensive IL-2 mRNA accumulation and ll..--2 protein synthesis 
cannot be detected in the outer region of the thymus by day 16 of gestation. Significantly, this 
population of ll..--2 expressing cells is not eliminated by the SCID mutation, thus induction of 
ll..--2 gene expression in these cells occurs independently from the generation of function TcRs. 
These results raise the possibility that this fetal subset of intrathymic ll..--2 producers may not 
belong to the T lineage (see below). 
The second class of intrathymic ll..--2 expressing/producing cells is also present in the 
fetal thymus. However, IL-2 expressing/producing cells of this class are also found in the 
postnatal thymus. Unlike the first class of IL-2 producers, induction of ll..--2 gene expression and 
ll..--2 protein synthesis in cells belonging to this class requires functional TcR expression. In the 
day 14-15 fetal thymus, ll..--2 expressing cells of this class represent a minor population of 
intrathymic ll..--2 expressing cells and reside in the inner region of intrathymic ll..--2 expressing 
cells and reside in the inner region of the organ (data not shown). In the postnatal thymus, IL-2 
expressing/producing cells are extremely rare and are found throughout the cortex and at the 
cortical-medullary junction. The absence of IL-2 expressing cells in the medulla demonstrates 
that these cells are not mature thymocytes nor recirculating T cells that have homed back to the 
thymic medulla. This class of IL-2 expressing/producing cells is not generated in TcR gene 
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recombination-defective mice, since the early block in T -cell development which eliminates all 
subsets of TcR+ cells also results in the abrogation of ll...-2 expression and IL-2 protein 
production in the postnatal thymus. 
Although results obtained in SCID (and RAG-2 -/-) mice suggest that intrathymic ll...-2 
production is contingent on productive TcR-gene rearrangement and expression, Ig-chain gene 
rearrangement is equally affected in these animals, thus it is conceivable that intrathymic ll...-2 
producing cells represent a population of non-T lineage cells in the thymus (i.e., could belong to 
the B lineage). B-cell development is not observed in the thymus; in fact, the thymus may even 
suppress development of B cells derived from the bipotentiallymphoid precursor found within. 
However, bone marrow-derived cells are found in the thymus and putative non-T-lineage ll...-2 
producing cells could be associated with this population. Nonetheless, results from the 
examination of ll...-2 production in mutant mice deficient in TcRJ>- and TcRo-chain expression 
indicated that ll...-2 producing cells in the thymus belong to the T lineage. In these animals, the 
development of nJ3 and yo T cells is impaired without affecting B-cell development. The 
complete block in the generation of TcR+ cells had a profound effect on intrathymic ll...-2 
production. Intrathymic ll...-2 producing cells were not found in TcRJ3-/-TcRo-/- double mutant 
mice, thereby demonstrating that intrathymic protein synthesis requires the exclusive generation 
of TcR+ cells. Finally, further characterization of intrathymic protein accumulation in mutant 
mice deficient in the expression of a single TcR chain resulting in the elimination of either ~- or 
..,.0-TcR+ cells showed that intrathymic ll...-2 producing cells were found irrespective of the 
absence of a single T-celllineage, hence both nJ3- and "(0-TcR+ cells are found in the second class 
of intrathymic ll...-2 producers. 
Identification of immature T cells capable of producing IL-2 in vivo reveals subtle 
differences between the acquisition of functional competence defined in vitro and the exercise of 
functional responsiveness in vivo. Whereas a high proportion of TcR- immature cells are 
competent to induce ll...-2 gene expression in vitro, they are not induced to do so in vivo. 
Likewise, TcR+ immature cells that are induced to express/produce ll...-2 in the thymic cortex are 
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functionally competent by definition, unlike the vast majority of cortical thymocytes that are 
functionally incompetent. It is not clear what other properties delineate functionally responsive 
TcR+ immature cells from functionally incompetent ones other than the display of ll...-2 protein 
synthesis in vivo. Due to the extreme infrequency of the activation event involved in inducing 
ll...-2 expression in vivo, additional characterization of cells exercising functional competence by 
producing ll...-2 and interactions involved in inducing expression in these cells is technically 
daunting. Lastly, since TcR+ intrathymic ll...-2 producing cells have theoretically not completed 
the maturation process, the developmental fate of these cells is still unknown. With the advent of 
in vivo cell lineage tracing techniques that permanently label cells that have transiently expressed 
a particular gene during the course of development with a heritable genetic marker (1-3), it may 
be possible to follow the fate of immature cells that have been induced to express ll...-2 in the 
thymus. Hence, the initial identification of functionally responsive cells in the thymus lays the 
foundation for new studies to examine the relationship between the exercise of functional 
competence during T-cell development and the actual generation of functionally mature cells. 
With regard to extrathymic sites of IL-2 gene expression, the identification of IL-2 
expressing cells in the gut and fetal hematopoietic tissues facilitates the interpretation of results 
obtained in studies of ll...-2 -/-mice. ll...-2 producing cells are found throughout the gut and can 
contribute to mucosal immune responses and immunologic balance in mucosal tissues. The 
association of ll...-2 producing cells with the lamina propria suggests that LPL populations are 
involved in the prevention of inflammatory bowel disease. The absence of IL-2 producing cells 
and/or the absence of IL-2 protein leads to a debilitating immunoreactive state. A more thorough 
characterization of intestinal ll...-2 producing cells will increase the understanding of how ll...-2 
regulates important immune-related processes in the gut. Since a significant number of gut-
associated ll...-2 producing cells are generated during fetal ontogeny, the susceptibility to contract 
ulcerative colitis could be a congenital defect resulting from a failure to produce functionally 
competent cells found in the gut prior to birth. Treatment of IL-2 -/-mice with fetally-derived 
gut-associated IL-2 producing cells or potential fetal precursors of these cells would certainly 
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define the role that these cells play in immunity and maintenance of immunologic balance in the 
mucosa. 
Since ll...-2 -/-mice also display defects in hematopoiesis, it is of particular interest that 
ll.. -2 protein synthesis was detected in fetal hematopoietic tissues. Although problems related to 
hematopoiesis are observed in older postnatal animals, it is particularly provocative to speculate 
that the disruption of ll...-2 production in the fetal liver, a major site of hematopoiesis, somehow 
contributes to abnormalities manifested later in postnatal life. It is known that precursors from 
the fetal liver seed the bone marrow. Again, it would be fascinating to investigate the possibility 
that cells which produce ll...-2 in fetal tissues with which hematopoiesis is associated contribute 
to processes involved in regulating balance of immune responses in the mucosa and 
hematopoiesis in postnatal animals. This issue can also be addressed using cell lineage tracing 
techniques to examine the developmental fate of ll...-2 producing cells in the fetal liver and 
omentum, an additional embryonic site of lymphopoiesis. Based on the ll...-2 knockout data, it 
can be postulated that descendants of cells induced to synthesize ll...-2 protein in the fetal liver 
and omentum would be found later in the fetal gut and postnatal hematopoietic and secondary 
lymphoid tissues. In addition, detection of ll...-2 protein in the fetal liver and omentum indicate 
that induction of ll...-2 expression and protein synthesis also occurs extrathymically in tissues 
actively participating in lymphopoiesis, thus signals exist outside the thymus to induce ll...-2 gene 
expression in subsets of fetal cells that may or may not belong to the T lineage; a more in depth 
characterization is required to determine the actual identity of ll...-2 producing cells in fetal 
hematopoietic tissues. 
Additional analysis of extrathymic ll...-2 expression in vivo revealed that ll...-2 can be 
implicated in the extrathymic expansion of T cells associated with the skin of normal mice. 
Temporal expression of ll...-2 in the skin depends on the presence ofT cells therein. The 
distribution of ll...-2 expressing cells in the dermis and epidermis of young mice is strikingly 
similar to that of resident CD3 +dendritic epidermal cells. The absence of both ll...-2 expressing 
cells and DECs in the skin samples taken from SCID mice provide strong circumstantial 
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evidence that these a-2 expressing cells belong to the T lineage. At a time when DEC 
populations are expanding, a-2 mRNA and protein are readily detected in the skin. The 
association of a-2 expressing cells in the skin with hair follicles in young mice indicates that 
inductive signals that regulate a-2 expression in these cells are found in follicles. Once DECs 
migrate away from follicles to populate the epidermis in older animals, they are no longer 
induced to express a-2. Hence transience of a-2 gene expression in DEC populations appears 
to be regulated by the interaction of DECs with hair follicles. In normal mice, the majority of 
CD3 + DECs express invariant yo TcRs that recognize keratinocyte specific antigen(s). 
However, interaction with hair follicles of DECs expressing completely "inappropriate" TcRs 
nevertheless resulted in a-2 protein synthesis, suggesting that expression of a particular TcR 
does not specify a-2 expression in expanding DEC populations. Dissection of the regulation of 
a-2 gene expression in DECs on a molecular level may provide insight into the apparent 
"flexibility" regarding TcR expression and induction of a-2 gene expression in DECs. 
The studies described here have primarily focused on a-2 expressing cells and a-2 
production in particular tissues. The precise identities of cells responding to a-2 have not been 
determined. Expression of the high affinity a-2 receptor as defined by the presence of the 
inducible component (CD25/IL-2Ra) was superficially examined in tissues where IL-2 
producing cells are found (data not shown). The absence of IL-2Ra expression is not necessarily 
indicative of nonresponsiveness to a-2, since cells expressing lower affinity ll..-2Rs (forms of 
ll..-2R that do not include the a-chain) are also functional and cannot be readily detected at this 
time. Detailed characterization of ll...-2 responding cells in vivo is an extensive undertaking in 
itself. However, the identification ofll..-2 producing cells in vivo provides a sound foundation on 
which studies to characterize cells responding to a-2 in specific tissues can be based. 
Overall, the results described in previous chapters pertaining to the patterns of ll...-2 gene 
expression in vivo reveal vital information regarding the regulation of ll...-2 gene expression and 
the function of a-2 in the mouse. Data presented here provide new opportunities to understand 
differential regulation of ll...-2 gene expression in specific populations of ll...-2 producing cells 
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identified initially in vivo. Likewise, the fate of cells induced to synthesize IL-2 protein in vivo is 
a fascinating issue with respect to the development of cells in the T lineage and precursor 
"potential" associated with particular IL-2 production found in fetal tissues. Finally, additional 
characterization of IL-2 producing cells induced in vivo and responding cells therein will 
generate a more complete picture of the function of IL-2 in the mouse. Hence this body of work 
provides a basis for fruitful areas of research for many years to come. 
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IL-2 GENE INDUCIBILITY IN T CELLS BEFORE T CELL RECEPTOR 
EXPRESSION 
Changes in Signaling Pathways and Gene Expression ReqUirements during 
Intra thymic Maturation 1 
ELLEN V. ROTHENBERG! ROCHELLE A. DIAMOND. KAREN A. PEPPER. AND JULIA A. Y ANG3 
From the Division of Biology. 156·29. California Institute of Technology. Pasadena. CA 91125 
The ability to express the growth hormone IL-2 
upon stimulation gives T lymphocytes one of their 
major effector functions in the immune system. IL-
2 is apparently synthesized only by T cells. and only 
by a subset of T cells which constitutes a "helper" 
class. It remains unknown how and when the IL-2-
producing lineage becomes distinct from other func-
tional effector lineages. We have therefore exam-
ined immature T cell precursors to determine when 
IL-2 inducibility is acquired in relation to other mat-
uration events. such as expression of an Ag-binding 
TCR, which is suspected to play an influential role 
in the determination of subclass commitment. In 
mature T cells, IL-2 is inducible via agonists of the 
phosphoinositide pathway, a network of signaling 
mediators shared by a wide variety of metazoan cell 
types. The universality of this activation pathway 
makes it seem less likely, a priori, to be a target of 
developmental change than the intrinsic suscepti-
bility to induction of the IL-2 locus. However, our 
results presented here refute this expectation. In 
this report, we show that both TCR• cells and pre-T 
cells too immature to express TCR can be induced 
to express IL-2 at high levels. The induction require-
ments for IL-2 expression. however. are different in 
TCR- and TCR• cells. Even by using ca•• ionophore 
and phorbol ester to bypass the requirement for the 
TCR in cell activation, the TCR- cells also require 
the presence of the polypeptide hormone IL-l. By 
contrast. TCR• mature cells not only can express 
IL-2 without IL-l, but also show no response to IL-l 
when ca•• ionophore and phorbol ester are present. 
IL-l-dependent IL-2 producers appear in the thymus 
of repopulating radiation chimeras before "mature" 
(TCR•) T cells. whereas IL-l-independent IL-2 pro-
duction is found only afterward. Thus, IL-2 induci-
bility per se apparently precedes TCR expression 
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and all TCR-associated fate determination events. 
However, developmental alteration of signal trans-
duction pathways may play a vital regulatory role 
in the later allocation of particular functional re-
sponses to appropriate lineages ofT cells. 
T lymphocytes are diverse In two essential features: 
their Ag-recognltlon specificities. and their functional 
responses to activation. These features are controlled by 
Independent molecular mechanisms. Recognition spec!· 
flclty Is determined by the particular combination of gene 
segments that a given T cell randomly selects for re-
arrangement during assembly of Its TCR transcription 
units . Functional responses are defined by the battery of 
transiently expressed genes that a gtven T cell will acti-
vate. reproducibly. upon stimulation. for example after 
Ag binding. In the best-studied case. that of competence 
to express the Important T cell growth factor IL·2. the 
response Is regulated by the availability of trans-acting 
transcription factors. some of which are cell type specific 
and/or activation dependent (reviewed In Ref. 1). A strik-
Ing but unexplained observation In mammalian T cell 
populations Is that separate T cell lineages distinguished 
by criteria of Ag recognition specificity ("MHC restric-
tion") are also largely distinct In functional response 
capabilities. That Is. T cells whose Ag receptors bind 
class ll MHC glycoprotelns tend to be much better IL-2 
producers. but poorer killers. than those whose receptors 
bind class I MHC targets (reviewed In Ref. 2). The corre-
lation Is strong but Imperfect. reinforcing the Interpre-
tation that target recognition and response are mechan-
Istically Independent. To shed light on how these separate 
lineage characteristics become linked In T cell develop-
ment. we have Investigated whether competence to make 
specialized f unctlonal responses Is acquired In a process 
that depends on expression of Ag-blndlng receptors. 
Developing T cells In the thymus undergo a pro-
grammed sequence of gene rearrangements at the loci 
encoding the Ag-blndlng chains of the TCR complex, 
coordinated with other changes In cell surface phenotype 
(reviewed In Ref. 3). It appears that just before expression 
of assembled TCR complexes. most thymocytes acquire 
the glycoprotein markers CDS and then CD4 (4-7). Soon 
thereafter. a selection event based on TCR recognition 
specificity appears to catalyze permanent separation of 
the TCR• cells Into CD8-only and CD4-only lineages (8. 
9). Those rare thymocytes which lack both CD4 and CDS. 
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I.e .. "DN"4 cells. are predominantly Immature cells that 
have not yet finished rearranging their TCR loci. The DN 
population thus provides the test case for whether partic-
ular functional responses are only acquired as a result of 
events dependent on TCR specificity. 
We have previously reported that there are cells In the 
DN population that could be Induced to express lL-2. 
provided that a chemical stimulus was u sed that by-
passed the need for a cell-surface TCR (10. 11). Recent 
work. however. has delineated minority subpopulations 
within the DN thymocyte set which have apparently re-
tained a CD4-cns- phenotype In spite of having a lready 
acquired potentially functional TCR. The present work 
was undertaken. therefore. to test directly whether IL-2 
gene inducibility was confined to cells already expressing 
TCR. We have found that the IL-2 locus is highly induci-
ble even in immature. TCR- cells. but that the biochem-
Ical triggering requirements for Its inducibility shift dra-
matically during T cell maturation. Thus. the alteration 
In signal transduction pathways provides a distinct tier 
of regulation in the developmental acquisition of compe-
tence to make IL-2. 
MATERIALS AND METHODS 
Animals. C57BL/6J and C57BL/6Boy-Tla" mice were bred and 
maintained In our own colony and used In most experiments between 
the ages of 4 and 6 wk . For radiation chimeras. 7 to9-wk-old C578L/ 
6J ml~ were used as recipients and BG.PL-Thy-1 . 1/Cy mtce (Jack-
son La bora tortes. Bar Harbor, ME) were used as donors of marrow. 
ln most experiments. splenocytes were taken from the same young 
animals as the thymocytes. For tsolaUon of purified splenic T cells. 
however, tn Table J. experiment 3, splenocytes were Isolated from 
older animals. 3 to 4 mo old. 
Reagents and anttbodfes. Human riL-lo and murine riL-2 and 
r!L-4 were obtained from Genzyme (Boston. MA). A I 000 U/ ml stock 
of IL-l In Ca2*- and Mg2 *-free Oulbecco's PBS was added to cultures 
to a final concentration of 50 U/ ml. The calcium lonophore A23187 
and TPA were obtained from Sigma (St. Louts. MO] and prepared as 
stock solutions In Me:a$0. Allquoted stocks were stored at -20°C. 
The concentration of the A23187 stock was detenntned spectropho-
tometrtcally to be 0.7 mM. TPA was dissolved at I 0 "g/ml. Antibodies 
used for cytolysis and to verify cell-surface phenotype by flow cytom-
etry were as described previously In detatl (12). Briefly. directly 
coupled fluorescein-conjugated 53.6.7 and phycoerythrin-conju-
gated GKI.5 detected CDS and CD4. respectively. and 500A2 with 
fluo~eln-conjugated goat-anti-hamster Ig d etected CD3/TCR com-
plexes. In some exper1ments. fluorescein-conjugated Mar-18.5 (Bec-
ton Dtcklnson. Mountain View. CA) detected residual antibody on C-
treated cell populations. For cytolytic elimination. RL172.4 (anti-
CD41 and 3.155 (anti-CD8) were used. with the addttlon of CG-16 
anu-cos (Cedarlane. via Accurate Chemical Co .. New York. NY) to 
eliminate CD5"'"" cells (10. 13). Rabbit complement was from se-
lected lots (•2728 and •3069. Pelfreez. Deer Park. Ml). and used In 
one-step Incubations with antibody at 1/25 final dilution. 
Preparation of cell papulatlons. DN thymocytes and splenocytes 
were prepared essentially as described preViously ( 12. 14). In general, 
one round of cytolysis with anti-COS or antt-CD4 and two with both 
antt-CDS(I/2000 ascites] and anti·CD4 (I /I 00 ascites or 1/8 dilution 
of a 1 O-f old concentrated su~matant) sufficed to prepare pure ON 
ccUs. CD4 .. contaminants survtved tn some cases where cells were 
exposed only twice to anti-CD4 (RLI72.4) hybridoma supernatant. 
Antlbcx:Hes currently available agatnst murine CD3 are not cytolytic 
and could not be used for complement-mediated lysis of TCR .. cells. 
Therefore. the correlated marker CDS was used as a target of cytol-
ysis Instead. For cos ~cow cells. CG-16 ascites was added In the second 
and third rounds of elimination. at l / 20 final dilution . The high 
concentration s necessary for this antibody did show some Interfer-
ence with the efficacy of antt-CD4 kJIIing. All populations were 
depleted of dead ceJls by centrifugation over a Flcoll-metr1zoate 
cushion after each round of eltmtnatlon. The enure procedure took 
about 8 h and resulted In cells of high viabtltty and responsiveness. 
Samples were taken and stained for flow cytometrlc analysts tm-
4 Abbreviations used in this paper: DN. double negative (CD4-CD8-) 
thymocyte: TPA. 12-0-tetradecanoyl phorbol 13-acetate: MTT. 3-(4.5-
dtmethylthtazol-2-yl)-2.5-dtphenyltetrazollum bromide. 
mediately. We have noted that slight variations in the densities of 
different Ftcoll-melrtzoate preparations result In variable recovery 
of small. nondiViding DN cells. which may Include many of the TCR". 
IL-1-tndependenl IL-2 producers. 
Enriched splenic T cell populations were prepared as described by 
Julius et al. (15). Brteny. after RBC lysis In Tris-buffered ammonium 
chloride (0.16 M). splenocyte cell suspensions In PBS/5% FCS/ 10 
mM HE PES (pH 7 .0). at a concentration of I to 5 x 108 viable cells 
in 2 ml medium. were loaded Onto nylon wool columns with warm 
medium (37°C). These columns (scrubbed n y lon wool fibers obtained 
from Cellular Products. Inc .. Buffalo. NY) had previously been 
washed and equilibrated overnight with the medium described above 
in a 37°C humidified Incubator. Columns were sealed with parafllm 
and left for 1 hat 37°C. Nonadherent cells were then s lowly washed 
from the columns with warm medium. Dead cells were depleted by 
centrifugation over a Ftcoll-metrtzoate cushion. This procedure re-
sulted in cells >95% viable. as determined by eosin exclusion. that 
were >93% Thy-1.2 .. as determined by flow cytometr1c analysis (data 
not shown). 
Radiation chlmeras. Boot: marrow cells were obtained by flushing 
tibiae and femora of four to five B6.PL-Thy-l.I /Cy mice with RPMI 
1640 containing 0.25% BSA. 1 mM HEPES + 5 "g/ml DNAse . Cells 
were treated with l/10 anti·Thyl h ybridoma supernatant T24/3 1.7 
and lysed wtth 1/25 C to clear bone marrow of c ircula ting T cells . 
Dead cells were removed by centrifugation over FlcolJ-metrtzoate. 
Bone marrow cells wen.~ washed twice with RPMI 1640 containing 
10 mM HEPES and 0.25% BSA before resuspending In PBS for t.v. 
tall Injection Into 25 to 35 C57BL/ 61ethally Irradiated (900 rad) mice. 
at 1 x 107 bone marrow cells/ mouse. 
Thymuses were harvested along a time course varying from 10 to 
35 days postinjectton. In all cases host Thy-1.2 thymocytes were 
twice eliminated by addition of anti-Thy-1.2 (H013-4) hybridoma 
ascites at l/10.000 dilution and Cat 1/25 dilution. Dead cells were 
removed as described above between each round of elimination. 
Thymocytes wtth and w1thout eltmtnation were analyzed by flow 
cytometry as described above. Thy-1.2 eliminated thymocytes were 
stimulated with A23187 and TPA and cultured for 20 h with and 
without IL-l as descrtbed below and supernatants assayed for IL-2 
production. 
Culture condttfons. Cells were cultured for 5 to 20 h tn RPMJ 
1640 medium (Irvine Scientific. Santa Ana. CA) supplemented with 
10% (v/v) FCS (Hyclone. Sterile Systems. Logan. UT). 50 "M 2-ME. 2 
mM L-glutamlne. I 00 U/ ml penicillin. and I 00 ,.g/ml streptomycin 
(- complete medium). with or without 50 U/ ml r!L·l and other 
additives as Indicated. TPA (17 nM. 10 ng/ml) and A23187 (70 nM) 
were diluted freshly from stocks tn Me2SO at the Initiation of the 
cultures. The final concentration of diluent. 0.11% Me2SO. gave no 
detectable effects alone. 
IL-2 bioassay. Supernatants from stimulated cells were collected 
ster1lely and stored at -70°C until assay. To detect JL~2 activity. a 
subllne of CTLL-2 cells ( 16} was used In a modtftcatton of the 
colorimetric cell viability assay described by Dentzot and Lang ( 17). 
which was originally developed by Mosmann (18). Before the assay 
CTLL-2 cells were grown to a density of 3 x 1 o~ cells/ml In complete 
m edium containing 19 U/ml of IL~2. The medium used for the assay 
consists of phenol red-free RPM! 1640. 5% (v/v) FBS. 50 "M 2-ME. 
2 mM L·glutamlne. I 00 U/ ml penicillin and I 00 ,.g!ml streptomycin. 
The cells were harvested and resuspended In the phenol red-free 
RPM! 1640 medium to a density of I x I o• cells/ mi. Doubling 
dilutions of the test samples were prepared to final volumes of 50 "'I 
In the wells of 96-well. flat bottom mtcrotlter plates (Coming 25860. 
Corning. NY) using the assay medium as diluent. To each well 50 "'I 
of CTLL-2 cells were then added. After 36 h of Incubation at 37"C. 
20 "I of MTT. prepared as a 5 mg/ml stock In PBS. was added . The 
plates were incubated for 3 hat 37°C. Next, 100 ~AI of Isopropanol 
were added to each weU and mixed vigorously to ensure the solubil-
Ization of the blue formazan product. The OD of each well was 
measured within the next 2 h by ustng a Molecular Devices (Palo 
Alto. CA) v_ Kinetic Microplate Reader with a 590 nm test wave-
length and a 650 nm reference wavelength. 
In each assay. an activity standard was Included for purposes of 
comparison between assays. The standard. a single preparation of 
conditioned medium from EL4.E1cells treated wtth phorbol ester. 
routinely gave 30% maximal stimulation {defined as 1 U/ ml here) at 
dilutions from l /500to 1/ 1100 In different assays. This corresponds 
to a titer of 300 standard U/ ml by comparison with a 200 U/ml 
commercial source of murine riL~2 (Genzyme). The titers reported In 
Table 1 are raw assay units. not converted to commercial units. to 
emphasize the difference between acuvtties seen and the threshold 
of detection. The minimum level of IL-2 detectable in a given assay 
ls0.5 U/ml. 
In sHu hybrtdt.zatfon analysts oJ IL-2 RNA. cRNA transcrtpts 
from the 3' half of the IL-2 mRNA were prepared essentially as 
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previously described (I I. 14}. except that I""S(UTP (850 el/ mM. 
Amersham) was used carrier-free at 17.5 to 19 #'MIn place of (3 HJ 
UTP and I3HJATP. Premeasured amounts of probe were subjected to 
limited hydrolysis for I 0 min on Ice In 0. I N NaOH before being used 
for hybridization to cell samples. 
The protocol for cell fixation and hybridiZation was modified tn 
several ways from our previous methods ( 11. 14. 19). 1 J Cells were 
centrifuged onto sltdes alive before ftxatton. at 1500 rpm at 25°C. 
They were not extensively washed to remove protein . This promoted 
better adhesion and quantitative cell recovery on sltdes. 2) Cel1s were 
fixed on slides with cold 4 % paraformaldehyde In PBS. for 1.5 to 2 
mtn. and then stored at 4°C In 70% ethanol. This gave lower back-
grounds and much higher signals than fixation wilh glutaraldehyde. 
3) The proteinase K digestion step was omitted. as It reduced reten-
tion of RNA In these lightly fixed cells. 4} Rehydrated slides were 
acetylated In 0.25% (v/v) acetic anhydride In 0.1 M triethanolamine 
(pH 8}. then washed In 2 X sse (I x SSe- 0.15 M Nael. 0 .015 M 
Na3 citrate) and soaked for 30 min In 0. I M Tris. 0. I M glycine (pH 
7 .0). 5) To block reactive sulfhydryl groups on the slides. the slides 
were washed In 2 x sse with I 'iC (v/v} 2-ME. then prehybridlzed for 
I to 3 h at 42•e In 50% formamlde. 0.9 M Nael. 20 mM 2-IN-
morphollno(ethanesulfonlc acid (pH 5.8}. I mM EDTA. I % 2-ME. 
and 2x Denhardt's solution (l X Denhardt's = 0.02% BSA. 0.02% 
polyvinylpyrrolidone. 0.02% Flcoll). They were not dehydrated at 
any Ume before adding the probe. Prehybrtdization resulted tn 
stronger signals and no Increase In background. compared with 
slides to which probe was added when dry. 6) Hybridization buffers 
contained 50 mM dlthlothreltol and 0.8% (v/ v} 2-ME. The pH of the 
hybridization buffer (I I J was adjusted lo 5.8 by addition of 50 mM 
2-(N-morphollno}ethanesulfonlc acid (pH 5.8}. The probe was dena-
tured at 80 to 85°C In hybridization buffer Immediate ly before load-
Ing on slides. 7} Hybridization proceeded for 3 to 6 hat 42 to 45•e. 
To minimize background. further processing was carried out Imme-
diately. 8} Buffer for soaking off the cover slips after hybridization 
(4 x SSC} and the RNase digestion buffer (0.5 M Nael. 10 mM Tris, 
I mM EDTA. with 20 ..g/ml boiled pancreatic RNase A) were not 
supplemented wtth 2PME. to avoid Interfering wtth the RNase . How-
ever. all subsequent washes 1) Included 1% (v/ v) 2-ME. The final 
wash. o. I x sse at 45•e (30 min}. was supplemented with 0. I % (v/ 
v) 2-ME. 9) To assure efficient detection of the energetic 3!:.5-tJ-
emlsstons over the tops of the cells. a thick emulsion was prepared 
w1th two pans Kodak NTB-2 emulsion (Eastman Kodak. Rochester. 
NY} to one part 0.9 M NH. acetate In distilled water. I OJ Slides were 
developed after 5 to 10 days Instead of after 4 to 18 wk . 
Data analysls. No positive cells were detected In any sample 
cultured without stimulation . This background. with the ~antisense'" 
probe. was always lower than the background with a negative control 
·sense· probe. which yielded 0 to 1% of cells with over 5 but less 
than 10 grains on stimulated and unstimulated cells alike. 
The use of "S-Iabeled probes resulted In stgntficantly higher 
backgrounds than with 3 H probes. This was partly due to the long 
path length of "S emissions rather than from nonspecific sUcking. 
because unstimulated cells or populations with few responders 
showed backgrounds almost as low as those with 3H probes (i.e .. the 
majority of cells had no grains over them). By contrast. samples wtth 
many high level JL-2 producers (e.g .. Immature populations stimu-
lated In the presence of IL- I) had regions with high numbers of 
grains In the emulsion between cells. In these cases. grain counts of 
I to 5 grains per cell often did not represent a concentration of 
radioacttvtty slgntftcantJy higher than In the Intercellular spaces. 
Figure 3 shows typical examples. To mtntmtze the counting of false 
JX>Sittves. we therefore adopted a stringent cutoff for posiUvtty (~8 
grains/cell. ;,:10 grains/cell on highly expanded blast cells). and 
excluded from the analysts cells located close to high level IL·2 
prOOucers (>30 grains/ cell) unless they clearly constituted a second. 
comparably Intense center of hybridization . In practice. this led to 
the exclusion of about 2 to 4% of cells from the tally. To equaltze 
vartattons In probe diffusion on the slides. counts were taken from 
at least 12 different fields photographed from randomly distributed 
regions over a cell sample. To allow low frequencies of postttve cells 
to be enumerated without observer btas. cell densities were set such 
that an average of 50 cells cou ld be scored In each photographic 
field . Thus. e.g .. with 2 % responding cells. only about one field In 
three would lack positive cells altogether. Grain counts were made 
on phase-contrast pictures (e.g . . Fig. 2) tn which Individual grains 
were better defined than In darkfleld photographs. Grain counts 
represent grains wtthln or touching the cell border, and do n ot 
Include the significant number of trailing grains surrounding many 
of the cells with >30 grains . 
RNase protection assayjor IL·2 transcripts. To quantitate levels 
of JL-2 transcripts. the 5 ' probe pJY. I. described In McGuire et al. 
(I 4} and Rothenberg eta!. (I 9). was used. RNA from stimulated cells 
was extracted. hybridized . and analyzed In a modification of the 
method of Melton et al. (20}. as previously described (14 ). After 
hybridization. the samples were digested with RNase . resolved in a 
denaturing 20% polyacrylamide gel. and exposed to x-ray film (Kodak 
XAR-5) wtth an intensifying screen at -70°C. In some experiments. 
radiation was quantitated directly with a planar tJ-counter developed 
by R. Britten and E. H. Davidson. The number of protected copies of 
IL·2 mRNA per average cell was calculated as follows : 
I 
cpm prcttected (planar) 
Average copy • cell - 11 of cell equivalents x 
(planar counter conversion factor) x 1 protected copy 
(dpm/ ng probe) 5.5 x 10-"ng 
The probe specific activity (dpm/ ng probe} was calculated from 
the known specific activity of the nucleotide precursors. The planar 
counter conversion factor (dpm/cpm(planar)) was measured empiri-
cally by loading a known amount of radloacttvtty as undigested probe 
In one lane of the analytical gel. then scanning the band with the 
planar counter. This method corrects not only for the geometry of 
radloacttvtty detection by the planar counter but also for general 
recovery during electrophoresis. 
RESULTS 
Effect of IL-l on IL-2 secretion by DN cells. Our stand-
ard conditions of stimulation wtth A23187 and TPA were 
chosen to provide the cytoplasmic slgnaltng Intermedi-
ates that would normally be generated during TCR Inter-
actions with Ag. but In a manner Independent of TCR 
(21). Dosages of A23187 and TPA that were optimal for 
IL-2 production from mature thymocytes were also opti-
mal for IL-2 production from ON cells tn our hands (10) 
(data not shown). However. several reports tndtcated that 
IL-l could further potentiate IL-2 production from DN 
cells (22. 23). Table I reports the IL-2 activity titers In-
duced In three Independent experiments (representative 
of over stx) with and without 50 U/ml of recombinant-
derived human IL-l a (IL-l). In all cases. the addition of 
IL-l eltctted htgh titers of IL-2 from the DN population. 
The degree of enhancement over levels Induced without 
IL- l depended on the purity of the starting population. 
because low levels of CD4• cell contamination often led 
to Increased IL-2 production In the absence of IL-l (see 
below, and data not shown). Notably, IL-l dtd not en-
hance IL-2 production from mature cells tn response to 
A23187 and TPA. For example, In all experiments with 
spleen cells or purified splenic T cells (Expts. 2 and 3) 
(24) (data not shown). tn each case the cells made vir-
tually lndtsttngutshable responses with and without IL-
l. The effect of IL-l on mature cells from total thymus 
and spleen will be discussed further below. 
To ensure that the growth factor activity enhanced by 
IL-l was due to IL-2, and not to some other lymphoklne, 
control experiments were carried out as Indicated tn Fig-
ure 1. These data show that our IL-2 Indicator cells fat! 
to respond to IL-l Itself or to the alternative T cell growth 
factor IL-4. alone or tn combination, and that neither 
IL-l nor IL-4 gtves a synergistic effect wtth IL-2 (data not 
shown). Thus it ts most ltkely that thts biologic assay 
measures IL-2 selectively, and the effect of IL- l ts Indeed 
to Increase production of IL-2 by the Induced cell popu-
lations. 
IL- l permits TCR- cells to participate In IL-2 produc-
tion. We reported previously that lndlvtdual-cell accu-
mulations of IL-2 RNA In DN cells activated with A23187 
and TPA alone were lower than those achieved In mature 
T cells (II. 19. 24). Thus, IL-l might either ampltfy the 
potential for IL-2 RNA accumulation In conventionally 
Inducible DN cells, or it might allow the recruitment of 
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TABLE I 
E1fecc q( IL· l on JL -2 produc tion by immature T lineage cells 
Tim~ or 
C~lls P('rcf!nt P('rC('nt IL·2 BiologiC' 
Expl S timulation Sam piC' 
(XIO-./ml) ON CD4 .. ., Acth·Uy'" 
Jhr 
16.7 ON. no IL - 1 3.0 98.5 < I 22 
DN. + I L- l 3.0 243 
2 20 cos- ON. no IL- 1 3.0 94 6 .0 2 6 
CDS- ON. +IL-l 3.0 333 
ON. no IL-l 3.0 95.5 4 .5 32 
ON. +IL-l 3.0 243 
Spleen ... no IL-l 4.0 < I 17 384 
Spleen ... + IL-l 4.0 332 
3 20 Splenic T cells. 
purified, 
no IL- l 5 .0 54 614 
+IL- l 5.0 717 
"Cells stimulated with A23187 and TPA. Human riL· ln added to 50 U/ml where indicated. 
".Percent CD4* =percent CD4", cos- as determined by two-color flow cytometry. 
""Untts/ml of IL-2 activity determined by colorimetric growth (MTT) assay with CTLL-2 cells. One unit/ mils here defined 
as giving 30o/c maximal stimulation. as described In Materials and Methods. This activity corresponds to 0 .33 to 0.53 U/ 
mltn standard commercial units. In different assays. 
d Spleen cel ls were 17% Co4·. 8 % cos·, and 29.4 % CD3. ( 18.8 Cfr CD3-bright). 
"In several expt-r iments. IL-l addition appt'ared to decrease the frequency of IL-2 producers In spleen by 20 h (Fig. 4). 
This dfect was not seen at the level of IL-2 RNA In purified T cells. nor in the yield of supt'rn atant IL-2 activity. It seems 
likely to rdlect prderentially augmented surviva l of 8 cells under these conditions. 
11 . 4 
a 
l·~· 
l • .. 
-........ 11.11 
b 
11 . 4 
I ~ 0 0 11 . 11 
1 5 
log of rll2 OtiLitton 
c 
8.4 
l ~ ~ 0 0 .. 
1 2 3 • 5 
Log of rll4 O.utton 
Ffgure 1. The IL-2 bioassay Is Insensitive to IL· 4 and unaffected by 
IL· l . The panels show growth factor activity tltratlons on CTLL-2 tndl· 
cator cells. measured by the colorimetric MTT assay as described in 
Materials and Methods. The A1180 value Is proportional to the number of 
mltochondrtalty active cells. Panel a shows the titration curve of our 
assay standard rP14w), an IL·2·contalnlng supernatant from TPA·In-
duced EL4 .El cells. Panel b shows the titration of murine riL-2. 10.000 
U/ ml before dilution (t.e .. 50 U/ ml during culture In the most concentrated 
sample). Panel c shows the titration of murtne rll..-4. 20.000 U/ml before 
dilution (I.e., 100 U/ml during culture In most concentrated sample). Soltd 
lfnes (open triangles) show data with the Indicated growth factors alone. 
Broken ltnes [/Wed trtangles) show data obtained when the first dilution 
was supplemented with IL-l to a final concentration of 12.5 U/ml. This 
ts the Uter that would be present In the most concentrated samples when 
assaying culture supt'matants supplemented with 50 U/ ml of IL·l. In 
other experiments. IL-l also failed to affect the assay when added t o the 
same final concentration to all dilutions of IL-2 or 11..-4. Furthermore. tl..-
2 failed to synerglZe with IL·4 In the presence or absence of 11..· 1. 
new IL-2 producers altogether. 
Although ON cells represent only 2 to 5 % of all thy-
mocytes. they are heterogeneous tn surface phenotype 
and developmental potential. About 10 to 15% of them 
express TCR and may therefore be relatively mature. To 
test whether Immature thymocytes could express IL-2. 
we utilized two approaches. Ftrst. we sorted ON cells 
directly for expression of any C03-assoclated TCR struc-
ture. preparing TCR• and TCR- fractions. To avoid per-
turbing cellular responsiveness. antt-C03 staining and 
sorting were carried out after stimulation. The second 
approach was based on negative selection before stimu-
lation. thus rigorously defining the phenotype of the In-
put cells before Incubation with A23187 and TPA. To 
avoid artifactual modulation of the TCR. we used anti-
bodies against the marker C05. which ls expressed at 
high levels on TCR• ON cells but at low levels on most or 
all TCR- ON cells. It ts the TCR- ON cells which include 
essentially all the Immature precursors with the capacity 
to repopulate the thymus (25. 26). Therefore. C05'ow ON 
cells were Isolated by antibody-dependent C elimination. 
sampled for analytical staining to verify lack of C03/TCR 
expression. and then tested for their responses to stim-
ulation with the Ca2 • lonophore A23187 and the phorbol 
ester TPA. as previously described ( 10. 11. 19). In situ 
hybridization was used to quantitate the frequency of 
cells wtth IL-2 mRNA at the indicated Urnes after stimu-
lation. 
In the first approach. we activated highly purified ON 
cells (Table I. Ex pt. 1) with and without IL-l. Incubated 
them for 17 h tn culture. and then sorted them prepara-
tively Into TCR• and TCR- fractions. These fractions 
were then analyzed for JL-2 RNA by ln situ hybridization. 
as summarized ln Table II. The results were strikingly 
different for the two populations. After stimulation with 
A23187 and TPA alone. the TcR· fraction clearly In-
cluded cells with IL-2 RNA. but the TCR- cells had essen-
tially failed to respond. with <0.5% expressing detectable 
IL-2 RNA. In parallel experiments. when TCR• cells were 
depleted from ON populations prior to culture by cytolysis 
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TABLE II 
Recr-uitment of IL -2 -tnductble cells by IL- l In TCR- DN cells tsolated by sorting after 17 h of sttmulaelon 
f"lrsl HybrldiUUion Second Hybrldlz.atlon 
~II Populallon• 
'Jl, >5 grains % >5 grains 
TCR•b no IL- l 7.1 239 NO 
TCR"'b + IL·l 8 .6 255 NO 
TCR-c- no IL-l 0 .26 385 0.39 768 
TCR-.. +IL- l 2.4 419 1.2 750 
• C~lls were Stimulated with A23187 and TPA for 16 h 45 min In the presence or absence of IL-l (Table I. Expt. I). Cells 
were then stained with anti-C03 and sorted to separate C03" (TCR") cells from CD3- (TCR- 1 cells. In the unsorted 
populallons. cells were 98.5% ON . The percentage of cells JCR"- after stimulation was about I I % for the samples 
stimula ted +IL-l and about 9% for the sample without IL- l. Thus. IL· I did not cause artlfactual collection of previously 
TCR" cells tn the TCR- fraction. 
"The brightest 14.5 to 16':r of the cells. The window Intentionally Included marginal and TCR- cells. to collect any 
cells that may have undergone TCR modulation. Resulting populations were 79.6 % TCR .. (no IL·l) and 90.2% TCR .. (+IL· 
I). 
c The dimmest 42 tt- of the cells. The window excludes many of the blast cells. probably T CR- f J 3). whose autofluores-
cence allows them to approach the brightness of the dimmest TCR .. cells. Resulting populations were <1 % TCR" In each 
case 
with anti-CD5 and C. the remaining cells failed to make 
IL-2 under these conditions (data not shown. and see 
below). However. the sorted. TCR- population stimulated 
with the addition of IL-l showed an appreciable fre-
quency of positive cells. some with high grain counts. 
These seemed unlikely to r epresent TCR· contaminants 
for two reasons. First. In the TCR·-sorted fractions. IL-l 
addition had caused no significant enhancement. either 
In frequency of positive cells or In grain counts per posi-
tive cell (Table II). Second. only a minority of the TCR. 
fraction expressed IL-2 RNA In either case. so that the 
number of TCR· cells that might remain In the TCR-
fractlon (<I % based on flow cytometry) Is likely to be 
quantitatively Insufficient to account for the IL-2 ex-
pressing cells there (-2%). A third possibility. that the 
TCR- IL-2 producers simply modulated their TCR In re-
sponse to stimulation. Is ruled out by the confirmatory 
results using CDS elimination (see below). Thus IL-l ap-
pears to allow Immature TCR" ON cells to participate In 
IL-2 production. 
Accelerated kinetics of IL-l-dependent IL-2 Induction 
In TCR- cells. The Increase In IL-2 RNA elicited by IL-l 
at 16 to 20 h (Table II and data not shown) was too modest 
to account for the dramatic enhancement of IL-2 secre-
tion reported In Table I. It was possible. therefore. that 
IL-2 RNA might be synthesized early In response to stim-
ulation with IL- l. translated, and then rapidly degraded. 
IL-2 RNA Is highly unstable. and although It appears to 
accumulate In splenic CD4. and cos· cells and ON thy-
mocytes under our standard conditions of stimulation 
(II. 14). It may exhibit sharp transients of production 
and decay under various other conditions (27-30). Alter-
natively. an Important population of IL-l responsive cells 
may have been missed In the analysis shown In Table II. 
since the most highly activated blasts were autofluores-
cent and excluded to preserve the purity of the TCR" 
fraction (data not shown). To sample the full TCR- ON 
population. therefore. we u sed depletion with anti-COS 
and C and analyzed the appearance of cells with IL-2 
RNA after S h or 18 to 20 h of stimulation. Results of two 
experiments are presented In Figures 2 to 4 and Table lll. 
Figures 2 and 3 show that although TCR" ON cells do 
not accumulate IL-2 RNA after S h of stimulation without 
IL-l. about I 0% of them do show a dramatic accumula-
tion of IL-2 RNA to high levels at this time If IL-l Is 
Included. The grain counts In these cells at S h signifi-
cantly exceed those In responding splenic T cells at the 
same time. with or without IL-l (Fig. 4: Table Ill). They 
are comparable to the grain counts In splenic T cells at 
20 h of stimulation. when the mature cells contain an 
average of SOO to 800 copies of IL-2 mRNA per cell ( 14, 
24). Thus. If IL-l Is provided. the Immature cells make 
an accelerated response relative to mature cells. and not 
a delayed response that might be Indicative of a require-
ment for some In vitro maturation event. Rough time 
courses for RNA accumulation. based on grain counts. 
are shown schematically In Figure 4. Note that, by 20 h 
of Incubation. the Immature IL-2 producers have lost 
most or all of their detectable IL-2 RNA. many of them 
now scoring as RNA-negative. whereas mature cells. with 
or without IL-l. continue to accumulate IL-2 transcripts. 
The TCR- IL-2 producers thus differ from mature IL-2 
producers both In their profound requirement for IL-l as 
a costimulus. and In their explosive accumulation and 
swift loss of the IL-2 transcripts they synthesize under 
these conditions. 
Subpopulatlon specificity of the IL-l-dependent re-
sponse. Depletion of TCR• cells, Including co4• contam-
Inants, Is not always complete by using complement-
mediated lysis. Comparison of the frequency of respond-
Ing cells with the frequency of these contaminants. how-
ever. excludes the possibility that the IL-l dependent 
responders are drawn exclusively from TCR· subsets. In 
three Independent experiments (Table III, Fig. 4, and data 
not shown). the frequency of ·cos-· cells making IL-2 
RNA In response to IL-l (S-h point) clearly exceeded the 
frequency of TCR• contaminants as determined by sur-
face expression of the TCR-IInked CD3 complex at the 
start of culture (Fig. 4). This Is most readily seen In the 
case of Table III, where the cos'•w cells were 97% TCR". 
but In all three cases the number of IL-2 producers was 
greater than the number of all TCR• cells by a constant 
Increment of 7 to 8% of the population. At these brief 
times of stimulation, Input ON cells are recovered with 
>90% viability (with or without IL-l) and do not undergo 
significant population shifts. Therefore. the majority of 
the IL-l-dependent IL-2 producers could not be accounted 
for by cells expressing any CD3-IInked TCR structure. 
These data do not exclude the possibility that some 
TCR• cells are also IL-l dependent. The TCR• contami-
nants represent two distinct populations: co4• cells sur-
viving lysis. and a subset of ON cells. Most CD4 • cells are 
unlikely to require IL-l under these conditions. because 
they respond In the absence of IL-l (19). and because we 
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Figure 2. Rapid accumulation of IL-2 
RNA In Immature c~lls stlmulat~d with IL-
l. The panels show phase-contrast fields of 
CD510- ON cells h ybridized with the anti· 
sense JL-2 probe b(ofore stimulation (ldtj or 
after 5 h of stimulation in the presence of 
IL-l (rtght). The panels shown are repre-
sent.atlve of photographs from which grain 
counts were made. Note the absence of la-
belt"d cells before stimulation. At 5 h. cells 
with > 15 grains are Indicated wtth whtte 
arrows 
I 
CD• CDS I 
cos·'· ~ THYMUS 
l 
NO ll·1 + ll·l 
:~~::·; -~·:~:: <5"~ ·:~:..·_:  _. 
;i~;F·~· 
~:,:s-~~-
Figure 3. High level Induction of JL-2 tn Immature cells dependent upon costlmulatlon with IL-l. Data are from 5 h of sumulaUon of the Indicated 
populations. as documented In Table III. The upper slx panels show representative Clelds of cos- ON cells. from cultures stimulated without IL-l 
(lejl) or w ith IL-l (rfghl) as Indicated. The lower jour panels show corresponding fields from spleen cells at the same ume points. with IL- l absent 
(left) or present (rtght) as Indicated. 
have shown previously that they are responsible for most 
of the IL-2 production f rom "mature" thymocytes. which 
Is unaffected by IL·l (24) (data not shown). However. 
because of the sharp transience of the IL-l effect on 
mRNA expression, we reexamined CD4 • cell responses to 
IL-l at an early time point. Figure 5 shows the levels of 
IL-2 RNA accumulated by total thymocytes and by a 
population comprising roughly equal numbers of CD4. 
thymocytes and DN cells. after 5 h of stimulation In the 
presence and absence of IL·l. Neither Is responsive to 
the presence of IL-l. The presence of the CD4. cells 
almost completely obscures the effect of IL·l on IL-2 RNA 
expression In the accompanying DN cells (cf. lanes 5 and 
6). resulting tn abundant but a lmost Indistingu ishable 
levels of IL-2 RNA In the presence or absence of IL- l. In 
lanes 3 and 4, both CD4. and DN cells are dtluted with a 
5· to I O-f old excess of cortical CD4 ·cos· thymocytes, 
many of them TCR• b u t u nresponsive under conven-
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Figure 4. Th~ IL-1-d~pendent Immature cell response shows acceler· 
ated kinetics both In cell partiCipation and in accumulation of RNA by 
Individual cells. In A (lej r-hand panels} are shown the percentages of 
cells positive for IL-2 RNA (>7 grains associated) as a function of time or 
stimulation In the samples descrt~d In Table 1. expt>rlment 2 . Dark bars 
represent samples stimulated without IL- l . and open bars sample s with 
IL- l . The figure graphically compares the maximum freque ncy of IL-2 
RNA-positive cells In the cos- ON population (lop) wtth the measured 
lev~ls of contamination of this sampl~ by two subs~ts of CD3 .. c~lls. Th~ 
dash~d lin~ (·· - -·I shows th~ fraction of th~ cells that Is C04*, and 
(- ·-) lndtcat~s th~ calculated fraction that Is CD3 ... (TCR*) but CD4- and 
Cos-. I.e .. TCR* ON. For compar1son. the J~vels of CD3"' and CD4• 
contamlnantsar~ Indicated similarly forth~ total ON population (middle). 
Note that th~ IL- l-dependent respons~ at 5 h does not Increase with the 
level of CD3* cells {cf. cop and middle panels). Note the slower kinetics 
of cellular response In the mature cells of the spleen (boctom). For 
discussion of the effect of IL-l on this population. see Table I. nore e . In 
B (right-hand panels). the kinetics of RNA accumulation In Individual 
cells are Indicated by plotting the f raction of the ·positive- cells In each 
population that have high RNA levels (>30 grains). Note that while those 
cells able to respond without IL-l In all populations show a progressive 
Increase tn high grain-count cells between 5 and 20 h (solid bars). the 
IL· l -dcpcndent lL-2 produc~rs In Immature populations hav~ already 
achieved these high levels of RNA In a maximal fraction of cells at only 5 
h (open bars). These results have been confirmed In thrtt lndepcnd~nt 
experiments. 
tiona! stimulation conditions ( 13. 19). Comparison of 
lanes 3 and 4 Indicates that this enigmatic population Is 
also probably unresponsive in the presence of IL-l . Thus. 
neither CD4 • contaminants nor other major thymocyte 
subsets appear likely to contribute to the IL- l-dependent 
IL-2 expression seen In TCR- DN cells. 
Although residual TcR• DN cells could not account for 
the magnitude of the transient IL-l-dependent response. 
we considered that they might participate In it. since 
their properties are less fully characterized. As noted 
above. most of them do not accumulate IL-2 RNA like 
mature cells over 17 h of Incubation (Table II). However. 
the "DN" populations analyzed In Table Ill and Figure 4 
contained about three times as many TCR• DN cells as 
the corresponding "CDS'"""" populations. and yet con-
tained no higher frequencies of IL-l-dependent IL-2 pro-
ducers than the CDS'" .. cells. when assayed at S h. Thus. 
It Is unlikely that a major fraction of the TCR• DN cells 
contribute to the IL-l-dependent response. although It 
cannot be excluded that a minority of these cells are also 
IL-l dependent. 
In summary. In the presence of A23187 and TPA. we 
were consistently unable to detect any enhancement of 
IL-2 production. or any shift to more rapid kinetics of IL-
2 expression. when IL-l wM added to mature (TCR· ) T 
cells from thymus or spleen. The results In Table III and 
Figure 4 and those of three other independent experi-
ments (data not shown) (24) gave indistinguishable titers 
of secreted IL-2 and indistinguishable levels of IL-2 RNA 
In splenocytes. whether stimulated in the presence or 
absence of IL-l. analyzed either at S to 6 h or at 18 to 20 
h of treatment. This was the case whether unfractionated 
splenocytes or purified splenic T cells were assayed. and 
whether they were stimulated under conditions which 
favored IL-2 expression from CD4• cells only or condi-
tions tn which both CD4. and cos· cells respond (14. 
24). At the opposite extreme. even In our ·cos•··· DN" 
populations where most IL-2 producers required exoge-
nous IL-l. the presence of as few as 4 to 6 % cells of 
mature phenotype always resulted in the appearance of 
2 to 3 % of cells making maximal levels of IL-2 In the 
absence of IL-l . Such contaminants also showed the slow 
Induction kinetics typical of mature splenic IL-2 produc-
ers (Fig. 4). Isolated mature subsets of thymocytes and 
the total thymocyte populations whose response they 
dominate consistently showed no IL-l effect (Fig. S) (24) 
(data not shown). The similar responses of cells of mature 
phenotype regardless of context. whether highly puri-
fied or Incubated in the presence of splenic non-T cells. 
of Inert cortical thymocytes. or of non lymphoid elements 
In the DN thymocyte population. Indicate that IL-l Inde-
pendence Is not a result of the presence of particular 
accessory cell populations. Rather. It appears that In the 
mature T cells themselves. any signals required for IL-2 
Induction that IL-l might supply are already provided by 
the combination of A23187 and TPA. 
Maturation and IL- l independence. The TCR- DN 
cells that do respond to IL-l clearly differ from mature T 
cells. It was formally possible. however. that lack of TCR 
expression in their case might not be a sign of Immatu-
rity. but rather of failure to make In-frame TCR gene 
rearrangements. or of differentiation along some alter-
native maturation pathway. To test whether IL-l depend-
ence was associated with Immaturity per se. we deter-
mined the kinetics of appearance of IL-l-dependent and 
IL-l-Independent IL-2 producers durtng the repopulation 
of thymus glands by donor cells In radiation chimeras. 
B6 (Thy-1.2) mice were lethally Irradiated and reconsti-
tuted with congenlc B6.PL-Thy-1.1 T -depleted bone mar-
row cells. At various Intervals afterward. the animals 
were sacrificed, donor-type cells Isolated from the thymus 
by cytolysis with anti-Thy-1.2 and C. and the resulting 
populations stimulated for IL-2 production In the pres-
ence or absence of IL-l . 
Table IV shows that the Thy-1- (T cell depleted) bone 
marrow cells used as donors could not secrete detectable 
IL-2. with or without IL-l. Upon arrival and expansion In 
the recipient thymus. however. the earliest IL-2 produc-
ers to arise were highly IL-l dependent. Similar results 
were obtained In two to five experiments with different 
ttme points. to be described In more detail elsewhere (data 
not shown) (R. A. Diamond. D. Chen. and E. V. Rothen-
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TABLE Ill 
IL- 1 enhances /L-2 RNA expression In Immature cells ar early times of stimulation 
Ttmeor Prr- OvC'rall Prrcent 
Overall Percent Overall Percent 
Stimulation Sample e<nt Positive for IL-2 
>15 Grains., >30Gratns• 
(h) co3- RNA., 
0 DW 7.5 622 <0.16 0 0 
Spleend 25 606 0.17 0 0 
5 CDS..,..... 3.2 
NolL- I 434 1.4 1.2 0.7 
+IL-l 823 IIO.O 8.5 6~ 
ON 7.5 
No IL-l 646 2.2 1.2 0 .8 
+IL-l 844 110.7 8.5 4.51 
Spleen 25 
NolL· I 5 10 9 .4 5.7 2.4 
+IL-l 453 6.8 3.5 1.8 
• Includes both CD4 .. and C03 .. ON cells (and Cos· cells In spleen only}. Compare with the overall percent positive for 
IL-2 RNA In ON and CDS- samples. 
• Positive cells determined by In sllu hybridization with the antisense IL-2 eRN A probe. Positive cells have >7 gratns. 
Samples showing IL-l-dependent enhancement are boxed. To highlight the relative abundance of transcrtpts/cell under 
different conditions. data are also gtven for the subsets of cells with >15. >30 grains. Percentages of these highly labeled 
cells are calculated with respect to the whole cell population. Note that all ceiJs with >30 grains are also Included among 
the ceiJs with >15 grains. which themselves are among the total fraction positive for n .. -2 RNA. 
o: ON cells :sO. 7% CD4 .... CDS undetectable. CD3 expression on 7.5% of ceiJs. 
• Spleen cells were 14.9% C04 .... 7.5% cos·. and 25$(. CD3'" (20% CD3-brighq. 
•cos._. contained 1.4% c04· contaminants. CDS undetectable. CD3 staining was detectable on only 3.2% of the cells. 
Implying that 1.8% were C03• ON. 
berg. In preparation). Only after full reconstitution were 
similar IL-2 tilers elicited with and without IL-l. At the 
earliest time point (day 10). when less than 2% of thy-
mocytes are of donor type, these are predominantly DN 
blasts undergotng exponential expansion. Less than 3 % 
have acquired CD4 or CD8. The great enhancing effect 
of IL-l on the ability of these cells to express IL-2 argues 
strongly that IL-l-dependent responses can be acquired 
early In T cell differentiation. not merely as a conse-
quence of maturation tn a variant lineage. 
DISCUSSION 
This work shows that the ability to express IL-2 upon 
Induction Is acquired relatively early In T cell differentia-
tion. before expression of a cell-surface TCR complex. 
IL-2 !nduc!bll!ty presumably develops as a result of con-
tact with the thymic microenvironment. for It Is not 
detectable In hemopoietic cells generally as found In the 
T cell-depleted bone marrow. However. the requirements 
for Induction of IL-2 In Immature cells are significantly 
different from those In mature thymocytes and periph-
eral T cells. even as measured with the TCR-!ndependent 
pharmacological stimuli of ea•· !onophore and phorbol 
ester. Unlike most mature IL-2 producers. the Immature 
cells utilize a signaling pathway that depends on IL-l 
even In the presence of TPA. It Is not certain that all 
TCR- cells require IL-l absolutely: however. the levels of 
TCR. contamination are always sufficient to account for 
the low responses seen without IL-l. and the TCR- DN 
population may contain cells capable of synthesizing IL-
l endogenously (31, 32). Thus, In spite of the precocoius 
Inducibility of the IL-2 locus In Immature thymocytes. In 
practice IL-2 Is not accessible to the same activating 
stimuli In TCR- as In TcR• cells. This makes It possible 
that changes In signaling pathways may be rate-limiting 
In the differentiation or lineage commitment of Th cells. 
Distinctive signaling requirements. The signaling bio-
chemistry of mature T cell activation has been studied 
Intensively In recent years. and In large part antigen 
binding appears to exert Its effects through the phos-
phoinosltlde breakdown pathway (reviewed In Ref. 21 ). 
ea•• ionophores mimic the rise In Intracellular free Ca2 • 
normally elicited by inositol trisphosphate (and/or other 
Inositol phosphates). whereas phorbol esters can opti-
mally activate protein kinase C in place of diacylglycerol. 
The natural triggers of these signaling events may be 
quite complex. including protein interactions with the 
TCR complex. t he accessory molecules CD4 and CD8. and 
other monomorphic accessory molecules. with possible 
participation of IL-l or IL-6 (33-40). Nevertheless. In 
general. the mixture of A23187 and TPA In vitro elicits 
as least as strong a functional response as the natural 
ligands. IL-l has a controversial status as an IL-2 acti-
vator. An Important assay In Its Initial characterization 
relied on Its synergy with mitogenic lecttns to Induce IL-
2 production from thymoma cells (41-44). Yet recent 
analyses of nonmalignant Th cell lines have Indicated 
that most IL-2 producers apparently lack IL-IR (45. 46). 
except for some relatively rare IL-2 producers in the Cos· 
population (47). In any case. even In those thymomas 
which can respond to IL-l as a costlmulus with TCR-
binding lect!ns. A23187 (or ionomycin) and TPA elicit 
maximal IL-2 production whether IL-l ts present or not 
(48). Although neither A23187 nor TPA precisely mimics 
the effects of IL-l In mature cells (49). the combination 
of these stimuli makes IL-l superfluous. 
Thus. two points are striking about IL-2 Induction In 
the Immature cells described here. One Is the Inability of 
A23187 and TPA to reveal the responsiveness of these 
cells In spite of their proliferation. blastogenesis. and 
high viability when treated with these compounds (12. 
19). The other Is their possibly unique possession of a 
distinct pathway for transducing signals from IL-l that 
can synergtze with the phospho!nosltlde pathway. A re-
cent report described a human thymic lymphoma line 
with similar activation requirements (50). The work pre-
sented here shows that the joint requirement for IL-l 
along with agents mlmlcktng phospholnos!Ude pathway 
mediators Is likely to be a characteristic property of nor-
mal immature cells. 
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Flgure 5. Ribonuclease protection analysts of 11 .. ·2 mRNA from thy· 
mocytcs. either untnduced or Induced In the presence or absence of JL·l. 
Cytoplasmic RNA was Isolated from total thymocytes (lanes 2 to 4) or 
from COS-eliminated (CD4• and ON) thymocytes (lanes 5 and 6) after 5 
h of stimulation In the presence or absence of 11..·1. Total thymocytes 
consist of 12 to 15~ mature cells (CD4 ... or cos·) and only 2 to 5% ON 
cells. wtth an excess of nonresponsive cortical thymocytc:s. The CDS· 
eltmtnated population consists of -60% CD4 • cells and -40% ON cells. 
The populations and their rc:laUvc: yields of IL-2 RNA at 20 to 24 h of 
stimulation arc: described In detail In Rothenberg et al. (19). The RNA was 
hybridized to the 220-nucleotidf' (nt) 32P-la~led pro~ In conditions of 
probe excess. JL-2 RNA Is ddected by Its stoichiometric protection from 
ribonuclease digestion of a 101 -nt fragment. The lanes show hybridiza-
tion with: 1. tRNA as a negative control: 2. total thymocyte RNA. cultured 
without stimulation: 3. total thymocyte RNA. Induced without IL-l: 4. 
tot.al thymocyte RNA. Induced with IL- l : 5, CDS- thymocyte RNA. stim-
ulated without IL-l : 6. Cos- thymocyte RNA. stJmulated with IL- l: and 
7. undigested probe. RNA from 0 .4 to 0 .6 x 107 v1able ce11 equivalents 
was used for each lane. The levels of IL-2 mRNA seen here correspond to 
the following copy numbers per average cell. calculated as described tn 
Materials and Methods : lane 2. < 0. 1: lane 3. 3.0; lane 4 . 3.3: lane 5, 
20: and lane 6. 31 transcripts/ cell. 
Possible developmental significance. It Is uncertain 
how many of the immature cells are competent to make 
this IL-2 Induction response. At 5 h tn the presence of 
IL-l, about 7 to 10% of the cells lacking TCR clearly 
contain IL-2 RNA. This low frequency of identifiable 
responders might define a discrete subpopulation tn the 
process of acquiring functional competence. Alterna-
tively. with the suddenness of IL-2 RNA accumulation 
and destruction in the immature cells, any asynchrony 
could markedly reduce the fraction of cells seen to be 
responding at any given time. Thus. this number repre-
sents a minimum estimate of cells that ultimately partic-
ipate In the response. Furthermore, the extent of any 
particular response. even as integrated over time by 
measurement of secreted IL-2 protein. may still under-
estimate the number of cells potentially able to respond. 
For example. the stimulatory stgnal may not last long 
enough to reach cells that were In refractory cell cycle 
stages at the Initiation of culture. Note that the ON pop-
ulation is enriched for cycling cells. a condition which is 
often associated with a constraint on IL-2 inducibility 
(51-53). Thus. our results leave open the possibility that 
a majority of the TCR" ON cells could express IL-2. Fur-
ther characterization will be required to determine which 
cells In the TCR" population are In fact the IL-l-depend· 
ent IL-2 producers. 
The early appearance of IL-l-dependent IL-2-inductble 
donor-type cells In radiation chimeras repopulated with 
bone marrow supports the interpretation that these cells 
are immature developmental intermediates. By contrast, 
another minor population of ON thymocytes. comprising 
cells that express TCR-all. does not appear for over a 
month in such animals (54). long after "mature" CD4• 
and Cos· thymocytes differentiate. Inducibility of the IL-
2 locus Is acquired In development before appearance of 
mature cell-surface phenotypic markers, including TCR 
complexes (R. A. Diamond. D. Chen, and E. V. Rothen-
berg. manuscript in preparation). Thus. expression of a 
TCR complex, and selection for an "appropriate" class II 
MHC binding specificity. cannot be a prerequisite for 
chromatin accessibility of the IL-2 gene or provision of 
necessary trans-acting transcription factors. 
We may speculate. then, that the IL-l dependent IL-2 
inducible cells may continue their development. rear-
ranging their TCR loci, and randomly acquiring recogni-
tion specificities for class I or class II MHC. Most cells (in 
steady state) that have completed their TCR gene re-
arrangements a re neither IL- l dependent nor IL-l sensi-
tive. when activated In vitro to express IL-2. An attractive 
hypothesis Is. thus. that the IL-l-dependent signaling 
pathway needed to complement the phosphoinos!t!de 
pathway in immature IL-2 Inducible cells might become 
permanently activated In selected mature cells. through 
an Interaction with the thymic stroma, at about the time 
of high level TCR acquisition. Such signal transduction 
alterations. by rendering the phosphotnosttide pathway 
sufficient to Induce IL-2 gene expression. could well be 
vital to the ability of a T cell to express IL-2 in vivo. 
It remains to be proven that the IL-l dependent Imma-
ture cells can serve as precursors of IL- l independent IL-
2 producers. It Is also unknown at what level the IL-l 
stgnal may be Integrated with the ea•· and protein klnase 
C signals, for example. whether exposure to tntrathymic 
IL-l alone (32) may convert a developing T cell to an IL-
l·tndependent state. Several striking implications re-
main. nevertheless. First, the involvement of the phos-
phoinosttide pathway in IL-2 Induction might suggest 
that most of the difference between IL-2 producers and 
non producers would reside in the accessibility of the IL-
2 locus to any activator, since the phosphotnos!Ude path-
way Is virtually ubiquitous in animals. Yet our results 
show that at different stages of development, the same 
gene may require activation through d![ferent induction 
pathways. Second. our results show that the IL-2 locus 
may be open for Induction before TCR specificity ts ac-
quired, and thus before all TCR-dependent fate determi-
nation processes. Thus. the btas toward association of 
IL-2 producer function with class 11-restrtcted TCR spec· 
tflctty may not be established at the level of IL-2 Induct· 
btl!ty per se. Rather. alterations In signal transduction 
pathways may play a central role In the events we per-
ceive as functional lineage commitment. 
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TABLE IV 
JL-1-dependenr /L -2 producers appear before I L · J independent IL-2 producers during rhymic repopulation in 
radcallon c himeras 
IL-2 Acuvtty (U/ml) 
Donor-Type Cells rrom•- Ex~rtmr-nt I Exper1m('nt 2 
-IL·I + IL· l -IL·I + IL-l 
Bone marrow {Thy- 1_)., <0.5 <0.5 <0.5 <0.5 
Thymus. day 1 0" <4 (S}d 58(83)' 
Thymus. day I I" <0.5 16 
Thymus. day 35' 18(27)" 27(26)' 
Thymus. day 34" 54( 109)' 5 1 (2 18)' 
• B6.PL/J·Thy-l . l donor bone marrow cells. treated with a llele-nonspecific anti-Thy· I to d eple te mature T cells. was 
used to reconsHtute 86/ J mice after lethal irradiation . Donor-type cells were recovered by anti-Thy- 1.2 elimination of 
recipient thymocytes . Cu lton~· times for stimulation In each case wer e from 18 to 21 h . 
•Donor marrow. cultured at 5 x 106 / ml (not t ran sferred). 
~ After elimination with anti·Thy-1 .2. cells were cultured at 5 x 1 0°/m l. Thy- 1. 14 cells were 85% pure and constituted 
1 to 2~ of thymocytes. 
• Values In parentheses were from the same cell preparations. b ut cultured at J 0 7 / mi. 
• After elimination with anti·Thy·1.2. cells were cullured at 1 x J 0 8 /ml. Thy-1 . 1 .. cells were 98% pure and con stit uted 
1% of thymocytes. 
J After elimination. cells were cultured at 4 x 1 0 11/ ml. Cells were 98% pure and consti tuted -95'1c: of thymocytes. 
11 From this time point. values In parentheses are from parallel samples cultured with addition of 0.0 1 'iC. anti·IL·2R 
ascites (704) to down-regulate IL-2R expression and prevent adsorptton of IL-2 t o activated cells. 
"After elimination. cells were cultured at 4 x 1 0 8 / ml. Don or-type cells were 98% pure a n d constituted 95% of thymocytes. 
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